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Abstract 
The filamentous fungus Aspergillus fumigatus is capable of causing a range of 
diseases in immunocompromised patients and is responsible for up to 3% of all hospital-
based deaths in the EU.  The yeast Candida albicans induces a range of diseases in 
immunocompromised patients. Caspofungin is a recently introduced antifungal 
compound that has good efficacy against these fungi with minimal side effects. The aim 
of the work presented here was to characterise the response of A. fumigatus and C. 
albicans to caspofungin.  The results obtained demonstrated that caspofungin has potent 
anti-fungal activity and retards fungal growth but that the response of fungi to this drug 
is influenced by a variety of environmental factors (e.g. pH, serum, glucose).   Exposure 
of A. fumigatus hyphae to this drug leads to the release of amino acids and gliotoxin.  
There is also an increase in internal levels of gliotoxin following exposure to the drug.  
Prolonged exposure to caspofungin leads to reduced growth but greatly elevated levels 
of secreted and internal gliotoxin. Since this toxin is highly immunosuppressive it is 
possible that in vivo elevated levels of this toxin may exacerbate the deterioration in the 
patient’s condition following caspofungin therapy.  A. fumigatus hyphae exposed to 
caspofungin demonstrated an increase in the expression of proteins associated with an 
oxidative response (e.g. catalase, antibiotic response protein) and in the activity of 
selected enzymes (catalase, glutathione reductase and superoxide dismutase).  The 
results presented in this thesis demonstrate that caspofungin is a potent antifungal agent 
but that A. fumigatus responds to the drug by increasing the synthesis of gliotoxin and 
by inducing an oxidative stress response.  
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Chapter 1 
1 INTRODUCTION 
 
1.1 Aspergillus fumigatus 
 
Aspergillus fumigatus is a fungus of the genus Aspergillus. A. fumigatus is a 
filamentous fungus producing bluish-green conidia (Figure 1.1), and is one of the most 
common Aspergillus species to cause disease in immunodeficient individuals. A. fumigatus 
is capable of growth at 37 °C (normal human body temperature), but can also grow at 
temperatures up to 50 °C, with conidia surviving up to 70 °C. Aspergillus conidia are 
released into the air from the colony of fungus and can be inhaled into the lungs. 
Aspergillus is a fungus whose spores are present everywhere in the air, but these are not 
normally harmful; typically these are quickly eliminated by the immune system in healthy 
individuals (O'Gorman et al., 2008). However an individual with a weakened immune 
status may be susceptible to Aspergillus infection.  
A. fumigatus is one of the major opportunistic fungal pathogens. It is associated with 
respiratory disorders such as hypersensitivity, allergic asthma, bronchopulmonary 
aspergillosis allergic type, and aspergilloma as well as invasive aspergillosis in 
immunocompromised individuals (Banerjee et al,. 1998). In immunocompromised 
individuals, such as AIDS or leukemia patients, and organ transplant recipients A. 
fumigatus is more likely to become pathogenic, causing a range of diseases generally 
termed aspergillosis. With the increase in the population of immunocompromised patients 
A. fumigatus has become the second most common opportunistic fungal pathogen of 
humans (Netea et al., 2003). 
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Figure 1.1 Images of A. fumigatus showing hyphae, conidiophore and conidia.  
(Images from www.Aspergillus.org.uk) 
 
1.2 Aspergillus fumigatus and the Environment  
Previous studies have examined the prevalence of A. fumigatus in air samples.  The 
concentration of viable aerosolised conidia varies depending on geographical location, 
climate, presence of decaying vegetation and other factors such as urbanisation and 
pollution (Vermani et al., 2010; Guinea et al., 2006). Aspergillus conidia were found 
everywhere in the air; however meteorological parameters such as temperature, rainfall and 
wind-speed affect the number of conidia in the air (Guinea et al., 2006). The distribution of 
A. fumigatus conidia is not limited. Several cases of filamentous fungi including A. 
fumigatus have been reported in public water and hospital water systems, thus confirming 
the widespread distribution of conidia (Gottlich et al., 2002). In immunocompetent 
populations, inhaled conidia are eliminated via alveolar macrophages that kill the conidia 
in an NADPH oxidase dependent manner and by polymorphonuclear leucocytes (PMNL) 
(Hohl and Feldmesser, 2007). A. fumigatus produces small hydrophobic conidia and each 
conidial head produces thousands of grey-green spores average size is between 2 – 3 µm in 
diameter which keeps them buoyant in the environment (Latge, 1999). Aspergillus conidia 
are estimated to be at concentrations of 1 – 100 conidia / m3 which can bypass the 
mucociliary clearance mechanism upon inhalation (Denning et al., 2002). Therefore, the 
fungus penetrate deep into the lung alveoli (Hohl and Feldmesser, 2007). 
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1.3 Diseases caused by Aspergillus fumigatus 
1.3.1 Aspergillosis: 
Aspergillosis is a group of diseases caused by fungus of the genus Aspergillus and 
usually occurs in patients with lung diseases or weakened immune systems. The diseases 
include invasive aspergillosis, allergic bronchopulmonary aspergillosis, and aspergilloma. 
Some individuals with very severe asthma may also be sensitised to fungi such as 
Aspergillus (Latge, 1999). Invasive fungal infection is a major cause of morbidity and 
mortality in immunocompromised patients. The mortality rate in allogeneic bone marrow 
transplant (BMT) recipients, who have invasive aspergillosis, is approximately 90% (Hovi 
et al., 2000). There are several forms of aspergillosis including pulmonary aspergillosis, 
aspergilloma and pulmonary invasive aspergillosis. Despite the availability of new 
antifungal agents, the morbidity rate due to invasive aspergillosis has increased steadily in 
recent years (Blyth et al., 2007).  
1.3.2 Invasive Aspergillosis  
Invasive fungal infections remain important life-threatening infections and they are 
a major cause of morbidity and mortality in immunocompromised patients. The incidence 
of invasive aspergillosis continues to increase, due to the rising number of patients 
undergoing bone marrow or solid organ transplantation or, corticosteroid treatment and 
those suffering from haematological malignancy or pulmonary disease (Maschmeyer et al., 
2007). In immunocompetent individuals, inhaled Aspergillus conidia are normally cleared 
by mucociliar transport and phagocytosis. However, if phagocytosis is impaired by the use 
of corticosteroids, Aspergillus conidia may germinate to form hyphae and invade the 
pulmonary tissue (Schneemann and Schaffner, 1999). Invasive aspergillosis is mainly 
caused by A. fumigatus, although other species such as Aspergillus terreus, Aspergillus 
niger and Aspergillus flavus can also cause invasive infection (Zmeili and Soubani, 2007). 
A. fumigatus hyphae may invade the surrounding pulmonary tissue and may then spread to 
other organs and tissues in the body (Dagenais and Keller, 2009). 
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Figure 1.2 Invasive aspergillosis spreads to body organs via bloodstream 
(http://www.scripps.org) 
 
1.3.3 Aspergilloma 
Inhalation of Aspergillus spores is the primary cause of aspergillosis. Aspergillosis 
may occur in different forms. A “pulmonary aspergilloma” occurs when aspergillosis 
develops in the sinuses or the lungs and forms a tangled ball of fungal mycelia and blood 
cells. Many fungal balls develop in areas of past lung disease or lung scarring such as 
tuberculosis or lung abscess. The Aspergillus spore settles in the lung cavity and grows 
free from interference because the immune system is impaired. As it multiplies it forms a 
ball, which incorporates dead tissue from the surrounding lung, mucus, and debris 
(Soubani et al., 2002). Aspergilloma can be treated by surgical removal of fungal ball and 
this usually carries a high mortality rate (Latge, 1999). 
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Pulmonary aspergilloma is a type of aspergillosis and usually does not spread to other parts 
of the body. In some cases aspergillosis can become very aggressive and rapidly spreads 
throughout the lungs and often through the bloodstream to the brain, the heart, the liver and 
the kidneys. This is called “invasive aspergillosis” and this occurs in most patients with a 
weakened immune system. 
 
 
Figure 1. 3 Aspergilloma is a formation of fungal ball in lung tissue 
(http://www.scripps.org) 
 
1.3.4 Allergic bronchopulmonary Aspergillosis (ABPA) 
Allergic bronchopulmonary type is an allergic reaction to the fungus that usually 
develops in people who already have problems in the lung (such as cystic fibrosis or 
asthma). It was reported that ABPA occurs in about 1% of A. fumigatus-sensitized 
asthmatics, while in case of cystic fibrosis (CF) patients the incidence varies from 10 to 
35% of the case (Bouchara et al., 1995). Allergic bronchopulmonary aspergillosis (ABPA) 
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is a hypersensitivity disease of the respiratory system mediated by an allergic late-phase 
inflammatory response to A. fumigatus antigens that occurs in approximately 1–2% of 
asthmatic and 7–10% of cystic fibrosis patients (Stevens et al., 2000). The allergic 
inflammatory response in ABPA appears to be quantitatively greater than in Aspergillus-
sensitive cystic fibrosis patients (Knutsen et al., 2012).  
 
Figure 1.4 Allergic bronchopulmonary Aspergillosis (ABPA), develops an allergy to the 
spores of Aspergillus 
(http://www.scripps.org) 
 
1.3.5 Aspergillus fumigatus and virulence factors 
Opportunistic fungal infections occur in susceptible patients who have weakened 
defense systems. Fungal-related characteristics such as dimorphism and phenotypic 
switching may play important roles in initiating and establishing infections by several 
fungi (Karkowska-Kuleta et al., 2009). Casadevall, (2005) defined virulence factors as 
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pathogen determinants of the fungus which cause damage within the host. The ability of A. 
fumigatus to grow on host tissues is important in virulence. The respiratory tract is 
regarded as the main entrance to the body for conidia. A. fumigatus conidia are inhaled by 
all individuals and transit through the respiratory tract. However, these characteristics do 
not fully explain the pathogenicity of A. fumigatus.  
Previously it has been demonstrated that some environmental strains are less virulent 
than their corresponding clinical strains and these observations support the view that A. 
fumigatus may have properties that protect it from the lung's defense mechanism (Maertens 
et al., 2004). Such properties could ensure its survival in lung tissue and initiate allergic 
reactions followed by infection in appropriate hosts (Tomee et al., 2001). A recent study 
showed that A. fumigatus has multi-genic virulence factors of pathogenicity (Wezensky 
and Cramer, 2011). Aspergillus virulence genes involved in different parameters include 
thermo-tolerance, cell wall composition, conidial surface, pigment biosynthesis, nutrient 
acquisition during infection, toxin production, signalling, metabolism and allergens (Hohl 
and Feldmesser, 2007; Abad et al., 2010). Nierman et al., (2005) suggested that the 
virulence of A. fumigatus may be supported by the number of secondary metabolism (SM) 
clusters and this may control secondary metabolism gene expression. Several groups of 
fungal SMs which are classed according to the class of enzyme involved in the 
biosynthesis process and listed as peptides, alkaloids, terpenes and polyketides (Keller et 
al., 2005). A. fumigatus gene clusters responsible for the biosynthesis of 
epidithiodioxopiperazines (ETP) have been identified and they are responsible for the 
biosynthesis of gliotoxin (Sugui et al., 2007; Spikes et al., 2008). 
1.4 Mycotoxins 
Certain fungi and molds have the capability to form chemicals that are harmful when 
eaten by humans or animals. Mycotoxins are secondary metabolites produced by mycelial 
structure of the filamentous fungi, which are capable of causing illness and death in 
humans and other animals (Bhatnagar et al., 2002). The growth of fungi on human and 
animal hosts produces the diseases called mycoses, while dietary, respiratory, dermal, and 
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other exposures to toxic fungal metabolites produce the diseases called mycotoxicosis 
(Bennet and Klich, 2003).  
1.4.1 A. fumigatus and mycotoxins 
Mycelia of A. fumigatus has been demonstrated to produce a range of secondary 
metabolites called mycotoxins with harmful actions on the host. These include gliotoxin, 
fumagillin, helvolic acid, fumitremorgin, fumigaclavine C, aureperone C, and restrictocin 
(Dagenais and Keller, 2009).  A. fumigatus displays a number of virulence factors that may 
facilitate colonisation of the host tissue (Amitani et al., 1995). One of these, gliotoxin 
(C13H14N2O4S2, molecular weight 326.4) (Figure 1.5), displays immunosuppressive 
properties in vivo (Bennet and Klich, 2003). Gliotoxin has been detected in human tissue 
where it may assist fungal colonisation (Bok and Keller, 2004; Lewis et al., 2005). 
1.4.2 Gliotoxin 
The production of gliotoxin by A. fumigatus strains is dependent upon culture 
conditions: previous studies pointed out different parameters that could affect in vitro 
gliotoxin biosynthesis (Kerzaona et al., 2007). Several species of Aspergillus and other 
fungi produced gliotoxin both in vitro and in vivo. Gliotoxin produced by A. fumigatus has 
received wide attention because it is considered a virulence factor for this organism, as 
well as being present in the sera of immunocompromised patients with aspergillosis (Sugui 
et al, 2008; Bok et al., 2005). In addition, gliotoxin has been implicated in the destruction 
of lung tissue in invasive aspergillosis (Sutton et al., 1996).  
Gliotoxin produced by A. fumigatus strains is a pipolythiodioxopiperazine 
immunosuppressive mycotoxin and is a cyclic non-ribosomal dipeptide (Figure 1.5) 
belonging to the epidithiodioxopiperazines (ETP). It demonstrates biological activities 
such as antimicrobial, antifungal, antiviral, genotoxic and immunosuppression (Nieminen 
et al., 2002). Previous work demonstrated that gliotoxin inhibits NADPH oxidase 
assembly and suppresses the production of reactive oxygen species (ROS) and weakens 
phagocytosis function of neutrophil (Tsunawaki et al., 2004; Orciuolo et al., 2007). 
Previous work showed that all A. fumigatus strains do not necessarily produce gliotoxin 
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and confirmed that the ability to synthesize gliotoxin is discontinuously distributed among 
Aspergillus isolates (Boudra and Morgavi, 2005; Lewis et al., 2005). Culture conditions 
have an effect on the production of gliotoxin by A. fumigatus. Kerzaon et al., (2007) 
demonstrated that different parameters could affect the in vitro gliotoxin biosynthesis.  
 
 
 
 
 
Figure 1.5 Chemical Structure of Gliotoxin. 
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Figure 1.6 Proposed biosynthetic pathway for gliotoxin biosynthesis 
 (Balibar and Walsh, 2006).  
 
 
Gene clusters responsible for biosynthesis and production of gliotoxin, have been 
identified in A. fumigatus (Gardiner and Howlett, 2005; Spikes et al., 2008). Previous work 
confirmed the molecular formula of gliotoxin (C13H14N2O4S2) and determined the activity 
of gliotoxin in inhibition of growth against some species of fungal and bacteria (Johnson et 
al., 1943).  
 
1.5 Candida albicans 
Candida albicans is an opportunistic fungal pathogen and is a normal part of our 
gastrointestinal flora. C. albicans has the ability to colonize every human tissue, especially 
the mouth and vagina.  The yeast may invade internal organs mostly in 
immunocompromized patients (Latge and Calderone, 2002). Depending on the Candida 
species, microscopically the colour of colony varies from cream-colured to yellowish and 
the texture may be smooth, pasty, glistening to dry (Eggimann et al., 2003). 
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1.5.1 Candida Virulence and colonisation 
C. albicans can convert from a benign commensal into a disease-causing pathogen, 
causing infections in the different human tissues and these can be defined in two broad 
categories; superficial mucocutaneous and systematic invasive. The morphogenetic 
conversions of C. albicans are undoubtedly important and the ability to reversibly switch 
between two forms (yeast and filamentous) is important for the pathogenicity of C. 
albicans. Several studies suggest that the ability to switch between the yeast and mycelial 
forms is one of the most important virulence factors of C. albicans (Chandra et al., 2001). 
C. albicans has several properties which allow it recognize and adhere to the host. A 
number of these including the morphological transition mechanism between two forms, the 
expression of adhesins and invasins on the host surface, thigmotropism, the formation of 
biofilms, phenotypic switching and the secretion of hydrolytic enzymes (Haynes, 2001). C. 
albicans is able to adhere to different tissues within the human body thus facilitating the 
occupation of many host niches. Remarkably, host niches can have very different 
environments for growth such as pH, O2 levels, temperature, and nutrient availability. 
Increased adherence to host tissue has been observed for the mycelial form and decreased 
adherence has been demonstrated by the non-germ tube form (Baillie and Douglas, 1999). 
This suggests that C. albicans has developed a large array of signaling and adaptation 
mechanisms in order to persist and proliferate, and is an effective colonizer of the human 
body which eventually causes disease (Ekkehard et al., 2011). To colonize any surface, 
fungal cells must first adhere to the biomaterial surface. Candida cells initially attach to 
biomaterials and this is mediated by both non-specific factors (cell surface hydrophobicity 
and electrostatic forces) and also specific adhesins on the fungal surface recognizing 
ligands, such as serum proteins (fibrinogen and fibronectin) and other factors such as 
saliva (Chaffin et al., 1998). It has been reported that Candida has the ability to grow in 
both aerobic and anaerobic conditions and possess adaptive mechanisms to survive in both 
situations (Sardi et al., 2011). The adhesion genes may be activated by diverse 
environmental triggers such as carbon and/or nitrogen starvation, or changes in pH or 
ethanol levels, switching between non-adherence and adherence probably allows yeasts to 
adapt to stress (Sampermans et al., 2005). Virulence factors of C. albicans can be induced 
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by environmental change and initiate signal transduction on the cell surface receptor to 
alter the transcription factors and modify the expression of several virulence genes 
(Haynes, 2001).  
1.5.2 Biofilm formation by C. albicans 
A positive correlation between biofilm formation and cell surface hydrophobicity 
has been demonstrated (Li et al., 2003), and this may also be mediated by cell surface 
proteins which are encoded by members of the ALS family of adhesin-producing genes and 
EAP1 (Green et al., 2004). It is clear that morphogenesis of C. albicans plays an important 
role in the formation and development of biofilm (Baillie and Douglas, 1999). The 
populations of C. albicans cells were observed microscopically in the formation of biofilm. 
Candida yeast and germ tubes were attached to the mucosal surface and consisted of a 
mixture of closely associated yeast and hyphae surrounded by an extracellular matrix 
(Harriott et al., 2010). The hyphal structure was demonstrated to be an essential element 
for providing the structural integrity and development of characteristic multilayered 
biofilm (Mayer et al., 2013). Candida infections can be caused by the presence of medical 
implants that provide a chance for the development of a biofilm which is resistant to 
antifungal agents (Douglas, 2003). One feature of biofilms formed by C. albicans is the 
mixture of different morphological forms (Figure 1.7). Biofilm development on catheter 
discs was first examined by scanning electron microscopy, which showed that yeast cells 
initial attach to the surface followed by germ-tube formation after 3–6 hours and after 
incubation for up to 48 hours a fully mature biofilm was produced which consisted of a 
dense network of mycelia (Hawser and Douglas, 1994). In polymicrobial biofilms, bacteria 
are often found with Candida species in vivo, and inter species interactions take place in 
these adherent populations.  For in vitro investigation of a mixed-species biofilm, catheter 
disc model systems have been used to investigate biofilms consisting of C. albicans and 
Staphylococcus epidermidis, the commonest agent of bacterial catheter-related infection 
(Adam et al., 2002). In vitro resistance of Candida biofilms to antifungal agents was first 
reported in 1995 (Hawser and Douglas, 1995). Biofilms in Candida albicans have been 
reported on most medical devices and frequently occur on catheters, dentures, voice 
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prosthetics implants and artificial joints (Ramage et al., 2006). Recent evidence suggests 
that biofilms also form on the mucosal surfaces of the mouth and vagina.  
 
 
 
Figure 1.7 Adhesion, invasion, biofilm formation, dimorphism, switching and fitness traits  
(Mayer et al., 2013) 
 
Biofilms of C. albicans form when single cells attach and grow on the surface to 
form microcolonies, which then produce 3-D structure complex that merge together 
hyphae and an exopolymer matrix (Chandra et al., 2001). Morphological biofilm is a 
heterogeneous component containing a mixture of yeast, hyphae and pseudohyphae forms 
(Hawser and Douglas, 1994). 
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1.5.3 Disease caused by Candida 
Candidiasis is a disease caused by yeast of the genus Candida. Candidiasis is 
treatable in the healthy individual. However, candidiasis can be more difficult to treat in 
people with weakened immune systems due to such conditions as HIV/AIDS, or taking 
steroid medications or chemotherapy (Mayer et al., 2013). In these cases, complications of 
disease may become life threatening. Impairment of immune system is the main cause of 
overgrowth of Candida cells. The immune system can be weakened by stress, illness and 
some medications. It is in such a state of weakness when harmless Candida yeast turns into 
an aggressive pathogens. 
Superficial fungal infections of skin and mucous membranes are the most common 
types of skin infection caused by Candida. In certain cases, Candida infection of the skin 
has increased in prevalence in recent years, principally because of the increased numbers 
of patients who are immunocompromised. C. albicans infections can occur superficially 
and most cases of candidiasis can be treated with antifungal drugs once there is no 
predisposing factors such as immunosuppressive agent or antibiotic treatment (Haynes, 
2001). 
The first Candida sytemic infection was recorded in 1862. Since then, large numbers 
of cases have been documented with infection in internal organs such as respiratory tract, 
urinary tract, cardiovascular system, CNS, bones and liver (Odds, 1994). Approximately 
90 % of HIV patients develop superficial candidiasis (Dorocka-Bobkowsk et al., 2003) 
with high possibility of disseminated candidiasis leading to a number of deaths among the 
immunocompromised population (Lupetti et al., 2003). 
 
1.6 Antifungal agents  
An antifungal agent is a drug that selectively eliminates fungal pathogens with 
minimal toxicity to the host. Treatment with antifungal agents has increased in the last 50 
years, however, the incidence of serious fungal infections continues to rise and the rates of 
mortality are usually between 40 – 90 % in high-risk immuno-compromised populations 
(Dagenais and Keller, 2009). Several new antifungal drugs have been or will be licensed in 
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the next few years but despite of this the number of deaths due to invasive aspergillosis has 
increased (Mihai et al., 2003). A clear understanding of the mechanisms responsible for 
defense against Aspergillus infection is required to develop strategies that boost the 
antifungal actions of the immune system. The three currently used antifungal agent 
classification and mechanism of action (Table 1.1)  
The polyene and azole antifungal agents are focused on the cell envelope particularly 
on the fungal cell membrane sterol, ergosterol, and its biosynthesis. Targets elsewhere in 
the cell would be very useful in the fight against fungal pathogens (Frank et al., 2003). The 
heat shock response, including major and minor heat shock proteins, has emerged as a 
promising antifungal target. Specifically, those heat shock proteins that are unique to fungi 
and (e.g. Hsp21) represent good candidates for specific drug targets (Mayer et al., 2013). 
The mechanisms of biofilm drug tolerance and phenotypic heterogeneity may lead to the 
development of the first antifungal drugs capable of eradicating infection, salvaging 
medical devices, and preventing relapse (Michael, 2011). 
 
 
Figure 1.8 Targets of systemic antifungal agents.  
[Thompson et al., 2008] 
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Class Examples Mechanism of Action 
Polyene 
Amphotericin B,  
Nystatin 
Binds ergosterol; creates pores in 
the cell membrane  
Azole 
Fluconazole,  
Voriconazole,  
Itraconazole, 
 
Inhibition of 14-alpha 
lanosteroldemethylase; 
accumulation of 14-alpha-methyl 
3,6 diol  
Echinocandin 
Caspofungin,  
Micafungin, 
Anidulafungin 
Inhibition of cell wall glucan 
synthesis by beta-1,3 glucan 
synthase  
 
Table 1.1 The main drug classifications and mechanism of action of some currently used 
antifungals agents. 
 
 
1.6.1 Echinocandins 
The echinocandins are a novel group of antifungal agents which have an unique 
mechanism of action that involves the inhibition of the synthesis of glucan in the cell wall 
via the enzyme 1,3-β glucan synthase (Figure 1.9). The echinocandin drugs are potent 
inhibitors of glucan synthase and are the first class of antifungal agents to target the fungal 
cell wall. The three principal drugs, caspofungin, micafungin and anidulafungin are highly 
serum protein bound (Wagner et al., 2006), and display favorable pharmacokinetic and 
pharmacodynamic properties, as well as excellent safety profiles. Echinocandins have been 
introduced into clinical practice for systemic fungal infections in immuno-compromised 
patients. Although initially approved for salvage therapy for invasive aspergillosis, 
treatment regimens are still evolving. The echinocandin drugs are moderately fungistatic 
against Aspergillus (Perlin, 2007; Morris et al., 2006). Echinocandins are poorly absorbed 
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when administered orally, however when administered by parenteral route they will reach 
most tissues and organs with concentrations sufficient to treat localized and systemic 
fungal infections (Wagner et al., 2006). Caspofungin was the first echinocandin antifungal 
agent to gain FDA-approval for human use in the United States under trade name 
Cancidas, (Merck & Co. Inc.). It has excellent clinical activity against Candida and 
Aspergillus.  
 
 
Figure 1.9 Schematic diagram of fungal Hyphae cell wall and membrane.  
Echinocandins acting on the enzyme ß-1,3-glucan synthase leading to inhibit the synthesis 
of  ß-1,3-glucan. [Kartsonis et al.,(2003)]. 
 
1.6.1.1 Caspofungin 
Caspofungin is a semisynthetic lipopeptide (echinocandin) derived from a 
fermentation product of Glarea lozoyensis. Caspofungin shows activity against infections 
by Aspergillus and Candida (Kahn et al., 2006). Caspofungin works by inhibiting the 
enzyme β (1,3)-D-Glucan synthase and thereby disturbing the integrity of the fungal cell 
wall (Baixench et al., 2007). Caspofungin has an excellent safety profile with reduced 
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toxicity, compared to other licensed antifungal agents (Maertens et al., 2004). It is used for 
treatment of acute invasive candidiasis and as salvage treatment for invasive aspergillosis 
(Denning et al., 2003). Caspofungin has been shown to be active both in vitro and in 
clinical infections against most strains of Candida and in regions of active cell growth of 
the hyphae of Aspergillus species (Odds et al., 2004). Caspofungin is the only 
echinocandin for which dosage reduction is recommended for patients with moderate to 
severe hepatic dysfunction. Caspofungin has few drug-drug interactions and clinician 
reports were promising to use caspofungin in combination with polyene and azoles 
antifungals due to the different mechanism of action (Eschenauer et al., 2007). In the case 
of invasive aspergillosis caspofungin was successfully used especially in patients intolerant 
to other antifungal agent such as amphotericin B and fluconazole (Maertens et al., 2004). 
In the structure formula of caspofungin (Figure 1.10) there is a long fatty acid side chain 
that may allow intercalation with bi-layer of the fungal cell membrane (Denning et al., 
2003), where it  interacts with the enzyme ß-1,3-D-glucan synthase in fungal cell wall. 
There is a positive correlation between the clinical outcome in vivo failure and elevated in 
vitro MICs of caspofungin (Hernandez et al., 2004). Resistance to echinocandins and 
especially caspofungin has been associated with mutation in the FKS genes or in RHO1 
(Letscher-Bru and Herbrecht, 2003). 
 
Figure 1.10 Structures of caspofungin, micafungin and anidulafungin 
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Non-growing C. albicans cells when exposed to caspofungin release a range of 
proteins which originate from different locations within the cell and these proteins may be 
strongly immunogenic to the host immune response and lead to increased inflammation 
(Kelly and Kavanagh, 2010). Echinocandins are active against most Candida species and 
caspofungin has an excellent safety profile and is reported to kill biofilms in vitro 
(Bachmann et al., 2002). Fungicidal effect by echinocandins may be due to cell wall lysis 
and osmotic stresses, and may be largely dependent on media and growth conditions 
(Michael, 2011). The rapid activation of both pathways Cap1 and Hog pathways in C. 
albicans during exposure of cells to caspofungin may give the cell the ability to self-
protect from the osmotic and oxidative stress induced by antifungal drug (Kelly et al., 
2009). C. albicans cells treated with caspofungin show increased expression of a number 
of genes associated with the oxidative stress response, including mitochondrial processing 
protease (MAS1) and catalase (CAT1) as well as elevated activity of glutathione reductase 
(GLR) and superoxide dismutase (SOD) (Kelly et al., 2009). 
 
1.6.2 Polyene antifungal 
A polyene (e.g. Amphotericin B, Nystatin) is a molecule with multiple conjugated 
double bonds. The polyene antimycotics bind with ergosterol in the fungal cell membrane 
and this alters the cell membrane fluidity, thereby placing the membrane in a less fluid, 
more crystalline state. As a result, small organic molecules leak and this induces cell death 
(Walsh et al., 2004). Animal cells contain cholesterol instead of ergosterol and so they are 
much less susceptible to the effects of polyene agents. However, at some stage of 
therapeutic doses, amphotericin B may bind to cholesterol, increasing the risk of adverse 
side effect such as nephrotoxicity (Denning, 2003).  Amphotericin B (Figure 1.11) has a 
narrow therapeutic index due to the toxicity to some human organs. Nystatin can only be 
used topically. However amphotericin B is formulated as intravenous use, and only used 
for the treatment of life-threatening fungal infection (Dannaoui, 2000).  
Conventional therapy for the treatment and control of invasive aspergillosis still 
depends on the use of the polyene, amphotericin B and the azoles, itraconazole and 
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fluconazole (Canuto & Rodero, 2002; Ellis, 2002). Amphotericin B displays novel 
antifungal activity and functions by forming apertures in the cell membrane, by 
complexing the ergosterol in the cell membrane, each pore forming consists of an annulus 
of eight amphotericin B molecules linked hydrophobically to ergosterol (Abu-Salah, 
1996). An alternative explanation suggests that the mode of action of amphotericin B 
involves an alteration in the permeability of the phospholipid bilayer to create pores 
leading to an increase in the fluidity of the membrane (Venegas et al. 2003). 
 
 
Figure 1.11 Structure of Amphotericin B. 
 
1.6.3 Azole antifungal 
Azoles (Imidazoles and Triazoles) are the largest class of clinically used antifungal 
agents (Figure 1.12 and Figure 1.13). Their mode of action involves the inhibition of the 
14α-demethylation of lanosterol in the pathway of ergosterol biosynthetic (Odds, 2003). 
The imidazole antifungals (e.g. miconazole, econazole, and fluconazole) are heterocyclic 
synthetic compounds that inhibit the enzyme lanosterol 14 α-demethylase; the enzyme 
necessary to convert lanosterol to ergosterol. The drugs block demethylation of the C-14 of 
lanosterol lead to depletion of ergosterol in fungal membrane. This disrupts the structure 
and many functions of fungal membrane leading to inhibition of fungal growth (Diaz-
Guerra et al., 2003).  Azole antifungal agents have been used widely to treat superficial 
and systemic fungal infections. Miconazole was the first azole used to treat fungal 
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infections (Utz, 1980), has been discontinued because of failure in some cases. In 
treatment of candidemia fluconazole has been shown to be as effective as amphotericin B 
(Rex et al., 1994). Voriconazole, posaconazole and ravuconazole are three triazoles that 
have broad spectrum of activity against fungi (Odds, 2003). In treatment of candidemia 
fluconazole has been shown to be active as amphotericin B with fewer side effects 
(Karthaus and Cornely, 2007). New triazoles have emerged: voriconazole, posaconazole 
and ravuconazole and each has broad spectrum of activity (Odds, 2003). The mechanism 
of resistance to azole antifungal agents in C. albicans have been elucidated and categorized 
as due to changes in the cell wall or plasma membrane, which lead to impaired azole 
uptake; alterations in the affinity of the drug target Erg11p due to target site mutagenesis 
and the increased efflux of drugs mediated by membrane transport proteins, deletion of 
these genes resulted in hypersensitivity to azoles (Sanglard and Bille, 2002).  
 
 
Figure 1.12 Structures of Imidazoles 
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Figure 1.13 Structures of Triazoles  
 
1.6.4 Pyrimidine analogues: 5-Fluorocytosine 
5-Fluorocytosine is a fluorinated analogue of cytosine (Figure 1.14) that has 
antifungal activity resulting from the rapid conversion to 5-fluorouracil within target cells 
(Odds et al., 2003). 5-FU inhibits fungal protein synthesis after incorporation into fungal 
RNA causing premature chain termination, and this inhibits DNA synthesis through 
inhibition of thymidylate synthetase. Antifungal resistance develops quickly to 5-FC 
therapy, so combination therapy with other agents has been reported to enhance the 
antifungal activity of amphotericin B (Siau and Kerridge. 1999), especially in anatomic 
sites where amphotericin B penetration is poor, such as cerebral spinal fluid (CSF) and 
heart valves (Smego et al., 1984). One explanation for the synergism detected with 
amphotericin B plus 5-FC is that the membrane-permeabilizing effects of low 
concentrations of amphotericin B facilitate penetration of 5-FC to the cells (Vermes et al., 
2000). 
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Figure 1.14 Structure of 5-Fluorocytosine 
 
1.6.5 Combination antifungal therapy 
The mortality rate among patients treated with polyene and azole antifungal agents 
has increased especially among immuno-compromised patients; therefore it is essential to 
find out new strategies for the treatment of invasive fungal infections. Echinocandins, 
polyenes, azoles and flucytosine, all belong to different pharmacological classes and 
possess distinct mechanisms of action (Georgopapadakou and Walsh, 1996). As different 
groups of antifungal drugs act on different targets, evaluation of their interactions is of 
potential interest for improving the strategies of treatments for invasive candidiasis and 
aspergillosis. Azoles act by inhibition of 14α-demethylase (Siau and Kerridge, 1999), 
flucytosine inhibits fungal RNA and DNA synthesis (Vermes, 2000), and polyenes binds 
to ergosterol in fungal cell membrane (Georgopapadakou and Walsh, 1996), whereas 
echinocandins inhibit the synthesis of beta-1,3-glucan (De-Lucca, 1999).  The combination 
of amphotericin B or liposomal formula with caspofungin is still a safe and a suitable 
option (Arikan et al., 2002) for the treatment of invasive fungal infections in 
immunocompromised individuals especially those with hematologic malignancies (Aliff et 
al.,2003; Arikan et al., 2002), both in vitro and in vivo in animals (Luque et al., 2003) 
showed no antagonism. Interactions between azole and echinocandins drugs deserve 
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consideration for the treatment of invasive aspergillosis and some in vitro testing has been 
conducted (Manavathu et al., 2003) and their use in animal models of aspergillosis was 
investigated (Luque et al., 2003).  
 
1.7 Aims of study 
1. To analyse the effect of culture conditions on the susceptibility of C. albicans and 
A. fumigatus to caspofungin. 
 
2. To investigate the effect of caspofungin on the biosynthesis and release of gliotoxin 
from A. fumigatus. 
 
3. To characterize the proteomic alterations occurring in A. fumigatus in response to 
caspofungin. 
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Chapter 2 
2 MATERIALS AND METHODS 
 
2.1 Strains used in this work 
Clinical strain of A. fumigatus ATCC 26933, (MARYLAND USA) was used in this 
study. C. albicans MEN was a kind gift from Dr. D. Kerridge, Cambridge, UK. 
2.2 Sterilization procedures 
All growth culture media were sterilized by autoclaving prior to use at 121°C and 15 
lb/sq.in for 15 minutes. Any liquid unsuitable for autoclaving was filter-sterilised using a 
pore size 0.2 µm (Sarstedt, Nümbrecht, Germany). All used liquid and solid cultures were 
autoclaved prior to disposal. 
Laboratory equipment such as micro-centrifuge tubes and pipette tips were kept in a 
tied sealed container and sterilized by autoclaving at 121ºC for 15 minutes prior to use. 
RPMI1640 and MEM minimal essential media were supplemented with 5% (v/v) fetal 
bovine serum (Hyclone). Semi-solid agar media were allowed to cool until hand hot, 
(approximately 45-50ºC) and poured under sterile conditions using 9 cm petri-dishes. All 
work involving A. fumigatus was performed using a class II safety cabinet. 
2.3 Chemical and reagent used in this study 
All reagents used in this work were of the highest purity and were purchased from 
Sigma Aldrich Ltd, Somerset, U.K unless otherwise stated. 
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2.4 Preparation of Caspofungin acetate 
  Caspofungin (as acetate) [Merck & Co., Inc., Whitehouse Station, NJ., USA] 
powder was reconstituted in molecular grade water to obtain a stock solution of 1.0 mg/ml. 
Each 1 ml of solution was stored at -20 oC until required. 
2.5 Statistical analysis of data 
Results presented in this work are the mean of at least two independent 
determinations and the results are presented as the mean ± standard error. Experimental 
data were tested for statistical significance using a Students t-test. For all experimentation 
a p-value of ≤0.05 was considered statistically significant. 
2.6 Culture media used in this work 
2.6.1  Phosphate Buffered Saline. 
Five tablets of PBS were completely dissolved in 500 mls deionised water and 
autoclaved at 121ºC for 15 minutes. PBS was stored at room temperature. For PBS-T, PBS 
was supplemented with 0.01% (v/v) Tween-80 (Merck), and was vortexed until mixed 
homogenously. PBS-T was sterilised by filtering through a 0.22 µm filter (Millipore), prior 
to use using 20 ml syringe. 
2.6.2  YEPD [Yeast Extract peptone D-glucose] 
YEPD broth was prepared by adding Glucose (2% w/v), Yeast extract (1% w/v), and 
bacteriological peptone (2% w/v), and completely dissolving in deionised water prior to 
autoclaving at 105ºC for 30 minutes. 
For YEPD agar plates 2% (w/v) agar was added and autoclaved as described. In some 
cases antibiotic was added to the hand warm agar prior to pouring to avoid bacterial 
contamination. Solution of erythromycin in DMSO was added when the agar solution was 
hand warm at final concentration of a 0.05 mg/ml. Once in the agar solution the plates 
were spread as per normal and stored at 4ºC.  
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2.6.3  Antibiotic Culture medium 3 
AB3 powder (17.5 gram) was dissolved in 1 litre of warm distilled water. When 
completely dissolved in the final volume it was sterilised by autoclaving at 121 oC for 15 
minutes.  
2.6.4  Malt Extract Agar [MEA] 
Malt extract agar was prepared by adding 50 grams of MEA per one litre of 
deionised water, mixing and autoclaving at 121 0C for 15 minutes. Agar was poured into 
petri-dish once it was hand hot. 
2.6.5  RPMI 1640 
A single plastic bottle of sterile RPMI1640 Medium (1X) (GibcoR Life 
technologiesTM) contained 500 ml.  
2.6.6  Nutrient broth (NB) 
NB (13 gram) powder was dissolved in 1 litre of distilled water. This was mixed 
well and sterilize by autoclaving at 121 oC for 15 minutes.  
2.6.7  Czapek-Dox broth 
Czapek-Dox broth powder (35 gram) was dissolved in one litre of deionized water, 
mixed well, and sterilised by autoclaving at 121 oC for 15 minutes. 
2.6.8  Minimal Essential Media (MEM) 
Sterile Minimum Essential Medium Eagle (Sigma) with Earles salts and NaHCO3 
without L-glutamine was delivered in 500 ml single bottle. 
2.6.9  Sabouroud dextrose liquid medium 
Sabouroud dextrose powder (30 gram) was dissolved in 1 litre of distilled water, 
mixed well, and sterilized by autoclaving at 121 oC for 15 minutes. 
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2.6.10 Liquid Culture of A. fumigatus 
Minimum essential medium (MEM) and RPMI1640 supplemented with 5% (v/v) 
FBS or aspergillus minimal medium (AMM), antibiotic media (AB3), sabouroud dextrose, 
and Czapek sterile medium were inoculated in a sterile laminar flow hood with A. 
fumigatus conidial at 5 x 105 cells per ml of culture. 
2.6.11  Aspergillus Trace Elements 
Na2B4O7.7H2O (0.04 g), CuSO4.(5H2O) (0.7 g), FeSO4.7H2O (1.2 g), MnSO4 (0.7 
g), NaMoO.2H2O (0.8 g) and ZnSO4.7H2O (10 g) were added to 800 ml of distilled water 
and mixed to dissolve. The solution was made up to 1 L with distilled water and 
subsequently autoclaved at 121 oC for 15 minutes. The solution was aliquoted in 50 ml 
volumes and stored at -20ºC. 
2.6.12  Aspergillus Salt Solution 
KCl (26 g), MgSO4.7H2O (26 g), KH2PO4 (76 g) and Aspergillus Trace elements 
(2.7.1) (50 ml) were added to 800 ml distilled water and dissolved completely. The 
solution was made up to 1 L with distilled water and autoclaved as before. The solution 
was stored at room temperature. 
2.6.13  Ammonium Tartrate 
Ammonium Tartrate (92 g) was completely dissolved in 1L of distilled water and 
autoclaved. The solution was stored at room temperature. 
2.6.14  Aspergillus Minimal Medium (AMM) 
Aspergillus minimal medium was prepared by adding Ammonium Tartrate (2.7.3), 
(10mls), Aspergillus Salt Solution (2.7.2), (20 mls), and Glucose, (10 g), to 800 mls of 
distilled water. pH of solution was adjusted to 6.8 and made up to 1 L using distilled water. 
The medium was distributed in final volumes, autoclaved at 121 oC for 15 minutes and 
stored at room temperature. 
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2.7 Microbial strains and culture conditions 
2.7.1  A. fumigatus strains and culture conditions 
Clinical strain of A. fumigatus ATCC 26933, (MARYLAND USA) was used in this 
study. Stocks of A. fumigatus were maintained on malt extract agar (MEA) [Oxoid Ltd] at 
37°C and sub-cultured every 4 weeks. Culture was grown in different type of media for 
susceptibility assay, AMM, YEPD, NB, Czapek, and AB3. RPMI1640 (Gibco-BRL, 
Uxbridge, UK) with L-glutamine and MEM (SIGMA) were supplemented with 5% (v/v) 
Fetal bovine serum [HyClone], prior to the experiment. 
 
Figure 2.1 Aspergillus fumigatus on MEA agar plate has been incubation for 3 days at 37 
oC. 
 
2.7.2  Inoculation of A. fumigatus 
Stocks of A. fumigatus spores were grown and maintained on Malt Extract Agar 
(Oxoid Ltd Basingstoke UK) at 37ºC in a thermally controlled incubator for 4 to 5 days. 
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Sterile medium was inoculated in a sterile laminar flow hood and A. fumigatus conidial 
inoculations of 5 x 107 cells per 100 ml culture were used. 
2.7.3  Harvesting A. fumigatus conidia 
Conidia of A. fumigatus were harvested in a safety cabinet Class II. 10 mls PBS-T 
[0.1% (v/v) Tween 80] was used to wash the plates. Conidia were harvested by 
centrifugation at (2,056 x g) for 5 minutes at room temperature on a Beckmann GS-6 
bench centrifuge. The supernatant was removed and the conidial pellet was washed twice 
in sterile PBS to remove excess Tween 80 and re-suspended in sterile PBS. The 
concentration of conidia in the suspension was determined by counting with a 
Haemocytometer. 
Concentration of cells in original prep:  
No. cells counted in 5 square X 5 X Volume in which cells have been counted X 
(dilution factor)= 
 
Figure 2.2 Images for Haemocytometer  
 
2.7.4 Candida albicans culture  
C. albicans MEN was a kind gift from Dr. D. Kerridge, (Cambridge, UK). An 
individual colony of cells was aseptically transferred to sterile YEPD broth (2.5.2) using a 
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sterile inoculating loop. The flask was re-plugged with cotton and incubated at 30ºC 
shaking at 200 rpm overnight. To obtain a suspension of cells, 50 ml culture was 
transferred to a sterile 50 ml tube and centrifuged at 500 x g for 5 minutes. The cellular 
pellet was washed twice in sterile PBS and the final cell concentration in a 10 ml volume 
of sterile PBS was ascertained by Haemocytometer. 
 
Figure 2.3 Candida albicans on YEPD agar plate has been grown at 30 oC for 48 hour 
 
2.8 Analysis of the effect of caspofungin on the growth of A. 
fumigatus 
RPMI1640 culture medium (25 ml) supplemented with 5% (v/v) fetal bovine serum 
(FBS) was inoculated initially with 5x103 A. fumigatus conidia/ml. Four different 
concentrations of Caspofungin plus control were used in this experiment. Cultures were 
incubated at 37 oC on a rotary incubator, samples were taken every 24 hour, filtered using 
miracloth, and Dry hyphae mass was measured (Dry weight).  
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2.9 Susceptibility of C. albicans and A. fumigatus to caspofungin 
C. albicans cells were grown to stationary phase in YEPD. Cells were counted on a 
Haemocytometer, and diluted to a density of 5 X 106 cells/ml.  Cell suspensions (100 µl) 
were added to each well of a 96 well plate except row two was used control media. MIC50 
and MIC90 were determined as the lowest concentration of caspofungin required to reduce 
growth by 50% and 90% relative to the growth of the control. 
All experimental work for susceptibility testing of A. fumigatus to caspofungin was 
conducted according to the reference method for broth dilution antifungal susceptibility 
testing of filamentous fungi; Approved standard (M38-A2, 2008) with some modification. 
The Minimum Effective Concentration (MEC) is read as the lowest concentration of 
caspofungin that lead to the growth of small, rounded, compact hyphal forms as compared 
to the hyphal growth seen in the control A. fumigatus. To improve the reading all 
Aspergillus plates were shaken befor read the result. The optical density was recorded at 
540 nm using a microplate reader (Synergy HT, Bio-Tek). MIC50 and MIC90 were 
calculated from the graph using Microsoft Excel sheet.  
 
2.10 Effect of different types of culture media on the efficacy of 
caspofungin against C. albicans and A. fumigatus 
 C. albicans was used to test the activity of antifungal drug Caspofungin. AB3, 
YEPD and Sabouroud dextrose were used for Candida susceptibility test using 96 well 
plate microdilution assays against Caspofungin. All plates were incubated for 24 h at 30oC. 
All plates were read using micro-plate reader (Synergy HT, Bio-Tek) to record the optical 
density at 540nm. MIC50 and MIC90 values were calculated using Microsoft Excel. 
 Caspofungin also was tested against A. fumigatus using 5 types of media and 
RPMI1640 was supplemented with 5% (v/v) FBS. AMM, CZOPEK, NB and AB3 media 
were prepared as describe in section (2.5). The 96 plates assay was used in toxicity assay 
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according to Reference method for broth dilution Antifungal susceptibility testing of 
filamentous fungi (M38-A2, 2008). 
 
2.11 Effect of the different concentrations of glucose on 
Caspofungin activity. 
 All culture media used were supplemented with 1%, 2%, 5% and 7.5% (w/v) 
glucose. In this experiment Caspofungin was tested against C. albicans and A. fumigatus. 
The effect of glucose on the activity of the drug was studied by determining the MICs of 
drug in all cases. 
 
2.12 Analysis of the activity of Caspofungin against C. albicans 
and A. fumigatus in media of different pH. 
 All media used were adjusted to PH 3, 4, 6, 7, 8 and 10 before sterilization. 
Caspofungin was tested against C. albicans and A. fumigatus at different pH value.  
 
2.13 Analysis of the activity of caspofungin against C. albicans and 
A. fumigatus at different concentration of Bovine Serum Albumin 
(BSA). 
 Four concentrations of BSA were used to test the activity of Caspofungin against 
C. albicans and A. fumigatus; 25 µg/ml, 50 µg/ml, 100 µg/ml and 200 µg/ml. AB3 was 
used in this experiment to determine the growth rate over the different concentrations used. 
All plates were read and variable MICs were calculated. 
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2.14 To examine the effect of aeration on the susceptibility of C. 
albicans and A. fumigatus to caspofungin. 
 C. albicans was grown at 30 oC and A. fumigatus was grown at 37 oC, under static 
or shaker conditions to supply oxygen to help fungus grown aerobically.  All plates were 
read at 540nm using plate reader to get the result and data were analysed using Microsoft 
Excel. 
 
2.15 Effect of different carbon source on susceptibility of C. 
albicans and A. fumigatus to caspofungin. 
 Before this experiment different concentrations of glucose were used for 
susceptibility assay using AB3 media. In this experiment different carbon sources were 
used. Glucose, lactose, sucrose, maltose, galactose and glycerol were used at 2% (w/v) in 
AB3 media. All susceptibility tests were conducted and the percentage of growth under 
different conditions was plotted in graphs to facilitate calculation of MICs at each 
condition.   
 
2.16 Morphological analysis of A. fumigatus when exposed to 
Caspofungin  
A. fumigatus cultures RPMI1640 were exposed to Caspofungin for 48 hours at low 
and high concentrations (0.1 and 1.0 µg/ml) at 37 oC in an orbital incubator. Hyphae were 
collected and washed twice with PBS. 0.5 gram of Aspergillus hyphae were transferred 
aseptically to sterile universal tube and resuspended in 5 ml of sterile PBS. All samples 
were sent to CMA (Trinity College Dublin) for examination under electron-microscopy 
using air dry, critical point drying and freeze drying techniques. 
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2.17 Extraction and evaluation of Ergosterol from A. fumigatus 
2.17.1 Ergosterol extraction 
The Method of Arthington-Skaggs et al. (1999) was used to extract the sterol with 
slight modifications. One gram dry weight of each A. fumigatus hyphae sample was 
washed twice with sterile PBS. Hyphae were resuspended in 3 ml of a solution containing 
20% (w/v) KOH (Sigma) and 60% (v/v) ethanol. Hyphae were broken up using spatula and 
vortexing. Samples were placed in a shaking water bath at (80 to 85 0C) for 2 hours. N-
heptane (1.2 ml) was added to the solution then vortexed for 10 seconds. The top aqueous 
layer containing ergosterol was separated by centrifugation for 5 min at 3000 xg then 
collected using Pasteur pipette. 
2.17.2 Ergosterol analysis 
Before the analysis of ergosterol a few grains of anhydrous sodium sulfate (sigma) 
were added to the extract to remove excess water. Gas Chromatograph (Hewlett Packard 
5890 Series II) was used to detect and quantify sterols (Figure 2.4). Different 
concentrations of ergosterol standard were prepared to calculate the standard curve (Figure 
2.5). 
2.17.3 Ergosterol retention time using gas chromatography (GC) 
The fungal sterol content was quantified using Gas Chromatograph (Hewlett Packard 
5890 Series II) with a flame ionization detector and a chromapack capillary column 
(Chromapack International BV, Middelburg, the Netherlands). Carried gas was N2, injector 
and detector temperature were 320 oC. The standard was ergosterol (Sigma Aldrich). 
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Figure 2.4 Peak at 4.187 minutes represent the 1 mg of standard Ergosterol  
 
 
Figure 2.5 Standard curve of Ergosterol 
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2.18 RP-HPLC 
High-performance liquid chromatography is a powerful tool in analysis. Reversed 
phase HPLC is the most commonly used form of HPLC. Different compounds have 
different retention times. For a particular compound, the retention time will vary 
depending on the pressure used (because that affects the flow rate of the solvent), the 
nature of the stationary phase (not only what material it is made of, but also particle size), 
the exact composition of the solvent and the temperature of the column. 
 
2.19 Buffer used in (RP–HPLC). 
2.19.1 Buffer A. 
(1 L) HPLC grade water was placed in a darkened Duran bottle. 0.1% (v/v) 
Triflouroacetic acid was added and mixed thoroughly. This was made fresh on the day. 
2.19.2 Buffer B. 
HPLC grade Acetonitrile (1 L) was placed in a clear Duran bottle. Triflouroacetic 
acid 0.1% (v/v) was added to the bottle and contents of the bottle were mixed thoroughly. 
This was made fresh on the day. 
 
2.20 Analysis of mycotoxins using RP-HPLC. 
Organic extracts were analysed by reverse phase HPLC detect the compounds at 
multiple wavelength (254, 351, and 220 nm) on Agilent 1200 series using a C-18 RP-
HPLC column at a flow rate of 1 ml/min. The concentration of gliotoxin in a given sample 
was ascertained by performing standards gliotoxin and diluted in HPLC-grade methanol.  
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Figure 2.6 Detection of gliotoxin by RP-HPLC. Gliotoxin detection was performed at 254 
nm with a retention time of approximately 13.432 minutes. Image shows gliotoxin 
detection of 1 µg/10µl.  
 
Figure 2.7 Standard curve of serial concentration of gliotoxin reference standard   
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2.20.1 Detection of Gliotoxin in sample 
Gliotoxin detection was performed at 254 nm with a retention time of approximately 
13.432 minutes (Figure 2.6). 
2.20.2 Culture and extraction of Gliotoxin 
Culture A. fumigatus were grown on MEA for 3 days at 37°C and the conidia were 
harvested using sterile 0.5% (v/v) Tween 80. The concentration of conidia was assessed 
using a Haemocytometer and adjusted to 5 x 105 conidia/ml in sterile PBS. This conidial 
suspension was used to inoculate 100ml of RPMI1640 supplemented with 5% FBS in a 
250ml conical flask. The culture was incubated at 37°C in a shaking incubator at 200 rpm 
for 3 to 4 days. The fungal biomass was harvested by filtration through Miracloth filter. 
The filtrate was extracted with an equal amount of chloroform by shaking for 2 hr in 50 ml 
falcon tube at 25°C. The chloroform fractions were pooled and evaporated to dryness on a 
rotary evaporator at reduced pressure and at 50°C.  The dried extracts were dissolved in 
250µl HPLC grade methanol, and stored at -20°C until used for detection of gliotoxin by 
HPLC. 
2.20.3 Analysis of the results of HPLC 
HPLC system is composed of six basic modules (reservoir, pump, injector, column, 
detector, and data system) connected by appropriate tubing and fittings. Pure samples will 
generally only have one peak. The compounds separate as they are carried through the 
column at the left. As each band leaves the column, it passes through the detector. The 
display at the right shows the detector response as a function of time.  
To prepare standards it is convenient to start with a 5 µg/10µl concentrated stock 
solution of gliotoxin. The largest amount that we need was 5µg, in a volume of 10µl. The 
calculations and the standard curve were shown in Figure (2.7). 
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2.20.4 Detection of gliotoxin in A. fumigatus samples grown in different type of 
culture media, 
Different types of culture media were used in this experiment to study the ability of 
A. fumigatus to produce gliotoxin internally and externally. In this section four types of 
culture media were used: Aspergillus minimal media (AMM), Antibiotic media (AB3), 
RPMI1640 and Minimal essential media (MEM) 
2.20.5 Evaluation of internal and external gliotoxin in A. fumigatus grown in 
different pH condition  
Culture pH is one of the main factors which affect the growth of fungi. Variable 
ranges of pH were used to determine the amount of biosynthesis of gliotoxin over a broad 
range of pH value (3.5, 4.5, 5.5, 6.5 and 7.5). 
2.20.6 Detection of Gliotoxin in A. fumigatus when grown in sub-inhibitory 
concentrations of Caspofungin.  
A 96 hour old culture of A. fumigatus was grown in RPMI1640 at low and high 
concentrations of caspofungin (0.1 and 1.0 µg/ml) in presence of negative (PBS) and 
positive (DMSO) control. All four samples were prepared to determine the amount of 
gliotoxin internally and externally. 
2.20.7 Preparation of extracts for detection of gliotoxin by reversed-phase HPLC. 
A standard curve of peak value versus gliotoxin concentration was constructed using 
gliotoxin standards [0.1, 0.2, 0.5, 1.0 µg/10µl]. A volume of 5x105 cells/ml A. fumigatus  
spore were inoculated in 100 ml of  RPMI1640 (GIBCO). Caspofungin (0.01, 0.1 and 1.0 
µg/ml) was added to the culture and the samples were removed at 24, 48, 72 and 96 hour.  
2.20.8 Extraction of gliotoxin from A. fumigatus culture filtrate. 
At each time interval the culture contents were filtered through miracloth 
(Calbiochem) and wet weights were recorded. Gliotoxin was extracted from the culture 
filtrate by mixing it with equal amounts of chloroform for 2 hour, separation of chloroform 
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layer, and extraction of gliotoxin by rotary evaporation at 55 oC. The dried extracts were 
dissolved in 250 µl of methanol and the level of gliotoxin determined using RP-HPLC. 
2.20.9 Extraction of gliotoxin from hyphae of A. fumigatus 
Intracellular gliotoxin was extracted from the hyphae of A. fumigatus as follows: one 
gram of hyphae was recovered from 100 ml of RPMI culture media by filtration. This was 
washed twice in PBS and ground to a fine powder under liquid nitrogen. The hyphae 
powders were re-suspended in 10 ml of 6 M HCl. Chloroform (35 ml) was added to 50 ml 
falcon tube and the mixture was stirred at room temp for 2 hours. Chloroform layer was 
separated and gliotoxin was extracted by evaporation of chloroform layer, the dried 
extracts were dissolved in 250 µl of methanol and the level of gliotoxin determined using 
RP-HPLC. 
2.21 Evaluation of amino acid leakage from A. fumigatus exposed 
to caspofungin 
A. fumigatus conidia were inoculated into 50 ml of RPMI 1640 to give a final 
concentration of 1X105 conidia/ml and incubated at 37 oC for 96 hour. Hyphae were 
collected by filtering through miracloth (Calbiochem) and washed twice with 10 ml sterile 
PBS. The hyphal mass (2 g) was re-suspended in 25 ml PBS containing 0.5% (v/v) 
Dimethyl-sulfoxide (DMSO) [as positive control], or caspofungin (0.1 µg/ml or 1.0 µg/ml) 
and the cultures were incubated at 37 oC and 200 rpm for another 0.5, 2 or 4 hour. At each 
time point 750 µl of culture filtrate was removed and filtered through 0.45 µM syringe 
filters (Sarstedt). Free amino acids were measured at 570 nm using the ninhydrin 
colorimetric method described by Ghosh and Ghosh (1963). Supernatant (750 µl) was 
added to 250 µl of a ninhydrin solution (0.35 g ninhydrin in 100 ml molecular grade 
ethanol). This was heated to 95 oC for 5 minutes. The absorbance at 570 nm was recorded 
on a spectrophotometer (Shimadzu UVmini-1240) and expressed in terms of aspartic acid 
and glutamic acid (1:1), which were used as standards (Figure 2.8).  
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Figure 2.8 Standard curve of aspartic acid and glutamic acid. 
 
2.22 Whole cell protein extraction from A. fumigatus ATCC 26933 
mycelium grown in MEM liquid culture media 
A culture of A. fumigatus was grown in MEM liquid culture media for 96 hour at 37 
oC in an orbital incubator. A 100 ml volume of the culture medium was filtered through 2 
layers of Mira-cloth and squeezed to dry. Hyphae were left 5 minutes to dry on filter paper. 
A certain weight of mycelia mass was added to 50 ml falcon tube and Snap frozen in liquid 
nitrogen to break-up by agitation. Frozen mycelium (1 gram) was placed into an 
autoclaved mortar. Liquid nitrogen was added and material ground into a fine powder. 
Four ml of protein extraction buffer [0.4 M NaCl, 10mM Tris HCl, 2 mM EDTA] 1 µl per 
1ml of buffer protease inhibitor were added and ground until a viscous liquid consistency 
was attained. The viscous liquid was centrifuged at 2500 x g, 4 oC for 5 min. The 
supernatant was retained and pellet was discarded.  
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2.23 Protein Leakage from A. fumigatus Hyphae 
2.23.1 Evaluation of protein leakage from A. fumigatus exposed to caspofungin 
Conidia of A. fumigatus were inoculated as described in section (2.7.2). Wet Hyphae 
mass (1.5 gram) was resuspended in 25 ml of PBS and incubated with drug in presence of 
positive control. The  quantity of protein release from the wet hyphae mass was determined 
for each sample using the Bradford assay (Bio-Rad), with BSA (Sigma Aldrich) as 
reference standard (Figure 2.9).  
 
Figure 2.9: Standard curve of Bovine serum albumin used to determine unknown protein 
concentrations 
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2.23.2 Extraction and Evaluation of protein released from A. fumigatus 
Conidia of A. fumigatus were inoculated in 100 ml RPMI1640 media supplemented 
with (5%) (v/v); FBS, to densty of 5x106 cell/ml and incubated  for 96 hours at 37 oC. cells 
were then harvested and washed twice with sterile PBS. Cell pellets were collected using 
Mira-cloth; all samples were weighed and adjusted to 1.5 g (wet weight). Cells were re-
suspended in either PBS (5 ml), DMSO (5% (v/v); 5 ml) or caspofungin (0.1 or 1.0 µg/ml; 
5 ml) and incubated at 37°C for 4 hours. Hyphae were harvested and the supernatants were 
placed on ice with protease inhibitors (100 µl pepstatin A (1 mg/ml; Sigma-Aldrich), 100 
µl aprotinin (1 mg/ml; Sigma-Aldrich) and 100 µl phenylmethanesulfonyl fluoride (PMSF; 
1 mM; Sigma-Aldrich)). Samples were diluted 1 in 10 in 100% (v/v) Trichloroacetic acid 
(TCA; dissolved in sterile distilled water; Merck) and placed at 4°C overnight to 
precipitate protein. Samples were centrifuged at 17,950 x g for 30 minutes at 4°C 
(Eppendorf centrifuge 5417R). Protein pellets were re-suspended in ice-cold acetone (300 
µl; Sigma-Aldrich) and held at -20°C for at least 1 hour to further precipitate protein. 
Protein was centrifuged at 17,950 x g for 30 minutes at 4°C (Eppendorf centrifuge 5417R) 
and the acetone was discarded.  
2.23.3 Assessment of protein leakage from A. fumigatus using the Bradford assay 
Bovine Serum Albumin standards (5 - 60 µg ml-1), were made in 800 µl deionised 
water and 200 µl Biorad Bradford protein assay reagent (Bio-Rad Munich Germany) and 
read on a spectrophotometer at 595 nm (Eppendorf Biophotometer). A standard curve was 
prepared. Bradford protein assay reagent was prepared by diluting the stock 1/5 using 
deionised water. Protein samples were added (20 µl) to 980 µl of Bradford protein assay 
reagent. The samples were inverted, allowed to stand for 5 minutes and read 
spectrophotometrically. 
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2.24 Solutions and buffers used for 1D and 2D SDS-PAGE 
2.24.1 Coomassie Blue Stain Solution: 
Brilliant Blue R      2 g 
Methanol               450 ml  
Acetic acid             100 ml  
Bring to 1 L Distilled water 
2.24.2 Coomassie Destain Solution: 
Acetic acid             100 ml  
Methanol               200 ml  
Distilled water      700 ml 
2.24.3 IEF Equilibration (Reducing) Buffer 
30% (v/v) Glycerol          (150 ml) 
2%   (w/v) SDS           (10 g) 
6M   Urea                      (180.1 g) 
50mM Tris HCl          (3.94 g) 
Up to 500ml distilled water adjust pH to 6.8 
Aliquot into 20ml (in 50 ml falcon tubes) 
Store at -20 oC 
When using, add 2% DTT (0.4 g), for reducing 
(2.5% IAA (0.5 g) + few grains of Bromophenol Blue) for alkylation 
2.24.4 IEF Buffer  
8 M Urea   (48 g) 
1% (v/v) Triton X100 (1 ml) 
4% (w/v) Chaps  (4 g) 
10 mM Tris HCl (0.158 g)  
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2 M Thiourea  (15.22 g) 
Bring up to 100 mls of sterile distilled water 
Aliquot into 2 ml samples and stored at -20 oC 
When using, add 65 mM DTT (0.2 g) and 0.8% (v/v) Ampholytes (2 µl) 
2.24.5 Running Buffer 10X = Electrode Buffer 
Trizma base   30 g 
Glycine    144 g 
SDS (sodium lauryl sulphate) 10 g 
Add distilled water to make up 1 L,  
pH should be 8.9  
Stored at room temp 
1:10 Dilution in distilled water = 1X 
2.24.6 1% Agarose (for sealing strips): 
1 g Agarose 
100 ml 10X Running Buffer  
Few grain of Bromophenol Blue 
Heat until boiling and sets when cool 
2.24.7 200 mM EDTA Solution: 
EDTA  (14.89 g) 
Make up to 200ml with Distilled water 
Adjust pH to 7.2 
Dissolved with NaOH tablets and autoclaved 
2.24.8 5X Sample Buffer for 1-D SDS–PAGE. 
SDS     2.0 g 
DTT                         1.54 g 
47 
 
Take 2 ml of (0.2 % (w/v) Bromophenol blue (0.1 g) + 50% (w/v) Sucrose (25 g) make 
up to 50 ml H2O) 
3 M Tris HCl (pH 6.7)    2.1 ml 
200 mM EDTA (pH 7)   0.5 ml 
Add deionized water- make up to 20 ml 
Aliquot to 500 microliter 
Store at -20 oC 
2.24.9 Tris–HCl 1.5 M 
Tris – HCl (1.5 M) was prepared by dissolving 11.8 g Trizma Base (Tris Base) in 50 
ml deionised water and adjusted to pH 8.9. Following pH adjustment 1.5 M Tris – HCl was 
filter sterilised through a 0.22 µM cellulose filter (Millipore) and stored at 4ºC. 
2.24.10 Tris – HCl 0.5 M 
0.5 M Tris-HCl was prepared by dissolving 3.94 g Trizma Base in 50 mls deionised 
water and adjusted to pH 6.8. Following pH adjustment 0.5 M Tris– HCl was filter 
sterilised through a 0.22 µM filter (Millipore) and stored at 4ºC. 
2.24.11 Ammonium Persulphate (APS) 10% 
APS (10% w/v) was prepared by adding 0.05 g APS into 0.5 ml of deionised water 
and vortexing to dissolve completely. APS (10% w/v) was prepared fresh every day and 
kept on ice when not in use. 
2.24.12 Sodium Dodecyl Sulphate (SDS) 10% w/v 
Sodium Dodecyl Sulphate (SDS), (10% w/v) was prepared by adding 10 g SDS to 
100 mls of deionised water and left to stir until all SDS had been solubilised. The solution 
was stored at room temperature after filtration through a 0.22 µM filter. 
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2.25 Preparation of SDS–PAGE minigels 
All glass plates were washed in warm soapy water and cleaned thoroughly with 70% 
ethanol prior to use in SDS–PAGE minigels, (Mini-Protean II gel casting apparatus). A 
12.5% acrylamide gel was normally used in experimental procedure. The leakage protein 
dimensional gels were: (8 cm x 6.5 cm x 1 mm). The separating gel separates the proteins 
from each other depending on size therefore aiding visualisation. All gels were used within 
24 hours of setting and were allowed to polymerise for at least one hour prior to being 
loaded. Solution component of separating gel 12.50%, 1.5 M Tris-HCl 3 mls, Deionised 
water 3.8 mls, 30% Acrylamide 5 mls 10% v/v SDS 120 µl, 10% v/v APS 75 µl, TEMED 
3 µl. These volumes were sufficient to make 3 minigels.  
2.25.1 Loading and voltages of 1-D SDS-PAGE  
Protein was extracted from A. fumigatus hyphae (grown with and without 
Caspofungin) using method described in Section (2.28). Bradford method was used to 
calculate the concentration of protein as described in Section (2.29.2) and equal 
concentrations were loaded into the wells of separating gel and run at 50 Volts for 10 
minutes followed by 80 Volts for 120 minutes on (Bio-Rad, CA, USA). Gels were stained 
with Coomassie Blue solution for 5 hours and destained with Coomassie Destaining 
solution for 8 hours. 
2.25.2 Preparation and analysis of 2-D SDS-PAGE  
Protein was extracted from A. fumigatus cultures as described in section (2.28). 
Using the Bradford method, a solution of 250 µg/ml protein was prepared and then 
precipitated by adding three times the volume of ice cold acetone and incubated overnight 
at -20 oC. The precipitated protein was collected by centrifugation (12,400 xg for 30 
minutes at 4 oC (Eppendorf centrifuge 5417R). The acetone was removed and the pellet 
was allowed to air dry. The dried precipitated protein was resuspended in 250 µl IEF 
buffer (2.30.4) with 0.8% (v/v) IPG buffer, pH 3-10 (G.E. Healthcare BioSciences AB, 
Uppsala, Sweeden;) and few grain of bromophenol blue. The solution was applied to a 13 
cm ImmobilineTM DryStrip pH 3-10 (G.E. Healthcare) and iso-electric focusing was 
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performed on an Ettan IPGphor II (Amersham Biosciences, NJ, USA) system using the 
following program. 
1. Step and Hold   50 Volts  12 hours 
2. Step and Hold  250 Volts  15 minutes 
3. Gradient    8000 Volts  5 hours 
4. Step and Hold   8000 Volts  8 hours 
Following IEF IPG strips were frozen at -80ºC or were transferred to equilibration. 
Strips were initially equilibrated in 5 ml reducing equilibration buffer for 15 minutes. 
Strips were transferred to the 5 ml alkylation buffer for 15 minutes. Following 
equilibration strips were rinsed in 1X electrode running buffer. Strips were placed on top 
of SDS-PAGE gels and sealed with 1% w/v agarose sealing solution. The top of the gel 
was sealed with molten cooled sealing solution and allowed to set. The second dimension 
of protein separation was achieved by placing the gels in ProteanXi-II vertical 
electrophoresis cells as per manufacturer’s instructions. The inner chamber was filled to 
the top with 5X electrode running buffer while the outer chamber was filled with 2X 
running buffer. Gels were initially electrophoresed for 1 hour at 50 volts and at 80 volts for 
the remaining time. Gels were monitored regularly to assess the level of electrophoresis 
and were transferred to a staining dish of Coomassie Blue solution and destained with 
destaining solution, until the blue background was removed.  
2.26 In gel trypsin digestion and bioinformatics analysis of LC/MS 
results. 
The method of Shevchenko et al., (2006) was used in processing of bands and spots 
for LC-MS analysis with slight modifications. LC/MS grade Acetonitrile100 % (v/v) was 
used to wash tubes and pipette tips. Following this 30-minute incubation period 500µls of 
Acetonitrile was added for 10 minutes shaking at room temperature. Samples were 
centrifuged at 20,000 xg for 10 minutes and the supernatant was removed. Gel pieces were 
placed in 40 µl of 1:1 ammonium bicarbonate (100 mM): acetonitrile (100 % (v/v) and 
incubated with occasional vortexing for one hour. The supernatant was removed and 40 µl 
of 100% (v/v) Acetonitrile was placed over gel pieces and incubated until gel became 
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white and shriveled. Acetonitrile was removed and gel pieces were covered with 500 µl 
50mM Ammonium Bicarbonate for 5 minutes. An equal volume of 100% (v/v) 
Acetonitrile was added and the pieces were incubated for a further 15 minutes. Supernatant 
was removed and pieces were again covered with acetonitrile until gel became white and 
shrinked. Trypsin (20 µg-Promega) was reconstituted in 100 µl of reconstitution buffer (10 
mM Ammonium Bicarbonate containing 10% Acetonitrile). This was aliquoted into 10 
x10 µL aliquots and to each of these 500 µl of 50 mM Ammonium Bicarbonate was added. 
The trypsin solution (50 µl) was added to each gel piece. This was incubated at 4°C for 1 
hour and at 37°C overnight. For peptide recovery samples were centrifuged at 20,000xg for 
10 minutes and supernatant was transferred to a fresh 1.5ml tube. Extraction buffer (1:2 
5% Formic Acid (v/v): Acetonitrile) was added to the gel pieces (50 µl) and incubated at 
37°C for further 15 minutes. Samples were centrifuged at 20,000 xg for 10 minutes and 
added to the supernatant. Extracts were dried in a vacuum centrifuge overnight. Dried 
peptides were resuspended in 20 µl of 0.1% Formic Acid and sonicated for 2 minutes. 
Samples were filter sterilized and supernatants were added to mass spectroscopy vials 
(Agilent Technologies, USA). Samples were analysed on a 6340 Ion Trap LC/MS 
spectrometer (Agilent Technologies) using BSA as external reference standards. Resulting 
data were analysed using the mascot search engine, (www.matrixscience.com). The mass 
error tolerance was 1 Da allowing for a maximum of no more than 2 missed cleavages. 
Verification of protein sequences was confirmed by blasting the protein sequence on the 
Uniprot, (www.uniprot.org), and NCBI, (www.ncbi.nlm.nih.gov), databases. Identified 
proteins are listed by their gi number as accessed through www.ncbi.nlm.nih.gov.  
 
 
2.27 Whole cell protein extraction for enzymatic assay of A. 
fumigatus 
A. fumigatus hyphae (96 hr culture, 1 g) were exposed to caspofungin (0.1 µg/ml) 
for 15, 30 or 60 minutes or to hydrogen peroxide (0.5 mM) for 15 minutes. At each time 
point hyphae  were harvested, washed in PBS and resuspended in 8 ml of lysing buffer (4 
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ml Tris-HCl (100 mM, pH 7.5); 4 ml EDTA (1mM, Sigma-Aldrich); 100 µl Pepstatin A (1 
mg/ml, added fresh); 100 µl Aprotinin (1 mg/ml, added fresh); 100 µl PMSF (1 mM, added 
fresh) and 5 mM DTT (added fresh)).  Cells were disrupted by vigorous vortexing on ice 
with glass beads (4 g, size: 425-600 µm, Sigma-Aldrich). Cellular debris and glass beads 
were removed by centrifugation (250 x g for 5 minutes at 4°C, Eppendorf centrifuge 
5417R) and the supernatant was used for evaluation of enzymatic activity.  
 
2.28 Assessment of Enzymatic activity  
2.28.1 Superoxide dismutase activity (SOD) Assay 
Superoxide dismutase activity was measured using a SOD Assay Kit (Fluka 
Biochemika) in accordance with the manufacturer’s instructions, using a concentration of 1 
µg/µl of protein extract as described in (R. Rowan et al, 2010). The SOD activity was 
calculated by a tetrazolium salt that produce a water-soluble formazon dye upon reduction 
with a superoxide anion. The absorbance at 450 nm was read using a microplate reader 
(Synergy HT, Bio-Tek) and the following formula was employed to determine SOD 
activity; 
 [(Ablank1 – Ablank3) – (Asample – Ablank2)]  
 X  100
 [(Ablank1 – Ablank3)]
SOD Activity =
 
 
2.28.2 Glutathione reductase activity (GLR) Assay 
 For analysis of the glutathione reductase activity of cells the method described by 
Foster and Hess (1980) was used. It is based upon the reduction of glutathione by NADPH 
in presence of glutathione reductase. The absorbance were read at 340 nm for 2 minutes at 
20 second intervals (Cary varian UV-Visible Spectrophotometer). The GLR activity was 
calculated using the following equation: 
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GLR (units/ µl) = 
 (Rate of change of sample – Rate of change of blank)
 6.22 mM/cm    X    Concentration of protein (µg/µl)  
 
2.28.3  Catalase activity Assay 
Catalase activity was measured as described by Larsen and White with slight 
modifications. A. fumigatus hyphae of 96 old culture was used. Caspofungin 0.1 µg/ml  or 
H2O2 (0.5 mM, 15 min) was added to the medium and the culture grown for a further ½, 2 
or 4 hours. Protein was extracted as in section 2.28 and used immediately. A 100 µl of 
protein extract (7.1 mg/ml) was added to 1.8 ml of 17 mM H2O2   in sterile tube. Mixture 
was left to rest at room temperature for 15 min then suspension was centrifuged at 10,000 
xg (Eppendorf centrifuge 5417R) for 1 min to stop reaction. The supernatant was placed in 
a clean quaetz cuvette. The absorbance at 240 nm was obtained on a Beckman DU640 
spectrophotometer. A blank consisted of 17 mM H2O2. 
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Chapter 3 
3 INTERACTION OF ENVIRONMENTAL 
FACTORS WITH THE ANTIFUNGAL 
ACTIVITY OF CASPOFUNGIN AGAINST 
C. ALBICANS AND A. FUMIGATUS 
 
3.1 Characterisation of factors affecting the response of C. 
albicans to caspofungin 
Microdilution assays were performed using various concentrations of caspofungin 
(0.02 to 10 µg/ml) in order to establish the response of the fungus to the drug when grown 
under different culture conditions. The method employed is described in section 2.9. The 
microdilution assay employed 5 x 106 C. albicans cells/ml and was performed under static 
conditions in a total volume of 200 µl per well in a 96 well plate as recommended by the 
CLSI. For each experiment the growth in the presence of caspofungin was calculated and 
MIC50 and MIC90 values were determined using Microsoft excel 2010. 
 
3.1.1 Effect of culture media on susceptibility of C. albicans to caspofungin 
In this experiment five different types of culture media were employed in order to 
establish whether the culture medium affected the susceptibility of C. albicans to 
caspofungin.  The susceptibility assay was performed using Antibiotic medium 3, 
Sabourud dextrose broth, YEPD broth, RPMI1640 and Minimal essential media (MEM) 
and the assay was performed as described previously.  After 24 hour of incubation at 30 oC 
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all the plates were read on the microplate reader (Synergy HT, Bio-Tek) at 450nm, the 
absorbances were recorded and the growth was expressed as a percentage of the control 
(Figure 3.1). 
It is clear from the results that caspofungin inhibits the growth of C. albicans in all 
types of media but high MIC90 values (7.5 and 5.0 µg/ml) were recorded in RPMI1640 and 
YEPD media (Table 3.1). It will be noted that there is a three-fold (0.15 – 0.45 µg/ml) 
difference in the MIC50 calculated in the different growth media. There is a big variation in 
the response of C. albicans to 0.05 and 1.25 µg/ml caspofungin when grown in the 
different media.  
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Figure 3.1 The effect of culture media on the susceptibility of C. albicans to Caspofungin.  
The assay was performed as in section 2.10. All values are expressed as a percentage of the 
relevant control and are the average of three independent experiments. 
 
 
Media used MIC 50  µg /ml MIC 90 µg/ml 
Antibiotic medium 3 0.045 3.50 
Sabourud Dextrose broth 0.015 1.25 
YEPD broth 0.030 7.50 
RPMI1640 0.015 5.00 
MEM 0.035 4.25 
 
Table 3.1 MIC50 and MIC90 values obtained in each culture medium.  
Caspofungin concentrations required to inhibit the C. albicans growth by 50% and 90% 
were determined relative to control culture. 
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3.1.2 Effect of BSA on the susceptibility of C. albicans to caspofungin 
The effect of protein on the activities of echinocandins has been evaluated against 
C. albicans. The relatively unpredictable nature of the effect of serum on antifungal 
activity has been demonstrated. A previous study described the effect of protein binding on 
the activities of caspofungin and observed that serum modestly affects the MICs of 
caspofungin (Odabasi et al., 2007). 
Bovine serum albumin (25, 50, 100 and 200 µg/ml) was added to medium prior to 
inoculation with C. albicans cells. BSA was added after AB3 media had been sterilized by 
autoclaving because it readily coagulates with heat sterilisation. The method is described in 
section 2.13.  The results demonstrated that the presence of BSA buffers the effect of 
caspofungin on C. albicans (Figure 3.2).  For example at a caspofungin concentration of 10 
µg/ml the culture supplemented with 25 µg/ml BSA showed approximately 15% growth 
but the culture supplemented with 50, 100 or 200 µg/ml BSA showed approximately 40% 
growth of C. albicans cultures.  
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Figure 3.2 The effect of bovine serum albumin (BSA) on the susceptibility of C. albicans 
to caspofungin using AB3 media.  
Average of three independent experiments. 
 
 
Assay MIC 50  µg /ml MIC 90  µg /ml 
25 µg/ml BSA 0.080 10 
50 µg/ml BSA 0.035 > 10 
100 µg/ml BSA 0.025 > 10 
200 µg/ml BSA 0.030 > 10 
 
Table 3.2 MIC50 and MIC90 values obtained from cultures supplemented with different 
concentrations of serum.  
Caspofungin concentration required to inhibit the C. albicans growth by 50% and 90% 
were determined relative to control culture. 
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3.1.3 Effect of Glucose on the susceptibility of C. albicans to Caspofungin 
Glucose supplementation of media has a significant influence on the growth of C. 
albicans. The activity of the antifungal agent miconazole against C. albicans is affected by 
increasing concentrations of glucose (Rodaki et al.,2009). Rodaki et al.,(2009) 
demonstrated the induction of a number of genes associated with the oxidative stress 
response in C. albicans under high glucose culture conditions, which contributed to the 
increased resistance to Miconazole. To investigate whether increasing glucose 
concentrations affected the response of C. albicans to caspofungin, AB3 medium was 
supplemented with different concentrations of glucose prior to a microdilution assay as in 
section 2.11. The results demonstrate that the greatest growth of C. albicans over the 
caspofungin range 0.02 – 1.25 µg/ml occurred in those cultures supplemented with 2, 5 or 
7.5% glucose. Table 3.3 shows a significant  increase in MIC50 and MIC90 values of 
caspofungin, when cells were grown in glucose supplemented medium. 
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Figure 3.3 The effect of different glucose concentrations on the susceptibility of C. 
albicans to Caspofungin.  
Average of three independent experiments. 
 
% Glucose MIC 50  µg/ml MIC 90  µg /ml 
1 % 0.010 0.020 
2 % 0.015 0.050 
5 % 0.040 5.000 
7.5 % 0.020 2.500 
 
Table 3.3 MIC50 and MIC90 values from each graph of varying percentage of glucose in 
AB3 media were determined.  
Caspofungin concentration required to inhibit the C. albicans growth by 50% and 90% 
were determined relative to control culture. 
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3.1.4 Effect of different carbon source on susceptibility of C. albicans to 
caspofungin 
In this experiment different carbon sources were employed to establish whether 
these had an effect on the susceptibility of C. albicans to caspofungin. AB3 medium was 
supplemented with  2% (w/v) lactose, glycerol, sucrose, galactose, maltose or glucose and 
used to determine the effect of carbon source on the susceptibility of C. albicans to 
caspofungin. C. albicans was grown to stationary phase with 2 % of each sugar and C. 
albicans (5 x 106 cells/ml) were inoculated in 96 well plates containing serial dilution of 
caspofungin in range from 0.02 to 10 µg/ml in the same culture medium. Plates were 
incubated at 30oC for 24 hours. The MIC50 and MIC90 for each experiment were 
determined. The results revealed that cultures grown in medium supplemented with 
galactose or  sucrose showed the highest MIC90 values (Figure 3.4). 
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Figure 3.4 The effect of varying carbon source on the susceptibility of C. albicans to 
caspofungin.  
AB3 media was supplemented with different carbon sources and used in a micro-dilution 
susceptibility assay to determine the effect of carbon source on the antifungal activity of 
caspofungin. Average of three independent experiments. 
Type of Carbon used MIC 50  µg/ml MIC 90  µg/ml 
Lactose 0.010 9.00 
Glycerol 0.015 > 10 
Sucrose 0.010 > 10 
Galactose 0.012 > 10 
Maltose 0.015 0.10 
Glucose 0.015 0.050 
Table 3.4 Determination of MIC50 and MIC90 values from graph of each experiment of 
AB3 media supplemented with 2% of different carbon source.  
Caspofungin concentration required to inhibit the C. albicans growth by 50% and 90% 
were determined relative to control culture. 
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3.1.5 Effect of pH on the susceptibility of C. albicans to caspofungin 
The pH range 5 to 7 was recommended by Merck Research Laboratories for use in 
caspofungin toxicity assays (Ripeau et al., 2002). Cultures of C. albicans were grown in 
AB3 media to stationary phase at 30 oC and 200 rpm. Cells  (5 x 106 cells/ml) were 
inoculated into a 96 well plates containing AB3 media of varying pH (3, 5, 7 or 8) in serial 
dilutions of caspofungin (0.02 to 10.0 µg/ml) and incubated at 30oC for 24 hours. The 
optical density (OD) was recorded at 450 nm as described in section 2.12. 
The MIC value of caspofungin required to inhibit the growth of C. albicans by 90% 
or 50% relative to the growth of the control was determined. From Figure 3.5 it can be 
seen that the maximum susceptibility of C. albicans to 0.02 – 0.63 µg/ml caspofungin 
occurred at pH 5. In contrast high growth of C. albicans was present in medium adjusted to 
pH 3, 7 or 8 over the same caspofungin range.  
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Figure 3.5 The effect of medium pH on the antifungal activity of caspofungin.  
C. albicans was grown to stationary phase in AB3 media of varying pH and subjected to a 
micro-dilution susceptibility assay to determine the effect of pH on the antifungal activity 
of caspofungin. Average of three independent experiments. 
 
 
 
Medium pH MIC 50  µg/ml MIC 90  µg/ml 
pH 3 0.315 1.250 
pH 5 0.019 0.075 
pH 7 0.125 0.250 
pH 8 0.100 0.215 
 
Table 3.5 Determination of MIC50 and MIC90 values from each graph of varying pH.  
The lowest concentration of caspofungin required to inhibit growth of C. albicans by 50% 
and 90% relative to the growth of the control. 
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3.1.6 Summary  
The results presented here indicate that the susceptibility of C. albicans to 
caspofungin is affected by a variety of factors including the type of medium used in the 
assay, the nature of the carbon source, the glucose content, the pH and the protein content 
of the culture medium.  
 
3.2 The effect of environmental conditions on protein expression 
in C. albicans . 
C. albicans must adapt to, and thrive in, a broad range of environmental conditions 
especially when confronted with environmental stresses such as low or high pH.  Previous 
studies have identified more than 500 genes that are differentially regulated in response to 
pH and also contribute to adaptation to environmental pH (Davis et al., 2003). The aim of 
the work described here was to analyse the changes in the expression of proteins when C. 
albicans was exposed to different environmental conditions, which might contribute to the 
altered susceptibility of C. albicans to caspofungin.  It is recognized that these conditions 
(e.g. pH, protein concentration, glucose concentration) might also affect the activity of 
caspofungin but this analysis was confined to assessing if these factors affected the ability 
of C. albicans to tolerate exposure to the drug. 
Cells of C. albicans were cultured in AB3 media and grown to the stationary phase. 
Whole cell protein was extracted as described in section 2.27. Table 3.6 shows the proteins 
identified following 1-D electrophoresis of protein samples from C. albicans cells 
incubated under different environmental conditions. Protein bands were excised, digested 
and identified by LC-MS. For identification, MASCOT analysis was used and scores 
greater than 62 were accepted. Table 3.6 illustrates all the peptides identified by LC-MS 
and the molecular function of each protein. In total, 21 spots were successfully identified 
and these were found to be up-regulated or down-regulated under different environmental 
condition. Densitometry was subsequently carried out on bands corresponding to proteins 
of interest to investigate the relative changes (increase or decrease) in expression of the 
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identified protein. The function and information about these proteins was determined using 
the UniProt data bank available at http://www.uniprot.org and / or the InterPro website 
available at http://www.ebi.ac.uk/interpro/ unless otherwise stated.  
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3.2.1 Effect of varying pH on protein expression in C. albicans  
C. albicans was incubated in AB3 media of varying pH (3, 5, 7 and 9) and   grown 
for 48 hour as described in section 2.7.2. One gram of cells (wet weight) was harvested and 
washed twice with PBS and the whole cell protein was extracted as in section 2.22. Protein 
concentration was evaluated using Bradford protein assay as described in section 2.23.3. 
One dimensional gel analysis of proteins was used as described in section 2.25.1. Equal 
concentrations of protein from cells grown in media of different pH were loaded into the 
wells of a 12.5% separating gel with a 5% stacking gel. Proteins were run for 10 min at 40 
Volts followed by 120 minutes at 80 Volts.  A staining solution of Coomassie Blue was 
used to stain the gels for 5 hours followed by destaining with destaining solution. The 
SDS-PAGE gel presented in Figure 3.6 shows the separation of proteins from C. albicans 
cultured in media of pH of 3, 5, 7 or 9. Proteins separated from different samples appeared 
to be either up-regulated or down-regulated across the pH range. The variation in protein 
expression may play a role in the susceptibility and response of C. albicans to a variety of 
conditions. In relation to pH 7, some proteins were up-regulated such as band 4A (Table 
3.7) the Enolase 1 OS at pH 3, 5 and 9. Glyceraldehyde-3-phosphate dehydrogenase (Band 
2A) at pH 9 was increased by 1.7 fold in expression. In addition to the role in glycolysis 
and an immunogenic protein, it also is involved in host interaction as evident by its binding 
to the extracellular matrix protein plasminogen (Kelly & Kavanagh, 2010). Enolase 1 OS 
(Band 4A) and hypothetical protein CaO19.8025 showed a change in expression at acidic 
pH 3 of 1.4 and 1.6 fold respectively and at pH 9 these proteins show 1.3 and 0.9 fold 
increase. Hypothetical protein CaO19.8025 (Band 1A, Table 3.7). At acidic pH values, C. 
albicans showed an increase in tolerance to caspofungin concentration range (0.02 to 0.6 
µg/ml) (Figure 3.6). This correlates to the increase in the expression of hypothetical protein 
CaO19.8025 that may play role in the stress response.  
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Figure 3.6 Coomassie stained SDS-PAGE gel (12.5%) of separated proteins from C. 
albicans inoculated in media of varying pH.  
C. albicans was cultured in AB3 media of varying pH from 3 to 9. Protein was extracted 
from stationary phase cultures and 20 µg proteins were resolved by 1D SDS-PAGE. 
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pH 7 pH 3 pH 5 pH 9
1A Hypothetical protein CaO19.8025 1 1.6 1.2 0.9 Annotation remark
2A Glyceraldehyde-3-phosphate dehydrogenase 1 0.8 0.9 1.7 Glycolytic enzyme; changes with drug exposure
3A Eno1 enolase, partial 1 0.8 1.2 1.1 Glycolysis
4A Enolase 1 OS 1 1.4 1.5 1.3 Glycolysis
5A Pyruvate decarboxylase, putative 1 0.9 1 0.9 Catalytic activity, magnesium ion binding
6A 29 kDa IgE-binging protein 1 0.7 0.9 1.2 Oxidative stress via Cap1
Fold Increase
Band Name of protein Molecular function
 
Table 3.7 Identity and fold change in expression of excised proteins from C. albicans 
cultured in media of varying pH.  
Identified protein by LC-MS and molecular function was determined using the UniProt 
data bank. Average of two independent experiments. 
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3.2.2 Effect of BSA on protein expression in C. albicans  
A previous study suggested that in C. albicans the cell wall could be associated with 
mediating the adhesion of fungal cells to serum, thus involved in contributing to the 
attachment of the microorganism to host tissues and to the dissemination of Candida 
infection (Gozalbo et al., 1998). Other studies demonstrated an elevation of the MIC50 of 
caspofungin against some Candida spp, including C. albicans in the presence of human 
serum albumin (Paderu et al., 2007; Odabasi et al., 2007). A previous study suggested that 
the activity of caspofungin was reduced in presence of serum albumin due to the direct 
interference on the drug as a result of protein binding (Paderu et al., 2007). 
C. albicans was grown for 48 hours in AB3 media containing different BSA 
concentrations. Protein was extracted as described in section 2.22 and resolved by 1D 
SDS-PAGE. Protein bands which appeared to be either increased or decreased in 
expression were analysed and fold changes in intensity were recorded. The image of the 
SDS-PAGE gel in Figure 3.7 shows the separation of protein from C. albicans grown in 
AB3 medium supplemented with varying BSA concentrations. In comparison to the 
control, an up-regulation of protein appears at high concentrations of BSA. Six excised 
proteins from C. albicans grown in media of varying BSA concentrations were 
successfully identified by LC-MS. It was found that the intensity of protein expression 
increased especially when 100 µg/ml and 200 µg/ml of BSA were applied to culture 
media. 
Band 7A (Table 3.8) was identified as cyclophilin type peptidyl-prolyl cis-trans 
isomerase, and the densitometry result showed the expression of this protein was up-
regulated at high levels of BSA, with a 1.5 and 1.3 fold increase recorded at 100 µg/ml and 
200 µg/ml of BSA respectively. Phosphoglycerate mutase and 
Adenosylhomocysteinase were identified from Band 8A and 10A and showed an up-
regulation and down-regulation of protein expression of 2.4 and 0.8 fold, respectively. 
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Figure: 3.7 Coomassie stained SDS-PAGE gel (12.5%) of separated proteins from C. 
albicans incubated in AB3 media supplemented with different concentrations of BSA.  
Protein was extracted from stationary phase C. albicans culture grown in medium 
supplemented with different BSA concentrations. 20 µg of protein from each sample was 
loaded into each well of the gel. 
 
 
 
 
 
 
72 
 
 
25 µg/ml 50 µg/ml 100 µg/ml 200 µg/ml
7A Cyclophilin peptidyl-prolyl cis-trans isomerase 1 1.7 1.5 1.3 Accelerate the folding of proteins
8A Phosphoglycerate mutase 1 1.4 1.6 2.4 Isomerase, Interconversion as the primer 
9A Alcohol dehydrogenase I 1 1.5 1.1 1.4 Oxidoreductase, Allergen
10A Adenosylhomocysteinase 1 1.7 0.9 0.8 Control of methylations, competitive inhibitor  
11A Fructose-bisphosphate aldolase, partial 1 1.5 0.9 1.3 Glycolysis, lyase
12A Likely mitochondrial malate dehydrogenase 1 1.3 0.8 1.4 Oxidoreductase 
Molecular functionBand Name of protein
Fold Increase
 
Table 3.8 Band ID of excised proteins from C. albicans cultured in media of varying BSA. 
Identified protein was carried out by LC-MS and molecular function was determined using 
the UniProt data bank. Control = 0 µg/ml BSA.  
Average of two independent experiments 
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3.2.3 Effect of Glucose on the protein expression of C. albicans  
A number of studies have reported that a high level of glucose resulted in the 
induction of a number of genes in C. albicans involved in the osmotic and oxidative stress 
response (Rodaki et al., 2009). As a result, an increase in the resistance of C. albicans to 
miconazole was observed. Interestingly Kelly et al., (2009) demonstrated that caspofungin 
caused an oxidative and osmotic stress response in C. albicans. 
C. albicans was grown in AB3 medium containing different BSA concentrations. 
Protein was extracted as described in section 2.29 and resolved by 1D SDS-PAGE. Protein 
bands were found to be either increased or decreased in expression and changes were 
recorded. The image of the SDS-PAGE gel in Figure 3.8 shows the separation of protein 
from C. albicans grown in AB3 medium supplemented with varying glucose 
concentrations. In comparison to the control an up-regulation of protein appears at high 
levels of glucose. Eight excised proteins from C. albicans grown in media of varying 
glucose concentration were successfully identified by LC-MS. Table 3.9 shows the down-
regulation of proteins at higher glucose concentrations in comparison to 1% glucose (Lane 
1).  
Densitometry recorded the highest increase in expression of protein band 14A and 
17A  (Table 3.9) which represent NADH-cytochrome b5 reductase and enolase; these 
proteins demonstrated 1.8 fold increases in expression at 10% glucose in comparison to C. 
albicans grown at 1% glucose level. A heat shock protein SSA4 (Band 18A) showed an 
increase in expression of 1.7 fold in cells grown at the 10% glucose level.  
 At low glucose concentrations, C. albicans was most susceptible to caspofungin. 
Previous results demonstrated that a number of genes involved in C. albicans response to 
osmotic and oxidative stress were induced at high levels of glucose (Rodaki et al.,2009).  
Therefore, pre-exposure of C. albicans to high glucose levels result in an up-regulation of 
stress response genes prior to drug treatment which confers an increased degree of 
protection (Rodaki et al., 2009).  Consequently this may contribute to an increased level of 
tolerance to antifungal activity of caspofungin. In addition, 1D SDS PAGE analysis 
showed an increase in expression of some proteins (NADH-cytochrome b5 reductase 
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precursor and conserved hypothetical protein) involved in the stress response at higher 
glucose concentrations compared to 1% supplemented media.  
 
3.2.4 Summary 
The result presented here show that culture conditions affect protein expression in C. 
albicans. Some of the proteins that increase in expression e.g (alcohol dehydrogenase and 
hypothetical protein) could alter the susceptibility of C. albicans to caspofungin. 
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Figure 3.8 Coomassie stained SDS-PAGE gel (12.5%) of separated proteins from C. 
albicans incubated in AB3 media of varying level of glucose.  
C. albicans was cultured in AB3 media containing different glucose concentrations, 
protein was extracted from stationary phase culture of each sample of varying glucose 
concentrations. 20 µg of protein from each sample was loaded into each well of the gel 
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1% G 2% G 5% G 10% G
13A Fructose-1,6-bisphosphate aldolase, putative 1 1.9 0.8 1.3 Catalyzes the aldol, Lyase
14A NADH-cytochrome b5 reductase precursor 1 2.3 1.7 1.8 Oxidoreductase 
15A ATP synthase beta chain, mitochondrial precursor 1 1.2 0.8 1.2 Hydrolase
16A Potential oxidoreductase 1 0.8 0.7 1.3 Flavin adenine dinucleotide binding
17A Enolase 1 2.5 0.9 1.8 Metabolic pathway via the GAL83 
18A Heat shock protein SSA4 1 2.9 0.8 1.7 Protein folding, ATP binding
19A Elongation factor 1-gamma 1 1 2.6 0.9 1.4 Translation elongation factor activity
20A Conserved hypothetical protein 1 1.8 1.1 1.3 Oxidoreductase 
Band Name of protein
Fold Increase
Molecular function
 
Table 3.9 Band ID of excised proteins from C. albicans cultured in media containing 
different glucose concentrations.  
Identified protein by LC-MS and molecular function was determined using the UniProt 
data bank. Average of two independent experiments 
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3.3 Effect of environmental conditions on the catalase activity of 
C. albicans  
Catalase exhibits antioxidant properties and is essential in maintaining the redox 
balance of the cell and has previously been implicated in the increased tolerance of C. 
albicans to caspofungin (Kelly et al., 2009).  The presence of catalase in a microbial or 
tissue sample can be tested by adding a volume of hydrogen peroxide and observing the 
reaction. The formation of oxygen bubbles indicates a positive result. Catalase has a very 
high specific activity, which produces a detectable response. Catalase is a tetramer of four 
polypeptide chains, each over 500 amino acids long. It contains four porphyrin heme (iron) 
groups that allow the enzyme to react with the hydrogen peroxide. The optimum pH for 
human catalase is approximately 7 (Maehly et al., 1954). The reaction of catalase in the 
decomposition of living tissue: 
2 H2O2 → 2 H2O + O2 
Cultures of C. albicans were grown under the following conditions: Chance in glucose 
concentration, change in pH and change in the concentration of serum (BSA)  
In this experiment catalase activity was measured. Cells were exposed to different 
environmental condition and catalase activity was assessed as described in section 2.39.3. 
Cultures of C. albicans supplemented with 10 % glucose showed an increase in the activity 
of catalase, induced a  one and half fold increase in catalase activity (Figure 3.9a) while 
200 µg/ml BSA  induced  an two-fold increase in activity (Figure 3.9b).  Exposure of C. 
albicans cells to pH showed a significant increase in activity of catalase, which resulted in 
a three-fold increase in catalase activity (Figure 3.9c).  
The result shows a large increase in the activity of catalase under conditions such 
as a high glucose level, high concentration of BSA and at acidic pH, which give to 
tolerance of caspofungin.  
 
3.3.1 Summary 
The enzymatic activity of catalase was found to be significantly increased in C. 
albicans cells upon different environmental conditions especially at acidic pH  
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Figure 3.9a Effect of glucose on the catalase activity of C. albicans 
 
Figure 3.9b Effect of BSA on the catalase activity of C. albicans 
 
 
Figure 3.9c Effect of pH on the catalase activity of C. albicans 
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3.4 Effect of culture condition on the susceptibility of A. 
fumigatus to caspofungin.  
 Microdilution assays to determine the activity of caspofungin against A. fumigatus 
were conducted according to the reference method for broth dilution antifungal 
susceptibility testing of filamentous fungi, (M38-A2, 2008). The concentration range of 
caspofungin was 0.02 to 10 µg/ml in order to establish the response of the fungus to the 
drug when grown under different culture conditions. 
 
3.4.1 Effect of culture media on susceptibility of A. fumigatus to caspofungin 
 Caspofungin was tested against A. fumigatus in different types of culture media as 
described in section 2.10 in order to establish whether the culture medium affected the 
susceptibility of A. fumigatus to the drug.  The assay was performed using Antibiotic 
medium 3, Sabourud dextrose broth, YEPD broth, RPMI1640, nutrient broth (NB), 
COZPT, Aspergillus minimal media (AMM) and Minimal essential media (MEM) as 
described previously. All the plates were incubated at 37oC for 48 hours. Plates were read 
on the microplate reader (Synergy HT, Bio-Tek) at 450nm, the absorbances were recorded 
and the growth was expressed as a percentage of the control (Figure 3.10). 
 Result presented here (Figure 3.10) show that caspofungin inhibits the growth of A. 
fumigatus in all types of media but high MIC90 values were recorded (Table 3.10). There is 
a big variation in the response of A. fumigatus to 0.02 - 1.25µg/ml caspofungin depending 
on the type of medium used in the assay.  
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Figure 3.10 The effect of culture medium on the susceptibility of A. fumigatus to 
caspofungin. 
The assay was performed as in section 2.10. All values are expressed as a percentage of the 
relevant control and are the average of three independent experiments. 
 
Media type MIC 50  µg/ml MIC 90  µg/ml 
AB3 0.020 > 10 
NB 0.015 > 10 
YEPD 0.010 10 
MEM 0.125 9.00 
AMM 0.085 > 10 
RPMI1640 5.500 > 10 
COZPT 0.100 > 10 
 
Table 3.10 Determination of MIC50 and MIC90 values from each graph of different media 
type. Caspofungin concentrations required to inhibit A. fumigatus growth by 50% and 90% 
were determined relative to control culture. 
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3.4.2 Effect of BSA on the susceptibility of A. fumigatus 
 Protein binding alters the activities of caspofungin and previous work observed that 
serum affects the susceptibility of A. fumigatus and C. albicans to caspofungin (Odabasi et 
al., 2007). In this experiment 25, 50, 100 and 200 µg/ml Bovine serum albumin was added 
to RPMI1640 medium prior to inoculation with A. fumigatus conidia. Toxicity assays were 
performed as described in section 2.10.  The results presented here demonstrated that BSA 
buffers the effect of caspofungin on A. fumigatus (Figure 3.11).  High concentrations of 
BSA lead to an increase in the growth of A. fumigatus in the presence of caspofungin from 
0.6 – 10 µg/ml. Table 3.11 show an MIC90 was increased according to the amount of BSA 
used in the media. 
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Figure 3.11 The effect of bovine serum albumin (BSA) on the susceptibility of A. 
fumigatus to Caspofungin using RPMI1640 
 
 
 
 
BSA Concentrations MIC 50  µg/ml MIC 90  µg/ml 
25 µg/ml BSA 0.45 7.5 
50 µg/ml BSA 7.50 > 10 
100 µg/ml BSA > 10 > 10 
200 µg/ml BSA 0.06 > 10 
 
Table 3.11 Determination of MIC50 and MIC90 values from each graph of different 
concentrations of serum. 
Caspofungin concentration required to inhibit the A. fumigatus growth by 50% and 90% 
were determined relative to control culture. 
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3.4.3 Effect of Glucose and FBS on the susceptibility of A. fumigatus to caspofungin 
using AMM 
 Glucose supplementation of media has a significant influence on the growth of A. 
fumigatus   and is associated with organic acid production (Kubicek et al., 1994). Serum 
contains iron-binding proteins, which inhibit the growth of most pathogenic 
microorganisms, including some fungi. In contrast Gifford et al., (2002) indicated that 
serum does not inhibit the growth of A. fumigatus and that the nutrients in serum result in 
high levels of proteinase secretion, potentially increasing the invasiveness of this species.  
The objective of this experiment was to assess the effect of combining glucose and 
serum on the susceptibility of A. fumigatus to caspofungin. Aspergillus minimal media was 
supplemented with 2% w/v glucose and/or fetal bovine serum (5% w/v) (FBS), and the 
response of A. fumigatus to caspofungin was determined as described in section 2.11.2. 
The results presented here (Figure 3.12) show increased growth of A. fumigatus in the 
presence of caspofungin when the medium contains glucose, serum or a combination of 
glucose and serum. Glucose and serum increased the tolerance of A. fumigatus to 
caspofungin. Table 3.12 show that the MIC50 values of caspofungin were elevated by 
presence of serum and glucose in AMM.  
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Figure 3.12 The effect of glucose and serum on the susceptibility of A. fumigatus to 
caspofungin using Aspergillus Minimal Medium (AMM).  
The results are the average of three independent experiments.      
 
 
 
 
Culture condition MIC 50  µg/ml MIC 90  µg/ml 
AMM 0.015 > 10 
AMM + G 0.035 > 10 
AMM + FBS 0.025 > 10 
AMM + FBS + G > 10 > 10 
Table 3.12 Determination of MIC50 and MIC90 values from each graph of glucose and 
serum culture conditions. 
Caspofungin concentrations required to inhibit the A. fumigatus growth by 50% and 90% 
were determined relative to control culture. 
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3.4.4 Effect of Glucose and FBS on the susceptibility of A. fumigatus to caspofungin 
using MEM 
 In this experiment minimal essential media was used to determine the susceptibility 
of A. fumigatus to caspofungin in presence of glucose and FBS. Glucose (2% w/v) and 5% 
(w/v)  serum were added to the media. The result show that the addition of glucose and 
combination of glucose and serum increased the MIC value of the drug over the range of 
0.08 - 10 µg/ml as shown in Figure 3.13. Table 3.13 demonstrates that glucose 
supplemented media results in a large increase in the MIC50 value of caspofungin 
compared to the control. 
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Figure 3.13 The effect of glucose and serum on the susceptibility of A. fumigatus to 
caspofungin using Minimal Essential Media (MEM) 
MEM media was supplemented with glucose and FBS prior micro-dilution susceptibility 
assay to determine the effect of glucose and serum on the antifungal activity of 
caspofungin. Average of three independent experiments. 
 
 
 
Culture condition MIC 50  µg/ml MIC 90  µg/ml 
MEM 1.250 > 10 
MEM + G 7.500 > 10 
MEM + FBS 1.250 10 
MEM + FBS + G 6.500 > 10 
Table 3.13 Determination of MIC50 and MIC90 values from each graph of culture was 
supplemented with glucose and serum. 
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3.4.5 Effect of Glucose and FBS on the susceptibility of A. fumigatus to caspofungin 
using AB3 
 Antibiotics 3 media (AB3) was used to conduct this experiment. Media was 
supplemented with 2% (w/v) glucose and 5% (w/v) serum. Susceptibility assay was 
performed as described in section 2.9. The same observation was recorded and the MIC 
value was elevated in presence of glucose and in case of combination of glucose and serum 
(Figure 3.14) in tested media. Table 3.14 show the significant increase in MIC when 
medium is supplemented with glucose. 
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Figure 3.14 The effect of glucose and serum on the susceptibility of A. fumigatus to 
caspofungin using Antibiotic medium 3 (AB3).  
Results are the average of three independent experiments. 
 
 
 
Culture condition MIC 50  µg/ml MIC 90  µg/ml 
AB3 1.250 > 10 
AB3 + G 7.500 > 10 
AB3 + FBS 0.080 9.5 
AB3 + FBS + G 1.000 > 10 
Table 3.14 MIC50 and MIC90 values, which calculated from the equation on each graph 
when culture of AB3 was supplemented with glucose and serum. 
Caspofungin concentration required to inhibit the C. albicans growth by 50% and 90% 
were determined relative to control culture. 
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3.4.6 Effect of different carbon sources on the susceptibility of A. fumigatus to 
caspofungin 
 The survival of all microbes depends upon their ability to respond to environmental 
challenges. The nature of the carbon source significantly influences the resistance of A. 
fumigatus and other pathogenic fungi to environmental stresses and antifungal drugs 
(Askew et al., 2008). Changes in carbon source also altered the virulence of C. albicans in 
models of systemic candidiasis and vaginitis, confirming the importance of alternative 
carbon sources within host niches during C. albicans infections (Ene et al., 2012). A 
previous study has shown that growth on alternative carbon sources, such as lactate; 
strongly influence the resistance of C. albicans to antifungal drugs (Ene et al., 2012). 
 
 RPMI1640 medium was supplemented with  2% (w/v) lactose, glycerol, sucrose, 
galactose, maltose or glucose and used to determine the effect of carbon source on the 
susceptibility of A. fumigatus to caspofungin. A. fumigatus conidia were grown in 
RPMI1640 with 2 % (w/v) of each sugar and Aspergillus conidia 5 x 105/ml were 
inoculated in 96 well plates containing serial dilution of caspofungin in range from 0.02 to 
10µg/ml in the same culture medium. Plates were incubated at 37oC for 48 hour. The 
MIC50 and MIC90 for each experiment were determined. The results revealed that cultures 
grown in medium supplemented with galactose or  glycerol showed the highest MIC90 
values Table 3.15 
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Figure 3.15 The effect of different carbon source on the susceptibility of A. fumigatus to 
caspofungin using RPMI1640. 
RPMI1640 medium was supplemented with different carbon sources and used in a micro-
dilution susceptibility assay to determine the effect of carbon source on the antifungal 
activity of caspofungin. The results are the average of three independent experiments. 
 
Carbon sources MIC 50  µg/ml MIC 90  µg/ml 
Lactose 0.010 0.040 
Glycerol 0.015 > 10 
Sacarose 0.020 > 10 
Galactose 0.015 10 
Maltose 0.015 > 10 
Glucose 0.015 9.2 
Table 3.15 MIC50 and MIC90 values, which calculated from the equation on each graph 
when culture was supplemented with different carbon sources. 
Caspofungin concentration required to inhibit the C. albicans growth by 50% and 90% 
were determined relative to control culture. 
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3.4.7 Effect of pH on the susceptibility of A. fumigatus to caspofungin 
 The pH range recommended by Merck Research Laboratories for use of 
caspofungin in toxicity assays is 5 – 7 (Ripeau et al., 2002). The aim of this experiment 
was to ascertain how the susceptibility of A. fumigatus to caspofungin varied under basic 
and acidic conditions. A. fumigatus conidia (5 x 105/ml) were inoculated into a 96 well 
plates in the presence of RPMI 1640 media at pH 3, 4, 6, 7, 8.5 or 10. Conidia were 
exposed to caspofungin (0.02 to 10.0 µg/ml) and incubated for 48 hour at 37oC. The 
optical density (OD) was recorded at 450nm as described in section 2.11.3. 
 The MIC value of caspofungin required to inhibit the growth of A. fumigatus by 
90% or 50% relative to the growth of the control was determined. From Figure 3.16 it can 
be seen that the maximum susceptibility of A. fumigatus to caspofungin over the 
concentration range 0.31 – 10.0 µg/ml occurred at pH 6 and pH 7. In contrast high growth 
of A. fumigatus was present in medium adjusted to pH 3, 4 or 10 over the same 
caspofungin range.  
 
 
 
 
 
 
 
 
 
92 
 
 
Figure 3.16 The effect of pH on the susceptibility of A. fumigatus to caspofungin. 
A. fumigatus was grown in AB3 media of varying pH and subjected to a microdilution 
susceptibility assay to determine the effect of pH on the susceptibility of A. fumigatus to 
caspofungin. The results are the average of three independent experiments. 
 
 
pH of culture media MIC 50  µg/ml MIC 90  µg/ml 
pH 3 > 10 > 10 
pH 4 > 10 > 10 
pH 6 0.10 9.0 
pH 7 0.16 7.5 
pH 8.5 2.00 > 10 
pH 10 > 10 > 10 
Table 3.16 MIC50 and MIC90 values from each graph of varying pH.  
The lowest concentration of caspofungin required to inhibit growth of A. fumigatus by 
50% and 90% relative to the growth of the control. 
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3.4.8 Summary 
 The results presented here indicate that the susceptibility of A. fumigatus to 
caspofungin is affected by a variety of factors including  the type of medium used in the 
assay, the nature of the carbon source, the % glucose in the medium, the pH and the 
protein content of the culture medium.  
 
3.5 The effect of environmental conditions on protein expression 
of A. fumigatus. 
 The ability of A. fumigatus to thrive in a wide range of environmental condition is 
one of its virulence factors. A. fumigatus can adapt to environmental stresses such as 
nutrition, pH, and oxygen limitation. McDonagh et al., (2008) demonstrated fungal 
adaptation to the mammalian lung during invasive aspergillosis. Selected genes were 
differentially expressed in vivo compared to laboratory media and correlated with genes 
expressed under alkaline conditions in vitro (McDonagh et al., 2008).  
 The aim of the work described here was to examine whether the altered 
susceptibility of A. fumigatus to caspofungin recorded in different environmental 
conditions correlated with changes in protein expression of A. fumigatus. 
 Conidia of A. fumigatus (5 x 105cells/ml) were inoculated in culture media as 
described in section 2.7.4.  Whole cell protein was extracted as described in section 2.22. 
Table 3.17 shows the proteins identified following 1-D electrophoresis of protein samples 
from A. fumigatus incubated under different environmental conditions. Protein bands were 
excised, digested and identified by LC-MS. All the peptides identified by LC-MS are in 
Table 3.17. In total 19 peptides were successfully identified and these were found to be up-
regulated or down-regulated under different environmental condition. Densitometry was 
subsequently carried out on bands corresponding to proteins of interest to investigate the 
relative changes in expression of the identified protein.  
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 Band
Score
Name of protein
PI 
Seq
Accession #
Nominal mass 
Seq Cav
Source
1B
60
46 kda IgE-binding antigen 
5.11
1(1)
AAB21854
3618
50%
Candida albicans
2B
141
catalase
5.67
3(1)
XP_001273665
80098
5%
Aspergillus clavatus NRRL 1
3B
85
IgE-binding protein 
4.43
1(1)
CAA12162
19413
11%
Aspergillus fumigatus
4B
65
L10A ribosomal protein
9.77
1(1)
CAB56219
24623
5%
Candida albicans
5B
70
FG-GAP repeat protein 
5.53
2(0)
XP_750162
33739
6%
Aspergillus fumigatus Af293
6B
442
Secreted dipeptidyl peptidase 
5.58
8(2)
AAB67282
79667
17%
Aspergillus fumigatus
7B
422
Catalase
  5.50
12(1)
AAB71223
79987
21%
Aspergillus fumigatus
8B
261
Secreted dipeptidyl peptidase DppV 
5.59
6(1)
XP_755237
79754
9%
Aspergillus fumigatus Af293
9B
282
Cobalamin-independent methionine synthase MetH/D 
6.33
6(2)
XP_752090
87072
10%
Aspergillus fumigatus Af293
10B
287
Mycelial catalase Cat1
5.5
7(2)
XP_748550
79919
10%
Aspergillus fumigatus Af293
11B
166
Likely cytosolic ribosomal protein S4 
9.96
4(0)
XP_718444
27295
13%
Candida albicans SC5314
11B
226
Potential mitochondrial inner membrane ATP/ADP translocator 
  9.62
6(1)
XP_716829
32908
27%
Candida albicans SC5314
12B
313
IgE-binding protein 
4.43
6(2)
CAA12162
19413
41%
Aspergillus fumigatus
13B
194
P-loop containing nucleoside triphosphate hydrolase protein 
  6.37
4(1)
EGV66030
94420
6%
Candida tenuis ATCC 10573
14B
119
Plasma membrane ATPase 
4.84
3(0)
EEQ44146
98186
4%
Candida albicans WO-1
15B
233
Translation elongation factor EF-1 alpha 
9.11
5(0)
XP_710148
50419
12%
Aspergillus oryzae 
16B
391
Alcohol dehydrogenase I
8.44
11(1)
EEQ46516
46598
32%
Candida albicans WO-1
17B
179
Hypothetical protein CANTEDRAFT_105339 
5.46
4(1)
EGV64126
35806
15%
Candida tenuis ATCC 10573
18B
358
Malate dehydrogenase, NAD-dependent
9.08
8(1)
XP_748936
35876
32%
Aspergillus fumigatus Af293
19B
207
Likely thioredoxin peroxidase 
4.98
5(1)
XP_716082
21962
27%
Candida albicans SC5314
 
T
able 3.17 Identities of proteins observed to be altered in intensity follow
ing 1-D
 electrophoresis of sam
ples from
 A. fum
igatus incubated 
under different conditions.  
Protein bands w
ere excised, digested and identified as described. For identification a M
A
SC
O
T score low
er lim
it of 62 w
as used. 
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3.5.1 Effect of varying pH on protein expression in A. fumigatus  
 Conidia of A. fumigatus were incubated in RPMI1640 media of varying pH (3, 5, 7 
or 9) and   grown for 72 hours at 37 oC. One gram of cells (wet weight) was harvested and 
washed twice with PBS and the whole cell protein was extracted as in section 2.22. One 
dimensional gel analysis of proteins was used as described in section 2.25.1. Equal 
concentrations of protein from cells grown in media of different pH were loaded into the 
wells of a 12.5% separating gel with a 5% stacking gel. Proteins were run for 10 min at 40 
Volts followed by 120 minutes at 80 Volts. The SDS-PAGE gel is presented in Figure 3.17 
and shows the separation of proteins from A. fumigatus cultured in media of pH of 3, 5, 7 
or 9. Proteins separated from different samples appeared to be either up-regulated or down-
regulated across the pH range. The variation in protein expression may play a role in the 
susceptibility and response of A. fumigatus to a variety of conditions. Compared to the 
expression at pH 7 some proteins were up-regulated at other pH values (Table 3.18). 
Catalase was increased by 2.1 fold in expression at pH 3 and up-regulated by 1.5 fold at 
pH 9. In addition to the role as an oxido-reductase, catalase is also involved in the stress 
response. An increase in the activity of catalase may contribute to the increase in the 
tolerance of A. fumigatus to caspofungin. Kelly et al., (2009) demonstrated that the 
induction of catalase activity in C. albicans HOG dependent manner in response to stress 
caused by caspofungin action.  Secreted dipeptidyl peptidase showed a change in 
expression at pH 3 of 0.9 fold and at alkaline pH9 of 0.7 fold.   IgG-GAP repeat protein is 
down regulated at acidic and alkaline pH which decreased in intensity by 0.7 and 0.9 for 
pH 3 and pH 9 respectively. FG-GAP repeat protein was up-regulated at pH 3 but it 
showed a 2.1 fold increase and at pH 9 decreased by 0.9 fold. 
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Figure 3.17 Coomassie stained SDS-PAGE gel (12.5%) of separated proteins from A. 
fumigatus inoculated in media of varying pH.  
A. fumigatus was cultured in RPMI1640 media of varying pH from 3 to 9. Protein was 
extracted from 72hr old Aspergillus cultures and 20 µg proteins were resolved by 1D SDS-
PAGE. 
pH 7 pH 3 pH 5 pH 9
1B 46 kda IgE-binding antigen 1 1.3 1.2 0.7 Transcript induced
2B Catalase 1 2.1 1.9 1.5 Oxidoreductase, Peroxidase
3B IgE-binding protein 1 0.7 0.9 0.9 Evidence at transcript level
4B L10A ribosomal protein 1 1.2 1.3 1.1 RNA binding
5B FG-GAP repeat protein 1 2.1 0.7 0.8 Calcium ion binding
6B Secreted dipeptidyl peptidase 1 0.9 0.5 0.7 Contributes to pathogenicity 
Band Name of protein Fold Increase Molecular function
 
Table 3.18 Identity and fold change in expression of excised proteins from A. fumigatus 
cultured in media of varying pH.  
Identified protein by LC-MS and molecular function was determined using the UniProt 
data bank. 
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3.5.2 Effect of BSA on protein expression in A. fumigatus 
 The purpose of this experiment was to examine if there were any changes in the 
protein expression of A. fumigatus when grown in different concentrations of BSA, which 
may contribute to the increased level of Aspergillus tolerance to caspofungin at high serum 
level. Previous studies demonstrated an elevation of the MIC of caspofungin against some 
Aspergillus and Candida species in the presence of human serum albumin (Paderu et al., 
2004; Odabasi et al., 2007). A. fumigatus was grown for 72 hours in RPMI1640 culture 
media containing different concentrations of bovine serum albumin (BSA). Whole cell 
protein was extracted as described in section 2.27 and resolved by 1D SDS-PAGE. Protein 
bands which appeared to be either increased or decreased in expression were analysed and 
fold changes in intensity were recorded.  
 One-dimensional SDS-PAGE gel in Figure 3.18 shows the separation of protein 
from A. fumigatus grown in RPMI1640 culture medium supplemented with varying BSA 
concentrations. Protein up-regulation was apparent at high concentrations of BSA. Seven 
excised proteins from A. fumigatus were successfully identified by LC-MS. It was found 
that the intensity of protein expression increased especially when 100 µg/ml and 200 µg/ml 
of BSA were applied to culture media. A. fumigatus produces three active catalases; one is 
produced by conidia, and two are produced by mycelia. The mycelial catalase Cat1p was 
studied previously; studies have shown that the mycelium of A. fumigatus produces two 
mycelial catalases, one that is monofunctional and one that is a bifunctional catalase-
peroxidase (Hearn et al., 1992). At high serum level, band 10B showed an increase in 
intensity of bands. At 100 and 200 µg/ml exposure to BSA was shown an increase in 
expression to 2.6 and 3.2 fold respectively. The protein synthesis inhibitor IgE-binding 
protein was up-regulated when the culture of A. fumigatus was supplemented with 50 and 
100 µg/ml BSA, by 2.1 and 2.7 fold respectively. 
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Figure 3.18 Coomassie stained SDS-PAGE gel (12.5%) of separated proteins from A. 
fumigatus incubated in RPMI1640 media supplemented with different concentrations of 
BSA.  
Protein was extracted from A. fumigatus culture grown in medium supplemented with 
different BSA concentrations. 20 µg of protein from each sample was loaded into each 
well of the gel. 
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25 µg/ml 50 µg/ml 100 µg/ml 200 µg/ml
7B Catalase 1 3.2 3.8 2.9 Immunoreactive protein
8B Secreted dipeptidyl peptidase DppV 1 2.8 3.7 3.1 Hydrolase, Protease
9B Cobalamin-independent methionine synthase MetH/D 1 3.2 3.5 2.9 Methyltransferase activity
10B Mycelial catalase Cat1 1 1.4 2.6 3.2 Heme binding, metal ion binding
11B Likely cytosolic ribosomal protein S4 1 2.4 2.6 3.5 RNA binding
11B Potential mitochondrial inner membrane ATP/ADP translocator 1 2.4 2.6 3.5 Transporter activity
12B IgE-binding protein 1 2.1 2.7 1.1 Protein synthesis inhibitor
Band Fold IncreaseName of protein Molecular function
 
Table 3.19 Band ID of excised proteins from A. fumigatus cultured in RPMI1640 media 
containing different BSA concentrations.  
Identified protein by LC-MS and molecular function was determined using the UniProt 
data bank. 
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3.5.3 Effect of Glucose on the protein expression of A. fumigatus 
 The aim of this experiment was to establish whether glucose supplementation of 
culture medium altered the protein expression of A. fumigatus and might contribute to the 
elevated tolerance to caspofungin evident in these culture media. Cultures of A. fumigatus 
were grown in RPMI1640 medium containing different glucose concentrations. Protein 
was extracted as described in section 2.27 and resolved by 1D SDS-PAGE. Protein bands 
were analysed by densitometry to be either increased or decreased in expression. The 
image of the SDS-PAGE gel in Figure 3.19 shows the separation of protein from A. 
fumigatus grown in medium supplemented with varying glucose concentrations. In 
comparison to the control an up-regulation of protein appears at high levels of glucose. 
Eight excised proteins from A. fumigatus grown in media of varying glucose concentration 
were successfully identified by LC-MS.  
 Band 14B  (Plasma membrane ATPase) was identified and the results show an up-
regulated in protein expression at 5% and 10% glucose level by 2.5 and 1.7 fold 
respectively in comparison to cells grown in 1% glucose media. The expression of Band 
16B (Alcohol dehydrogenase 1) was up-regulated 1.9 and 2.3 fold in 5% and 10% glucose 
media respectively in compared to cells grown in 1% glucose medium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101 
 
 
 
Figure 3.19 Coomassie stained SDS-PAGE gel (12.5%) of separated proteins from A. 
fumigatus incubated in RPMI1640 culture media of varying level of glucose.  
A. fumigatus was cultured in media of varying glucose; protein was extracted from culture 
of each sample of varying glucose concentrations. 20 µg of protein from each sample was 
loaded into each well of the gel. 
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1% G 2% G 5% G 10% G
13B P-loop containing nucleoside triphosphate hydrolase protein 1 1.4 2.7 2.1 Nucleoside-triphosphatase activity
14B Plasma membrane ATPase 1 1.2 2.5 1.7 ATP binding
15B Translation elongation factor EF-1 alpha 1 1.7 2.9 2.4 Elongation factor
16B Alcohol dehydrogenase I 1 0.9 1.9 2.3 Oxidoreductase, Allergen
17B Hypothetical protein CANTEDRAFT_105339 1 1.5 2.2 2.7 DNA repair
18B Malate dehydrogenase, NAD-dependent 1 1.9 3.1 2.9 L-malate dehydrogenase activity
19B Likely thioredoxin peroxidase 1 2.4 3.4 3.1 Thioredoxin peroxidase activity
Band Name of protein Fold Increase Molecular function
 
Table 3.20 Band ID of excised proteins from A. fumigatus cultured in media of varying 
glucose. Identified protein by LC-MS and molecular function was determined using the 
UniProt data bank. 
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3.6 Effect of environmental conditions on the catalase activity of 
A. fumigatus 
 Previous work demonstrated an increase in the activity in catalase when C. albicans 
and A. fumigatus were exposed to caspofungin (Kelly et al., 2009). A. fumigatus conidial 
and mycelial catalases protect the fungus against hydrogen peroxide in vitro. However, 
both mycelial catalases, Cat1p and Cat2p, are involved in the degradation of hydrogen 
peroxide to detoxifying cells in vitro and transiently protected the fungus against oxidative 
stress (Paris et al., 2003). The aim of the work presented here was to establish whether 
different culture conditions induced an increase in catalase activity that might contribute to 
the increased tolerance to caspofungin. 
 For the determination of catalase activity protein extracts from cells grown under 
different conditions were used. Proteins were extracted as described in section 2.27. In a 
sterile tube, the fresh protein (100 µl, 7 mg/ml) was added to 17 mM H2O2. The mixture 
was vortexed and left at room temperature for 20 min to allow for reaction, after this time, 
the suspension was centrifuged at high speed for one minute to stop the reaction. The 
supernatant was removed and placed in a clean quartz cuvette. The absorbance was read at 
240 nm using (UV-2550, UV-VIS spectrophotometer SHIMADZU). Solution of 17 mM of 
H2O2 was used as a blank. Catalase exhibits antioxidant properties and is essential in 
maintaining the redox balance of the cell. Exposure of A. fumigatus to specific 
environmental conditions results in a significant rise in the activity of catalase.  
 Results demonstrate that catalase activity is changed according to the growth 
condition of A. fumigatus. At 10 % glucose the catalase activity was increased significantly 
compared to that in 2% glucose supplemented media (Figure 3.20a), the activity of catalase 
was increased when the media was supplemented with 200 µg/ml compared to 25 µg/ml 
BSA Figure 3.20b, and also at the acidic pH 3 catalase was increased in activity by two 
fold compared to neutral pH 7 (Figure 3.20c). 
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Figure 3.20a Catalase activity of A. fumigatus grown in the presence of 2 or 10% w/v 
glucose 
 
Figure 3.20b Catalase activity of A. fumigatus grown in medium supplemented with 
different BSA concentrations. 
 
Figure 3.20c Catalase activity of A. fumigatus grown at pH 3 or 7. 
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3.7 Summary 
The results presented here indicate that culture conditions affect protein expression 
in A. fumigatus. Some of the proteins that increase in expression e.g (mycelial catalase 
Cat1, IgE-binding protein and plasma membrane ATPase), could alter the tolerance of A. 
fumigatus to caspofungin. 
The enzymatic activity of the catalase was increased in A. fumigatus at some 
conditions, at high level of glucose (10% w/v) and serum (200 µg/ml), and also at the 
acidic pH 3.0 (Figure 3.21a,b & c).  
 
3.8 Effect of caspofungin on the germination of A. fumigatus 
conidia under different environmental condition.  
A. fumigatus is an opportunistic fungal pathogen of various immunocompromised 
populations. It has the ability to form filaments within the lungs, and producing dense 
mycelial balls, which make it difficult to treat. The aim of this work was to determine the 
activity of caspofungin on germination of A. fumigatus conidia grown under different 
environmental conditions. Germination of A. fumigatus conidia is the most crucial step in 
the development of Aspergillus as hyphae represent the invasive form (Manavathu et al., 
1999). Germination was assessed morphologically using microscopic examination of 50 µl 
of A. fumigatus culture from microdilution plates containing different concentrations of 
caspofungin in media with specific alterations, including serum, pH or glucose, after 24 
hours.  The effect of caspofungin on the germination ability of A. fumigatus at 0.2, 5.0 and 
10 µg/ml was examined. 
3.8.1 Effect of culture conditions on germination of A. fumigatus in caspofungin.  
The germination ability of A. fumigatus spores was determined at different 
concentration of caspofungin in medium supplemented with FBS. A. fumigatus was 
cultured in media supplemented with 2.5, 5.0 and 10.0 µg/ml FBS prior to microdilution of 
caspofungin in 96 plates. Mature spores were collected by gently pipetting 50 µl of culture 
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after 24 hour of incubation at 37oC. The purpose of this study was to determine the effect 
of FBS on the activity of caspofungin against A. fumigatus conidia, and morphological 
change in conidial germination. Previous studies showed that caspofungin alone 
demonstrated no significant inhibition of hyphal growth, whereas the addition of 5% 
human serum to the inactive drug, increased the activity of caspofungin. This study 
suggests that human serum acts synergistically with caspofungin to enhance its inhibitory 
activity in vitro against A. fumigatus (Manavathu et al., 1999). 
Studies have looked for evidence that FBS adversely affect the activity of 
caspofungin. In this study we examined the effect of various levels of FBS on the activity 
of caspofungin against A. fumigatus by microscopic examination of germ-tubes and 
hyphae. This interaction was studied under a variety of conditions. 
  
At high serum concentrations germination and growth of hyphae were observed 
but, in contrast, at low serum concentrations germination was inhibited at 5 and 10 µg/ml 
caspofungin (Figure 3.21). In medium supplemented with high levels of glucose 
germination and hyphal development were observed at 5 and 10 µg/ml caspofungin 
compared to medium supplemented with 2% glucose (Figure 3.22). Conidia incubated in 
medium of pH 3 and 9 showed higher level of germination at 0.2 and 5 µg/ml caspofungin 
compared to the pH 7.0 (Figure 3.23). These results show that culture conditions affect the 
germination rate of A. fumigatus in the presence of caspofungin 
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0.2 µg/ml Caspofungin 5  µg/ml Caspofungin
Image of A. fumigatus culture on RPMI1640 media supplemented with 10% FBS
Image of A. fumigatus culture on RPMI1640 media supplemented with 5% FBS
Image of A. fumigatus culture on RPMI1640 media supplemented with 2.5% FBS
0.2 µg/ml Caspofungin 5  µg/ml Caspofungin 10  µg/ml Caspofungin
10  µg/ml Caspofungin
 
Figure 3.21 Effect of caspofungin on germination of A. fumigatus conidia exposed to 
varius FBS.  
Aspergillus culture grown in RPMI1640 with (2.5, 5 and 10% FBS) for 24 hour at 37 oC. 
Image taken at concentration 0.2, 5, and 10 µg/ml caspofungin (magnification X40) 
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Image of A. fumigatus culture on RPMI1640 media supplemented with 2% Glucose
10  µg/ml Caspofungin
10  µg/ml Caspofungin
0.2 µg/ml Caspofungin 5  µg/ml Caspofungin
0.2 µg/ml Caspofungin 5  µg/ml Caspofungin
Image of A. fumigatus culture on RPMI1640 media supplemented with 10% Glucose
Image of A. fumigatus culture on RPMI1640 media supplemented with 5% Glucose
0.2 µg/ml Caspofungin 5  µg/ml Caspofungin 10  µg/ml Caspofungin
 
Figure 3.22 Effect of caspofungin on germination of A. fumigatus conidia exposed to 
varius glucose level.  
Aspergillus culture grown in RPMI1640 with (2%, 5% and 10%) glucose for 24 hour at 37 
oC. Image taken at concentration 0.2, 5, and 10 µg/ml caspofungin. (magnification X40) 
109 
 
10  µg/ml Caspofungin5  µg/ml Caspofungin0.2 µg/ml Caspofungin
10  µg/ml Caspofungin
Image of A. fumigatus culture on RPMI1640 media at pH 7
0.2 µg/ml Caspofungin 5  µg/ml Caspofungin
Image of A. fumigatus culture on RPMI1640 media at pH 9
Image of A. fumigatus culture on RPMI1640 media at pH 3
10  µg/ml Caspofungin5  µg/ml Caspofungin0.2 µg/ml Caspofungin
 
Figure 3.23 Effect of caspofungin on germination of A. fumigatus conidia at varius pH.  
Aspergillus culture grown in RPMI1640 with different pH value (3, 7 and 9) for 24 hour at 
37 oC. Image taken at concentration 0.2, 5, and 10 µg/ml caspofungin. (magnification X40) 
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3.9 Summary 
The result presented here indicate the increase in glucose, change pH and also high 
serum levels that elevate the germination and growth rate of A. fumigatus even in presence 
of 5 or 10 µg/ml caspofungin 
 
3.10 Discussion  
The primary goal of the work presented in this Chapter was to characterise the effect 
of environmental factors on the susceptibility of C. albicans and A. fumigatus to 
caspofungin. The effect of glucose, serum and pH on the susceptibility of each fungus to 
caspofungin was examined and an alteration in the expression of proteins induced by these 
conditions was characterized. The increased level of tolerance of both C. albicans and A. 
fumigatus to caspofungin is evident in this study by the elevated growth of both organisms 
in presence of caspofungin. The results in this Chapter may explain the paradoxical effect 
of echinocandin antifungal drugs (Steven et al., 2006). This phenomenon has been 
demonstrated in vitro with echinocandins against Candida and Aspergillus species 
(Wiederhold 2009). The increase in tolerance of fungal cells may be correlated with an 
increase in cell wall chitin even at high doses of caspofungin (Steven et al., 2006). 
Elevated levels of chitin may substitute for the reduction of ß-(1, 3) D glucan which may 
enable the cells to increase their tolerance to caspofungin activity.   
Caspofungin is a member of the echinocandins and was first licensed for clinical 
used in the United States in 2001 (Kartsonis et al., 2003). This group of antifungals target 
ß-(1,3)-glucan synthesis, which is essential for the structural integrity of the fungal cell 
wall. Caspofungin has an excellent safety profile and limited side effect (Maertens et al., 
2004). In this work we looked at the antifungal activity of caspofungin on A. fumigatus by 
the broth microdilution toxicity assay. Due to the fact that there is no specific and 
standardized susceptibility methods for the ß-(1,3)glucan synthesis inhibitors (Deresinski 
and Stevens, 2003) and there is a variation in MIC value (Odds et al., 2004) the reference 
method for broth dilution antifungal susceptibility testing of filamentous fungi was used in 
this study (M38-A2, 2008). Determination of the actual MIC of caspofungin appears to be 
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difficult because of the paradoxical effect of caspofungin at certain concentrations (Stevens 
et al., 2004), which allowed the growth of A. fumigatus at 37 oC. This phenomenon has 
been previously characterised as an increase in the growth rate of C. albicans at 
concentrations above MIC and some researchers demonstrated that this effect occurs when 
echinocandins are used against Candida and Aspergillus species (Wiederhold, 2009; 
Chamilos et al., 2007). Although the explanation of this phenomenon is not clearly 
defined, a number of studies support the hypothesis that the protection of fungal cells is 
associated with an increase in chitin at high echinocandin concentrations as a dramatic 
increase in cell wall chitin has been shown to correlate with an increase in tolerance 
(Chamilos et al., 2007; Stevens et al., 2006). From the results presented here it can be 
deduced that environmental conditions affect the susceptibility of A. fumigatus and C. 
albicans to caspofungin over the range of 0.1 to 10.0 µg/ml caspofungin as shown in 
section 3.1 and 3.4 of the results. On the other hand caspofungin may induce the cell to 
remodel the cell wall as a result of an increase in chitin content which may substitute for 
the reduction of ß-1,3 D glucan that leading to an increase in the tolerance of cell to drug 
activity. This phenomenon may not be restricted to in vitro studies but may be of clinical 
relevance in the in vivo setting.  
Investigation of the effect of culture conditions on protein expression of C. albicans 
lead to the discovery of differentially expressed proteins. From the 1D SDS PAGE gel 
analysis, it was evident that the expression of some proteins (e.g. catalase and IgE-binding 
protein) was increased while the expression of others was down regulated.  One of the 
important virulence factors of C. albicans is the ability to thrive in a wide range of 
environmental conditions, thereby supporting it as a successful opportunistic pathogen 
(Calderone and Fonzi, 2001). The results presented here show that C. albicans is capable 
of growing in the diverse range of culture conditions. It is important to note that changes in 
environmental conditions may have a direct effect on caspofungin activity and the degree 
of susceptibility of C. albicans. Environmental conditions also altered the protein profile of 
cells, with various sized proteins up or down-regulated within a variety of conditions. This 
suggests that the C. albicans and A. fumigatus may respond to the growth condition and 
attempt to protect themselves by altering various biosynthetic pathway and in so doing 
alter their susceptibility to caspofungin. 
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Low environmental pH has been shown to affect the antifungal action of azoles 
against C. albicans, and an increase in MIC of fluconazole in an acidic environment has 
been demonstrated (Marr et al., 1999). From the result in section 3.1.5 and 3.4.7 we can 
speculate that the pH of the environment is important for the in vitro response of C. 
albicans and A. fumigatus to caspofungin. Analysis of the protein expression of C. 
albicans and A. fumigatus cultured at various pH levels allowed us to assess the change in 
protein expression which may have contributed to the altered susceptibility of these 
organisms to caspofungin. From data analysis of 1D SDS-PAGE gel (Figure 3.1.5) there 
was an apparent decrease in expression of a number of C. albicans proteins in acidic (e.g. 
pyruvate decarboxylase and IgE-binding protein) and basic (e.g. hypothetical protein) 
environment in comparison to the proteins visualised at the pH 7. LC-MS facilitated the 
identification of proteins of interest from the 1D gel shown in Figure 3.6 and of the 
proteins successfully identified, glyceraldehyde-3-phosphate dehydrogenase and enolase 1 
OS were of particular interest. Increase in the   expression of these proteins compared to 
that at neutral pH correlated with increase in tolerance of C. albicans to caspofungin. 
Interestingly glyceraldehyde-3-phosphate dehydrogenase is involved in cell wall 
biogenesis as well as having other function in glycolysis, adherence and modulation of 
immune system (Kelly & Kavanagh, 2010). Enolase is involved in the glycolytic pathway 
as a vital component, catalyzing the dehydration of 2-phosphoglycerate to create 
phosphoenolpyruvate (Sundstrom and Aliaga, 1992). Enolase is predominantly found in 
the cytoplasm and may also be found in cell wall as glucan associated cell wall protein 
(Pitarch et al., 2002). Proteins extracted from A. fumigatus and analysed using 1D SDS-
PAGE are shown in Figure 3.18. Results show that an increase in protein expression 
compared to that at pH7 was correlated with increase in tolerance of A. fumigatus to 
caspofungin (Figure 3.16). One protein (FG-GAP repeat protein) showed an up-regulation 
(2.1 fold increase) at pH 3. Other identified A. fumigatus protein e.g. 46 kda IgE-binding 
antigen, catalase and L10A ribosomal protein gave similar results and showed shown 
increased expression at acidic and basic pH. The increase tolerance of A. fumigatus to 
caspofungin may be due to elevated expression of certain proteins due to the change in 
environmental pH.  
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Rodaki et al., (2009) demonstrated the induction of a number of genes when C. 
albicans was grown at high levels of glucose and these genes were involved in combating 
osmotic and oxidative stress. As a result of this an increase in the tolerance of C. albicans 
to azole antifungal drugs was observed. Caspofungin is known to cause oxidative and 
osmotic stress in C. albicans (Kelly et al., 2009). A number of proteins were altered in 
expression in C. albicans when grown in elevated concentrations of glucose. A range of 
proteins were identified by LC-MS, some showed altered expression as shown in Table 
3.20. Malate dehydrogenase, NAD-dependent and thioredoxin peroxidase showed an 
increase in protein expression at 10% glucose by increase to 2.9 and 3.1 fold respectively 
compared to 1% glucose supplemented media. This alteration in the protein expression 
may be important in detoxifying the cell at different environmental conditions. 
There was a strong increase in expression of proteins when the culture serum 
concentration was increased; an increase in expression of particular proteins may 
contribute to the decrease in susceptibility of C. albicans and A. fumigatus to caspofungin.  
A number of identified A. fumigatus proteins showed a change in expression when the 
serum level was altered e.g Catalase increase in expression by 3.8 and 2.9 fold in case of 
100 and 200 µg/ml BSA supplemented culture respectively. The proteins Secreted 
dipeptidyl peptidase DppV and Cobalamin-independent methionine synthase Met H/D 
were up-regulated by 3.7 and 3.5 fold respectively when cultures were supplemented with 
100ug/ml BSA. Mycelial catalase Cat1 was increased in expression by 3.2 fold when 
200µg/ml BSA was applied to the culture media. The potential mitochondrial inner 
membrane ATP/ADP translocator and IgE - binding protein were increased in expression 
by 2.6 and 2.7 fold at 100 µg/ml BSA respectively. A similar result was shown in the case 
of C. albicans when the cells were grown in different serum level e.g Cyclophilin type 
peptidyl-prolyl cis-trans isomerase and Phosphoglycerate mutase were increased in 
expression by 1.3 and 2.4 fold at 200ug/ml BSA.  Alcohol dehydrogenase 1 and Fructose-
bisphosphate aldolase, were increased in expression by 1.4 and 1.3 fold at 200 µg/ml BSA. 
The mitochondrial protein identified is likely mitochondrial malate dehydrogenase wich 
showed an increased in expression by 1.4 fold at 200 µg/ml BSA. Some of these proteins 
may help the cell to combat oxidative stress and thus withstand the effects of caspofungin. 
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Differences in germination of A. fumigatus conidia were found in a variety of carbon 
sources, including glycerol, acetate, sorbitol, and lactose (Xue et al., 2004). Spore swelling 
is dependent upon an external supply of carbon compounds. Germination at a fixed 
incubation time is much reduced by lack of nutrients and is influenced more by the level of 
external carbon than by that of external nitrogen compounds (Carmbell, 1971). In this 
study we examined the effect of various levels of FBS on the activity of caspofungin 
against A. fumigatus using a microscopic examination of germ-tubes and hyphae 
formation. Under a variety of conditions we found a change in the germination rate. At low 
serum concentrations germination is inhibited at 5 and 10 µg/ml caspofungin as shown in 
(Figure 3.22), in contrast, at high serum concentrations there is an increase in the 
germination rate. Similar results were obtained when cultures of A. fumigatus were 
supplemented with high levels of glucose (Figure 3.24).  
The results presented here demonstrate that environmental conditions e.g. high 
glucose level (10%), high serum concentration (200 µg/ml) and acidic pH all increased the 
activity of catalase, glutathione reductase (GLR) and superoxide dismutase (SOD) in C. 
albicans and A. fumigatus. These enzymes may allow the fungus tolerate the osmotic and 
oxidative effects of caspofungin. 
 
Acidic pH, high serum level and high glucose level lead to an increase the enzymatic 
activity of C. albicans and A. fumigatus, which may correlate to the tolerance of these 
organisms to caspofungin activity. The results presented in this Chapter demonstrate that a 
variety of environmental conditions alter the susceptibility of C. albicans and A. fumigatus 
to caspofungin. These conditions may also alter the activity of caspofungin but this work 
shows that environment-induced alterations in protein expression, enzymatic activity and 
germination have the capacity to reduce the sensitivity of these fungi to caspofungin.   
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Chapter 4 
4 ANALYSIS OF THE EFFECT OF 
CASPOFUNGIN ON THE LEAKAGE OF 
INTRACELLULAR CONTENTS FROM 
ASPERGILLUS FUMIGATUS 
 
4.1 Introduction 
Caspofungin shows excellent in vitro and in vivo activity against Candida and 
Aspergillus species (Maertens et al., 2004; Zaoutis et al., 2009). It has an excellent safety, 
it is as effective as, and usually better tolerated than, liposomal amphotericin B (Maertens 
et al., 2004). Caspofungin was the first member of the echinocandins to be licensed for 
use, and functions by inhibiting the synthesis of β -1,3-D-glucan, an essential component 
of the fungal cell wall (Deresinski et al., 2003). It is unlike polyenes and azoles that target 
ergosterol or the ergosterol biosynthetic pathway, respectively. Caspofungin mediated 
disruption of glucan synthesis leads to the formation of an osmotically fragile aberrant cell 
wall and osmotic lysis of the cell at high concentrations due to a long fatty acid side chain 
that may allow intercalation in the bi-layer of the fungal cell membrane (Deresinski et al., 
2003; Denning, 2003). A. fumigatus is an important fungal pathogen, particularly affecting 
those with pre-existing pulmonary malfunction (e.g., asthma, cystic fibrosis), disease (e.g., 
cancer, tuberculosis, chronic granulomatous disease), or undergoing immunosuppressive 
therapy prior to organ transplantation (Brookman and Denning, 2000). The fungus can 
induce a variety of diseases including allergic and invasive aspergillosis (Denning, 1996). 
A. fumigatus displays a number of virulence factors that may facilitate tissue colonization 
and persistence in the host (Amitani et al.,1995; Rementeria et al.,2005). One of these, 
gliotoxin (C13 H14 N2 O4 S2), is an epipolythiodioxopiperazine toxin (Waring and Beaver 
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1996), which displays immunosuppressive properties in vivo (Sutton et al.,1995). 
Gliotoxin is capable of inhibiting macrophage function and may alter the immune response 
to Aspergillus as it can induce apoptotic cell death in macrophages (Waring and Beaver 
1996; Sutton et al., 1995), and disrupt the function of neutrophils (Tsunawaki et al., 2004). 
In addition, gliotoxin has been implicated in the destruction of lung parenchyma in 
invasive aspergillosis (Sutton et al., 1995) and the penetration of blood vessels in angio-
invasive aspergillosis (Fraser, 1993). Caspofungin has previously been shown to induce 
amino acid and protein leakage from growth-arrested stationary phase C. albicans cells 
indicating that inhibition of glucan biosynthesis may not be the only mode of action 
exhibited by this drug (Kelly and Kavanagh, 2010). It was postulated that caspofungin 
could have a secondary effect in altering membrane permeability. The aim of the work 
presented here was to establish if exposure of A. fumigatus to caspofungin induced leakage 
of intracellular amino acids, protein and gliotoxin and whether the fungus responded to this 
by synthesizing elevated levels of toxin intra-cellularly. The immunosuppressive effects of 
gliotoxin are well established (Sutton et al., 1995; Tsunawaki et al., 2004) and any therapy 
that inadvertently induced the increased biosynthesis and release of this toxin could 
exacerbate inflammation and tissue damage at the site of infection. 
 
4.2 Analysis of amino acid leakage from A. fumigatus  
A. fumigatus hyphae were assessed for amino acid leakage following caspofungin 
treatment. Free amino acids were measured using the Ninhydrin method as described 
previously in section 2.26. All results expressed are in term of aspartic acid and glutamic 
acid, which were used as standards. 
4.2.1 Effect of DMSO on the amino acid leakage from A. fumigatus hyphae 
A. fumigatus conidia were inoculated into 50 ml of RPMI1640 and grown for 96 
hours as described in section 2.26. Hyphae were collected by filtering and washed as 
previously described. The hyphal mass (2 g) was re-suspended in 25 ml PBS containing 
0.5% v/v Dimethyl sulfoxide (DMSO), cultures were incubated at 37 °C and 200 rpm for 
another 4 hours. At 4-hour time point 750 µl of culture filtrate was removed and filtered 
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through 0.45 µM syringe filters (Sarstedt). Free amino acids were measured using the 
Ninhydrin colorimetric method (Reeves et al., 2004). The results show a significant 
increase (P = 0.02) in the amount of free amino acids when the culture was supplemented 
with DMSO compared to control as shown in Figure 4.1. 
 
4.2.2 Effect of culture media on the amino acid leakage  
Four different types of culture media (Antibiotic medium 3, Aspergillus minimal 
media, Nutrient broth and RPMI1640) were used to determine the amount of amino acid, 
which leaked from A. fumigatus hyphae at three different time point (0.5, 2 and 4 hours) of 
incubation at 37 oC, and 200 rpm. Ninety six hour old culture hyphae were collected using 
miracloth (Calbiochem) to remove the A. fumigatus hyphae, one gram of dry hyphae was 
washed twice with PBS, and resuspended in 25 ml PBS. At each time point 750 µl of 
culture filtrate were removed and filtered through 0.45 µM syringe filters (Sarstedt). Free 
amino acids were measured using the ninhydrin colorimetric method as previously 
described. Results in Figure 4.2 show that different media affect the amount of amino acid 
released from A. fumigatus hyphae, as the highest release of amino acid occurred when A. 
fumigatus was grown in RPMI1640 culture media for 4 hour. 
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Figure 4.1 Determination the effect of DMSO on amino acid leakage from A. fumigatus 
hyphae.  
96 hour old hyphae were used to assess the amount of amino acid that escaped from the 
cells. * p = 0.02 
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Figure 4.2 Four different types of culture media were used to determine the amount of 
amino acid leakage. 
Amino acid released from A. fumigatus hyphae for 0.5, 2 and 4 hours incubation at 37 oC 
and 200rpm.  
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4.2.3 Effect of low and high dose of caspofungin on amino acid leakage 
Caspofungin has previously been shown to induce amino acid and protein leakage 
from stationary phase C. albicans (Kelly and Kavanagh, 2010). A. fumigatus culture was 
grown for 96 hours as described in section 2.21. Two gram of hyphae were re-suspended in 
25 ml PBS and exposed to 0.5% v/v DMSO (as a positive control), or caspofungin (0.1 
µg/ml or 1.0 µg/ml) for 4 hour. The amount of amino acid in the supernatant was measured 
as described previously. The result in Figure 4.3 shows highest amount of amino acid was 
detected when the hyphae were exposed to 1.0 µg/ml caspofungin 
 
4.2.4 Effect of the caspofungin dose and incubation time on the amino acid leakage 
Three different concentrations of caspofungin were used on A. fumigatus hyphae 
which were grown for 24, 48, 72 and 96 hour in RPMI1640. Amino acid leakage was 
measured for all samples. Results show a proportional increase in the amount of amino 
acid leakage with the increase in caspofungin concentration, the highest level of amino 
acid was detected in 72 hour old culture exposed to 1.0 µg/ml caspofungin as shown in 
Figure 4.4. 
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Figure 4.3 The effect of caspofungin on amino acid leakage from the hyphae of A. 
fumigatus.  
Four hours incubation with 0.1 and 1.0 µg/ml caspofungin, 0.5 % v/v DMSO as a positive 
control. Average of three independent experiments. *P = 0.03 
 
Figure 4.4 Amino acids leakage from A. fumigatus hyphae at various incubation times 
with three different concentrations of caspofungin compared to control.  
*P = 0.025,  
122 
 
4.2.5 The effect of time on the amino acid release from the A. fumigatus hyphae in 
presence of drug 
Further investigations of amino acids leakage from the A. fumigatus hyphae were 
conducted using low and high doses of caspofungin at three time points (1/2, 2 and 4 
hours). The release of intracellular amino acid was investigated as described previously. In 
Figure 4.5 the results indicate the variable amount of amino acid leakage detected when the 
cultures were exposed to drugs at different times. Results show an increase in the release 
of amino acid when hyphae were treated with drugs particularly at 4 hours, the highest 
amount of amino acid detected was 5.5 µg/ml at a dose of 1.0 µg/ml caspofungin. 
 
4.3 Analysis of protein leakage from A. fumigatus 
Caspofungin is widely used in the treatment of systemic fungal infections and has the 
advantage of being highly effective but of negligible toxicity to humans (Denning, 2003). 
Previous work established that exposure of A. fumigatus to the polyene antifungal agent 
Amphotericin B lead to leaking of intracellular content including proteins (Reeves et al., 
2004). To determine the quantity of protein released from the A. fumigatus hyphae, 
samples were assayed using the Bradford assay (Bio-Rad) as previously described in 
section 2.23, with BSA (Sigma Aldrich) as standard. 
4.3.1 Examination of the effect of DMSO on protein Leakage from A. fumigatus 
Stationary phase (96 hour) A. fumigatus hyphae were chosen for this analysis since 
glucan synthesis would be low in a stationary phase cultures. Figure 4.6 shows the amount 
of protein released into the media at indicated time. Results indicate that the amount of 
protein released increased as the exposure of hyphae to DMSO increased compared to the 
control. 
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4.3.2 Effect of caspofungin on protein leakage from A. fumigatus 
 A. fumigatus conidia were inoculated into 50 ml of RPM1640 plus 5% (v/v) FBS, 
the culture was incubated and hyphae were harvested as described in section 2.23.  Hyphae 
(1.5g) were re-suspended in either PBS (5 ml), DMSO (0.5% (v/v); 5 ml) or caspofungin 
(0.1 or 1.0 µg/ml; 5 ml) and incubated at 37 °C for 240 minutes. To determine the quantity 
of protein released from the hyphal mass, supernatants at 0, 30, 120, and 240 minutes were 
assayed for their protein content using a Bradford assay. The result is shown in Figure 4.7. 
The amount of protein released was increased when the culture was treated with DMSO 
and different doses of caspofungin at three time points.   
4.3.3 Summary 
These result show that large amounts of amino acids and protein escaped from the 
cells when hyphae were exposed to DMSO and caspofungin at different time point. 
 
4.4 Analysis of the effect of caspofungin on biosynthesis and 
release of gliotoxin from A. fumigatus  
A. fumigatus is known to produce various immunosuppressive mycotoxins including 
gliotoxin and the high concentration of oxygen in the lung may provide optimal conditions 
for the production of gliotoxin by A. fumigatus. A. fumigatus has been shown to produce a 
range of secondary metabolites/mycotoxins with different harmful effects. These include 
gliotoxin, fumagillin, helvolic acid, fumitremorgin, fumigaclavine C, aureperone C, 
restrictocin (Kamei and Wanatabe, 2005; Dagenais and Keller, 2009). Gliotoxin is an 
epipolythiodioxopiperazine (ETP) type toxin, which is characterised by a disulphide bridge 
(Fox and Howlett, 2008), and is the best-characterised mycotoxin and most potent 
secondary metabolite produced by A. fumigatus (Kwon-Chung and Sugui, 2009). Spikes et 
al., (2008) demonstrated that gene clusters responsible for the biosynthesis of ETP type 
toxin have been identified in A. fumigatus, which is responsible for the production of 
gliotoxin.  
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 Figure 4.6 Protein leakage from A. fumigatus at different time points for control and 
DMSO treated hyphae.  
P = 0.02 
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Figure 4.7 Amount of protein leaking (µg/ml) from A. fumigatus exposed to 0.1 and 1.0 
µg/ml caspofungin as determined using standard curve of BSA at three different times 0.5, 
2 and 4 hour.  
*P = 0.023, **P = 0.05 
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4.4.1 Effect of different type of culture media on the growth of A. fumigatus 
Sterile flasks containing 100 ml of RPMI1640, AB3, AMM and NB were 
inoculated with A. fumigatus conidia as described in section 2.18 to give a concentration of 
1x105conidia/ml and incubated at 37 °C and 200 rpm for 96 hour. After 96 hours the 
contents were filtered and squeeze through Miracloth filters (Calbiochem). Dry weights 
were recorded for each type of culture media. Results show that when AB3 and RPMI1640 
were used to culture the A. fumigatus, a high growth rate was achieved at ninety-six hour 
incubation and gave 2.8 and 2.3 gram per 100 mls, respectively. 
4.4.2 Effect of caspofungin on the Growth of A. fumigatus using RPMI1640 
MEA plates containing sporulating A. fumigatus colonies were washed with 10 ml 
of 0.01% (v/v) Tween 80 (Merck) in Phosphate Buffered Saline (PBS, pH 7.2; Sigma 
Aldrich) to isolate conidia. The latter were washed twice in sterile PBS, harvested by 
centrifugation (1,500 g, 5 min in a Beckman GS-6 centrifuge) and enumerated using a 
haemocytometer. A. fumigatus conidia were inoculated in RPMI1640 as described in 
section 2.8. Cultures were supplemented with caspofungin (0.01, 0.1 or 1.0 µg/ml) for 
various times (24, 48, 72 and 96 hours). 
It was previously determined in section 3.4 that a concentration of 0.1 µg/ml 
caspofungin inhibited growth of A. fumigatus by approximately 50%. A growth curve was 
constructed of fungal biomass versus incubation time. Results show the A. fumigatus 
growth was inhibited by 50% at a concentration of 0.1 µg/ml caspofungin and 80% at 
concentration of 1.0 µg/ml caspofungin at 72-hour incubation time (Figure 4.9). 
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Figure 4.8 Determination of hyphal weight (gram) after 96-hour incubation at 37oC, 
200rpm, and using four types of culture media.  
250 ml conical flasks were used and the total volume was 100 ml for each medium. 
 
 
Figure 4.9 Hyphae weight at different incubation times with three different Caspofungin 
concentration using RPMI1640 culture media. 
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4.4.3 The effect of environmental conditions on the biosynthesis and release of 
gliotoxin 
Cultures of A. fumigatus (72-hour-old) were used in this experiment.  Aspergillus 
hyphae or culture contents from different environmental conditions were filtered through 
miracloth (Calbiochem), weights were recorded and gliotoxin was extracted from the 
culture filtrate by mixing with an equal amount of chloroform (Sigma-Aldrich) for 2 hour. 
The extraction of gliotoxin from the chloroform layer was accomplished by rotary 
evaporation at 55 °C. The dried extracts were dissolved in 250 µl of molecular-grade 
methanol (Sigma-Aldrich) and the level of gliotoxin determined by Reverse phase high 
performance liquid chromatography (RP-HPLC).  
 
4.4.3.1 The effect of Glucose on Gliotoxin biosynthesis and release from A. fumigatus 
hyphae 
RPMI1640 culture media was used in this experiment. A range of glucose 
concentrations were used to determine the effect of glucose on the gliotoxin release from 
the A. fumigatus hyphae. Cultures were supplemented with different amounts of glucose 
(0.5, 1.0, 2.5 or 5.0 %), cultures were incubated as described in section 2.18, gliotoxin 
concentration from each condition was determined using RP-HPLC. Results were recorded 
and presented in Figure 4.10. Results show the highest amount of gliotoxin release was in 
2.5% glucose supplemented culture media and the high at value for intracellular gliotoxin 
was recorded in 1.0% glucose supplemented culture media. 
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Figure 4.10 Effect of glucose on the extracellular (A
) and intracellular (B
) gliotoxin, A. fum
igatus w
as grow
n on R
PM
I1640 for 72 hour in 
different concentrations of glucose.  
P = 0.025 
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4.4.3.2 Effect of Fetal bovine serum (FBS) on the biosynthesis and release of Gliotoxin 
from A. fumigatus hyphae 
RPMI1640 medium was supplemented with FBS (1.0, 2.5, 5.0 or 10 %) and all 
cultures were incubated as described in section 2.20.2. Gliotoxin concentration was 
determined as described in section 2.20.7.  Further experiments were conducted in MEM 
using 10, 20 and 30 % FBS compared to optimal condition (pH 7, 2% glucose and 5% 
FBS). The HPLC results were recorded and the results plotted are shown in Figures 4.11 
and 4.12. Results in Figure 4.11 indicate that the 10% FBS supplemented cultures show the 
highest amount of extracellular gliotoxin and 5% FBS medium gave the high amount of 
intracellular gliotoxin. The result in Figure 4.12 show the highest amount of internal and 
external gliotoxin was observed for hyphae grown in 20% of FBS medium. 
 
4.4.3.3 Effect of pH on gliotoxin biosynthesis and release from A. fumigatus hyphae 
Media of different pH (3.5, 4.5, 5.5, 6.5 or 7.5) were used and values were adjusted 
for the culture media before conidia were inoculated. A. fumigatus culture conditions were 
maintained as described in section 2.18. Gliotoxin release from the hyphae was determined 
using RP-HPLC; the results are presented in Figure 4.13. Results show that the media with 
pH value of 7.5 gave the highest amount of gliotoxin biosynthesis and release from the 
hyphae and the lowest amount was recorded at pH 3.5. 
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Figure 4.11 Effect of FB
S on the external (A
) and internal (B
) gliotoxin, A. fum
igatus w
as grow
n in R
PM
I1640 for 72 hour at different 
concentration of FB
S.  P = 0.05 
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Figure 4.12 Effect of three different concentrations of FB
S on the release (A
) and biosynthesis (B
) of gliotoxin from
 A. fum
igatus, using M
EM
.  
The optim
al condition (pH
 7, glucose 2%
 and 5%
 FB
S). P = 0.023 
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Figure 4.13 Effect of pH
 on the internal and external concentration of gliotoxin. A. fum
igatus w
as grow
n on R
PM
I1640 for 72 hour at different 
pH
 values.  P = 0.05 
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4.4.3.4 Effect of aeration on gliotoxin release from and biosynthesis in A. fumigatus 
In order to study the effect of aeration on gliotoxin release from A. fumigatus, 
hyphae were incubated at 25 oC, 30 oC and 37 oC under static or shaking condition to 
provide an oxygen supply to the culture. After 72 hours of incubation, all samples were 
taken and A. fumigatus filtrates were used to extract the gliotoxin released from the hyphae 
by mixing with equal volums of chloroform. The gliotoxin concentration in each sample 
was determined using RP-HPLC and the results are plotted in Figures 4.14 and 4.15. The 
results show the highest amount detected in Aspergillus filtrate media and intracellular 
gliotoxin at 37 oC and 200 rpm which show 6.5 (±1.1) µg/ml and 180 (±12.1) µg/g of 
hyphae. For the 25 oC incubation there was not enough growth for internal and external 
gliotoxin concentration to be measured. 
 
4.4.3.5 Determination of the effect of incubation time on gliotoxin production using 4 
types of culture media 
To determine the effect of incubation time on the gliotoxin release from A. 
fumigatus hyphae, four types of culture media were used in this experiment.  A. fumigatus 
conidia were inoculated into each medium as described in section 2.20.4. Gliotoxin was 
extracted from culture filtrate using chloroform. Results are expressed as µg/ml.  
The level of gliotoxin released by A. fumigatus was detected in culture filtrate after 
24, 48, 72, and 96 hour incubation at 37 oC, 200 rpm and measured using RP-HPLC. 
Results show different types of culture media gave different amounts of gliotoxin release, 
Figure 4.16 and 4.17 show highest values were recorded at 72 hour with RPMI1640 and 
AMM, but in 96 hour old culture greater values were recorded when the MEM and AMM 
were used as shown in Figure 4.18 and 4.19.  
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Figure 4.14 Effect of aeration on the release of gliotoxin from A. fumigatus.  
Cells were grown on RPMI1640 for 72 hour at different aeration [Shaker, static,] and 
temperature conditions [25, 30 and 37 oC]. 
 
Figure 4.15 Effect of aeration on the internal gliotoxin, A. fumigatus  
Conidia were grown on RPMI1640 after 72-hour incubation at different aeration [Shaker, 
static,] and temperature conditions [30 and 37 oC]. 
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Figure 4.16 Gliotoxin production at 24, 48, 72 and 96 hour when the A. fumigatus conidia 
were grown in RPMI1640 supplemented with 5% FBS at 37 oC and 200rpm. 
 
 
 
Figure 4.17 Gliotoxin production at 24, 48, 72 and 96 hour when the A. fumigatus conidia 
were grown in AB3 at 37 oC and 200rpm. 
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Figure 4.18 Gliotoxin production at 24, 48, 72 and 96 hour when the A. fumigatus conidia 
were grown in MEM supplemented with 5% FBS at 37 oC and 200rpm. 
 
 
 
Figure 4.19 Gliotoxin released at 24, 48, 72 and 96 hour when the A. fumigatus conidia 
were grown in AMM at 37 oC and 200rpm. 
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Figure 4.20 Effect of caspofungin on gliotoxin release, from
 A. fum
igatus (96 hour old).  
C
ulture treated w
ith low
 (1.0 µg/m
l) and high (10 µg/m
l) doses of C
aspofungin, at 0.5, 2 and 4 hour using one gram
 hyphae m
ass of (96 hour old 
culture). *P < 0.05, **P = 0.02 
140 
 
4.4.3.6 Effect of caspofungin on the gliotoxin production by A. fumigatus.  
Ninety six hour old hyphae were resuspended in low (1.0 µg/ml) or high (10 µg/ml) 
doses of caspofungin for 0.5, 2 and 4 hour (Figure 4.20). After each time the supernatants 
were collected and the gliotoxin was extracted as described in section 2.18. Results show 
the highest concentration of gliotoxin recorded with high dose of caspofungin at 0.5 hour 
other results show an increase in the amount of gliotoxin when the cells were exposed to 
drug for 4 hour using RPMI1640 and MEM (Figure 4.21). 
4.4.4 Effect of different doses of caspofungin on the amount of Gliotoxin detected at 
different time of incubation. 
Cultures of A. fumigatus were grown at 37 °C for 96 hour, harvested, washed and 
resuspended in PBS supplemented with caspofungin (0.01, 0.1 or 1.0 µg/ml). The release 
of gliotoxin was quantified by RP-HPLC after 4-hour exposure to the drug or DMSO. The 
results (Figure 4.22 and Figure 4.23) indicate that the culture supplemented with 1.0 µg/ml 
caspofungin released a significantly greater amount of gliotoxin than the untreated control 
(P ≤ 0.03). Results indicate that exposure of stationary phase A. fumigatus hyphae to 
caspofungin leads to increased leakage of gliotoxin.  
 
4.4.4.1 Effect of long term exposure (24 hour) to caspofungin on gliotoxin release 
from A. fumigatus 
Exposure of cultures of A. fumigatus to caspofungin for 24 hours leads to increased 
internal and external concentrations of gliotoxin. Cultures of A. fumigatus were grown in 
RPMI medium for 96 hour at 37 °C at which time caspofungin was added to cultures to 
give final concentrations of 0.1 or 1.0 µg/ml. The cultures were then incubated for a further 
24-hour in RPMI1640 medium at which time the internal and external gliotoxin 
concentrations were ascertained as described. The results reveal an increase in the external 
gliotoxin concentration in cultures that were supplemented with caspofungin. The culture 
supplemented with 1.0 µg/ml caspofungin had a significantly higher level of gliotoxin in 
culture medium at 8 h (8.29 ± 0.08 µg/ml), 16 h (6.09 - 0.5 µg/ml) and 24 h (6.78 ± 0.29 
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µg/ml) (Figure 4.22A) compared to the relevant controls. In addition, the intracellular 
concentration of gliotoxin at 24 hour also increased in the cultures supplemented with 0.1 
or 1.0 µ g/ml caspofungin relative to the control (Figure 4.22B). These results indicate that 
incubation of stationary phase cultures of A. fumigatus with caspofungin for 24 hour leads 
to increased extracellular and intracellular levels of gliotoxin. 
 
4.4.4.2 Effect of short term exposure (4 hour) to caspofungin on gliotoxin released 
from A. fumigatus 
Cultures of A. fumigatus were grown for 96 hour in RPMI1640 medium at 37 °C. 
Cultures were supplemented with caspofungin (0.01, 0.1 or 1.0 µg/ml) for 4 hour. After 
this time hyphae were harvested, washed, and resuspended in the same volume of fresh 
RPMI medium as previously. The concentration of gliotoxin in the culture medium and 
within the hyphae (intracellular) was assessed for up to 48 hour after the short-term (4 
hour) exposure to caspofungin. Cultures exposed to 1.0 µg/ml caspofungin had 
significantly higher gliotoxin concentrations in the medium at 24 hour (7.94 ± 1.88 µg/ml) 
and 48 h (11.19 ± 0.57 µg/ml) post-exposure to caspofungin compared to the relevant 
control (Figure 4.23A). Internal concentrations of gliotoxin were also measured, as 
described, 48 hour post-exposure to caspofungin (Figure 4.23B). Internal gliotoxin levels 
were significantly higher (224.8 µg/g of hyphae) in the cultures that had been exposed to 1 
µg/ml caspofungin for 4 hour compared to the control. These results reveal that short-term 
(4 hour) exposure to caspofungin has the ability to potentiate the production of gliotoxin 
when cells are placed in fresh medium.  
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Figure 4.21 Effect of caspofungin on gliotoxin production after short-term
 exposure of 96 old cultures.  
1 g of H
yphae (96 old) w
as exposed to low
 (1.0 µg/m
l) and high (10 µg/m
l) doses of C
aspofungin for 4 hours using M
EM
 and R
PM
I1640 
supplem
ented w
ith 5%
 FB
S. 0.5 %
 D
M
SO
 is the positive control. 
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Figure 4.22 Effect of long-term
 caspofungin exposure (24 hour) on gliotoxin release and biosynthesis in A. fum
igatus.  
Extracellular and intracellular gliotoxin levels in 96-hour-old cultures after exposure to caspofungin for 24 hours. G
liotoxin release w
as 
m
easured at 8, 16 and 24 hours after addition of caspofungin to cultures (A
). The intracellular concentration of gliotoxin w
as m
easured at 
24 hours (B
). Statistically significant difference com
pared to control indicated by * P ≤ 0.03. 
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Figure 4.23 Effect of short-term
 caspofungin exposure (4 hour) on gliotoxin release and biosynthesis in A. fum
igatus.  
Extracellular gliotoxin concentration (A
) and internal concentration of gliotoxin (B
) in A. fum
igatus 4, 24 and 48 hours after exposure of 
hyphae to caspofungin for 4 hours w
as m
easured. The intracellular concentration of gliotoxin w
as m
easured at 48 hours. Statistically 
significant difference com
pared to control indicated by * P ≤0.04. * * Indicates P ≤ 0.023. 
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4.4.5 Effect of Caspofungin (0.01, 0.1 and 1.0 µg/ml) on extracellular and 
intracellular gliotoxin levels when hyphae were exposed to drug for 4 hours. 
Cultures of A. fumigatus were grown in RPMI medium for 96 hour at 37 ° C at 
which time caspofungin was added to cultures to give final concentrations of 0.01, 0.1 or 
1.0 µg/ml. The cultures were incubated for a further 24 hour in RPMI1640 medium at 
which time the internal and external gliotoxin concentrations were ascertained as described 
previously. The results reveal an increase in the external gliotoxin concentration in cultures 
that were supplemented with caspofungin. The culture supplemented with 1.0 µg/ml 
caspofungin had a significantly higher level of gliotoxin in culture medium compared to 
the relevant controls as indicated in Figure 4.24 (P = 0.02). In addition, the intracellular 
concentration of gliotoxin at 24 hour also increased in the cultures supplemented with 0.1 
or 1.0 µg/ml caspofungin relative to the control. These results indicate that incubation of 
stationary phase cultures of A. fumigatus with caspofungin for 24 hour leads to increased 
extracellular and intracellular levels of gliotoxin. 
 
4.4.6 Summary 
Exposure of A. fumigatus hyphae to caspofungin show increased in the biosynthesis and 
release of gliotoxin 
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Figure 4.24 Effect of caspofungin on gliotoxin biosynthesis (A) and release (B) from A. 
fumigatus  
Hyphae (1.0 gram) of 96 old cultures were exposed to three different concentration of 
caspofungin for 4 hours. Gliotoxin was extracted, intracellular and extracellular gliotoxin 
were detected using RP-HPLC. 
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4.5 Ergosterol Extraction from A. fumigatus 
The amount of ergosterol present in the cell membrane of fungi is important for the 
action of polyene and azole antifungal drugs. Polyenes demonstrate antifungal activity by 
binding to ergosterol leading to leakage of metabolites, which may lead to cell death (Abu 
Salah, 1996). Azoles disrupt ergosterol biosynthesis leading to the formation of toxic sterol 
intermediates, which may prove lethal to fungal cells (White et al., 1998). The ergosterol 
content of A. fumigatus exposed to caspofungin was analysed in order to establish if the 
drug affected cell membrane integrity or structure.  
4.5.1 Effect of caspofungin on the ergosterol biosynthesis of A. fumigatus 
Sterols were extracted using the technique by Arthington-Skaggs et al. (1999) with 
some modification as described in section 2.13. Incubation times of 24, 48 and 72 were 
used (Figure 4.25), and different concentrations of caspofungin were used (Figure 4.26). 
Miconazole was used as a positive control (Figure 4.26). Two gram dry weight of hyphae 
were collected for each sample. Results show an increase in ergosterol biosynthesis at 0.1 
and 1.0 µg/ml caspofungin relative to control culture (Figure 4.25). Figure 4.26 shows a 
significant increase in ergosterol level over three caspofungin concentrations range used 
compared to control (P = 0.05).  
4.5.2 Summary 
Caspofungin increased the biosynthesis of ergosterol in A. fumigatus. Increased 
ergosterol may be produced to stabilise the fungal cell membrane. 
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Figure 4.25 D
etection of ergosterol in A. fum
igatus using G
as chrom
atography.  Sam
ples w
ere exposed to 1.0 µg/m
l C
aspofungin for 24, 
48 and 72 hour. 
P=0.02 
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Figure 4.26 D
etection of ergosterol in A. fum
igatus using G
as chrom
atography, 72 hour old R
PM
I1640 culture.  
Sam
ples w
ere exposed to 0.01, 0.1 and 1.0 µg/m
l C
aspofungin for 4 hour exposure. 
P=0.05 
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4.6 Analysis of the A. fumigatus hyphal wall by Scanning 
Electron Microscopy following exposure to caspofungin.  
A. fumigatus hyphae were exposed to low (0.1 µg/ml) or high (1.0 µg/ml) doses of 
caspofungin for 48 hours. Hyphae were harvested and were prepared for scanning electron 
microscopy (SEM) as described in section 2.16. Three different sample preparation 
techniques were employed (Air drying, Freeze drying and Critical point drying) to ensure 
no artifacts due to the drying process were observed. Samples that were processed by the 
Air-drying technique (Figure 4.27) or Freeze-drying technique (Figure 4.28) demonstrated 
no alteration in the morphology of the hyphae following exposure to caspofungin. The 
sample prepared using the critical point drying technique (Figure 4.29) demonstrated some 
change in the hyphae shape as the hyphae surface appeared smoother and possibly thinner 
than the control especially in those hyphae exposed to  1.0 µg/ml caspofungin. These 
results demonstrated the lack of gross morphological changes to the hyphae of A. 
fumigatus following exposure to caspofungin.  In particular no evidence for cell lysis was 
detected nor was the presence of deformed hyphae observed in any of the caspofungin 
treated samples.  
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Dose 0.1 µg/ml Casp
Dose 1.0 µg/ml Casp Dose 1.0 µg/ml Casp
Air Dry Technique Air Dry Technique
ControlControl
Dose 0.1 µg/ml Casp
 
Figure 4.27: Image of Aspergillus fumigatus hyphae when treated with 0.1 and 1.0 µg/ml 
caspofungin using air-dry technique at magnification power 1.5 KX.  
Result taken in duplicate. 
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Dose 1.0 µg/ml Casp Dose 1.0 µg/ml Casp
Freeze Drying Technique Freeze Drying Technique
Control Control
Dose 0.1 µg/ml Casp Dose 0.1 µg/ml Casp
 
Figure 4.28 Image of Aspergillus fumigatus hyphae when treated with 0.1 and 1.0 µg/ml 
caspofungin using freeze drying technique at magnification power 1.5 KX.  
Result taken in duplicate. 
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Dose 1.0 µg/ml Casp Dose 1.0 µg/ml Casp
Critical Point Drying technique Critical Point Drying technique
Control Control
Dose 0.1 µg/ml Casp Dose 0.1 µg/ml Casp
 
Figure 4.29 Image of Aspergillus fumigatus hyphae when treated with 0.1 and 1.0 µg/ml 
caspofungin using Critical point drying technique at magnification power 1.5 KX.  
Result taken in duplicate. 
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4.7 Analysis of the proteins released by A. fumigatus following 
exposure to caspofungin   
In order to ascertain whether caspofungin induced the release of proteins from A. 
fumigatus, hyphae were suspended in PBS, exposed to 0.1 and 1.0 µg/ml caspofungin or to 
5% (v/v) DMSO for 4 hours and the released constituents were precipitated as described in 
section 2.28.1. The protein which was released from hyphae by 240 min was collected and 
placed on ice with protease inhibitors as described in section 2.28.2  
 
4.7.1 One-dimensional SDS-PAGE analysis of released protein 
Proteins were resolved on a 1-D SDS PAGE gel and stained with Coomassie blue 
(Figure 4.30). It was evident that several proteins were released from the control cells 
during the 4-hour incubation period. Cells treated with DMSO and caspofungin released 
more proteins. When hyphae were exposed to caspofungin, increased release of protein 
was evident when compared to the control. It was noted that the pattern of proteins 
released from DMSO and caspofungin-treated cells differed in that there was a greater 
number of larger proteins released when cells were treated with the DMSO. Released 
proteins ranged in size from 40 to 220 kDa. There was a significant increase in the 
abundance of band 1 (IgE-binding protein), 2 (aldehyde dehydrogenase) a cytoplasmic 
protein, 3 (alpha-1-antiproteinase precursor), 4 (secreted dipeptidyl peptidase), and 5 
(ATPB_NEUCR ATP synthase beta chain, mitochondrial precursor) also showed 
increased abundance when hyphae were exposed to 0.1 µg/ml caspofungin for 240 minutes 
(Table 4.1). A number of the released proteins are associated with the cytoplasm e.g band 2 
(aldehyde dehydrogenase), and could be released due to the activity of caspofungin on cell 
wall. However, mitochondrial protein band 5 (ATPB_NEUCR ATP synthase beta chain, 
mitochondrial precursor) may be a result of the increased permeability of the cell wall.  
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4.7.2 Effect of Caspofungin on the protein leakage from A. fumigatus as assessed by 
Two Dimensional SDS-PAGE analysis 
Two–dimensional SDS-PAGE was employed in order to further separate the 
released proteins and thus facilitate their identification by LC-MS. Cells were exposed to 
drugs for 4 hours and the released proteins were collected, separated by 2-D 
electrophoresis and stained with Coomassie blue (Figure 4.31). It is obvious that 
caspofungin induced the release of a number proteins and a change in spot intensity was 
observed as shown in the Figure 4.31. Selected spots were excised, washed, trypsin 
digested and analyzed on LC-MS as described previously in section 2.33.  Twelve peptide 
spots were successfully identified. The spot intensity changed following the treatment of 
cells with caspofungin. There was a significant increase in the abundance of spots 2 (14-3-
family protein ArtA), 4 (Triosephosphate isomerase), 6 (methyltransferase Sir-like), 7 
(Allergen Asp F3), 8 (mitochondrial peroxiredoxin Prx1), 9 (6-phosphogluconolactonase), 
10 (EEef1-beta subunit) and 12 (cobalamin-independent methionine synthase) (Table 4.2).  
A number of proteins (spots 6, 7, 8, 10, 11, 12) also showed increased abundance when 
hyphae were exposed to 0.1 µg /ml caspofungin for 240 minutes (Table 4.2). A number of 
the released proteins were associated with the cell wall e.g. spot 5 (endochitanase), and 
spot 7 (Asp F3)) and may have been released due to the perturbation in the cell wall 
structure associated with the activity of caspofungin. However, a number of proteins are 
normally located within the cell, e.g. spot 4 (Triosephosphate isomerase), spot 6 
(methyltransferase Sir-like), and spot A8 (mitochondrial peroxiredoxin Prx1) and their 
release from treated hyphae may be a result of the increased permeability of the cell wall. 
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Figure 4.30 V
isualization by 1 D
 SD
S-B
A
G
E of released proteins from
 A. fum
igatus follow
ing exposure to caspofungin.  
H
yphae w
ere exposed to caspofungin or D
M
SO
 and released proteins w
ere precipitated and separated by SD
S-PA
G
E.  
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T
able 4.1 Identified leaked peptides from
 A. fum
igatus plus fold increase in response to 0.1 and 1.0 µg/m
l caspofungin.  
B
ands w
ere excised, trypsin digested and analysed using LC
-M
S. The identity of bands w
as analysed to assess fold change in intensity. 
PBSDMSO
1.0 µg/ml0.1 µg/ml
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Aspergillus fumigatus
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1.28
3.6
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2
aldehyde dehydrogenase 
XP_746831
276
20%
Aspergillus fumigatus
1
1.28
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Figure 4.31 A
nalysis of protein leakage from
 caspofungin treated A. fum
igatus 
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T
able 4.2 List of identified proteins, using LC
-M
S, leaking from
 the A. fum
igatus hyphae w
hen the culture w
as exposed to 0.1 and 1.0 µg/m
l 
caspofungin.  
D
M
SO
 is the positive control 
0.5%
0.1 µg/ml 1.0 µg/ml
DMSO
Casp
Casp
1
245
Conserved hypothetical protein 
XP_749979
29%
Aspergillus fumigatus Af293
80
1.0
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2.3
2
731
14-3-3 family protein ArtA [H
2 O
2  induced]
XP_749464
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Aspergillus fumigatus Af293
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Conserved hypothetical protein [CAP1 dependent & H
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2  induced]
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4.7.3 Summary 
Protein was released from A. fumigatus hyphae throughout the incubation period 
but the greatest release occurred from hyphae exposed to 1.0 µg/ml caspofungin for 240 
minutes.  Protein was also released from hyphae exposed to 0.1µg/ml caspofungin and the 
level of release was comparable to that induced by exposure to DMSO which was 
employed as a positive control (Reeves et al., 2004).  Proteins were identified from 
different locations within the cell. e.g. cell wall, cytoplasm and mitochondria as shown in 
Table 4.1.  
 
4.8 Discussion  
Treatment of aspergillosis has previously centered on the use of the polyene 
antifungal (liposomal amphotericin B), however its limited efficacy and financial cost has 
limited its use. Furthermore the nephrotoxic effects have been reported with studies 
demonstrating high renal failure in patients (Bates et al., 2001). In recent years the use of 
caspofungin has been demonstrated as a combination therapy with azole antifungals. 
Caspofungin inhibits hyphal growth by targeting cell wall glucan synthesis and 
demonstrates limited toxicity thus highlighting utility in antifungal treatment (Patterson, 
2006; Sable et al., 2008). Its low toxicity makes it a more attractive antifungal agent for 
therapy than amphotericin B, which has characterized toxic side effects. The results 
presented in this Chapter demonstrate that exposure of A. fumigatus to caspofungin results 
in increased membrane permeability as measured by the elevated release of intracellular 
content (amino acids, protein and gliotoxin).  
Leaking of amino acid was reported previously when A. fumigatus hyphae were 
exposed to polyene antifungal Amphotericin B (Reeves et al., 2004). In this work the 
leaking of amino acid was significantly increased due to the effect of caspofungin on the A. 
fumigatus hyphae. This effect was confirmed by using DMSO as a positive control at 
different times of exposure.  However A. fumigatus is known to produce various 
immunosuppressive mycotoxins including gliotoxin (Watanabe et al., 2003). Part of the 
ability of A. fumigatus to colonise tissue is achieved through the action of gliotoxin 
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(Reeves et al., 2006). The release of immunosuppressive agents from A. fumigatus 
following exposure to caspofungin could indicate a general increase in cell permeability 
thus suggesting the need for the cell to counteract the elevated permeability of the cell. The 
results presented in this work indicate that caspofungin is capable of inhibiting the growth 
of A. fumigatus but that cultures exposed to this drug for short (4 hours) or long (96 hours) 
periods demonstrated increased secretion of gliotoxin and elevated levels of internal 
biosynthesis. Gliotoxin is a potent suppressor of the local and systemic immune response 
and increased production by caspofungin-treated cultures could have a negative effect on 
the immune response of the patient.  
Exposure of A. fumigatus to caspofungin leads to enhanced internal and external 
gliotoxin concentrations up to 48 h after the beginning of the exposure period as shown in 
Figure 4.23A and 4.23B. Interestingly exposure of growing cultures of A. fumigatus to 
caspofungin results in reduced biomass but the production of gliotoxin is comparable to 
that in control cultures (Figure 4.22A and 4.22B). While gliotoxin has well established 
cytotoxic properties (Kwon-Chung and Sugui 2009), its primary function may be to act as 
an antioxidant within the fungal cell and so protect it from the effects of exogenous and 
endogenous oxidants (Schrettl et al., 2010). The activation of the Cap and Hog pathways 
occurs in C. albicans when exposed to caspofungin indicating the drug induces oxidative 
and osmotic stress within the cells (Kelly et al., 2009). The increased level of gliotoxin 
within A. fumigatus following exposure to caspofungin as evident by this study may be an 
attempt by the cell to restore the redox balance disrupted by exposure to caspofungin, or by 
the loss of toxin from within the cell. While gliotoxin may represent a means by which A. 
fumigatus regulates its environment, the net effect of increased biosynthesis and release 
following exposure to caspofungin is the possibility of enhanced tissue damage and 
inflammation at the site of infection. Previous work established that exposure of growth 
arrested stationary phase C. albicans cells to caspofungin induced the release of amino 
acids and a variety of intracellular peptides (Kelly and Kavanagh, 2010). Caspofungin 
inhibits glucan biosynthesis, which results in disruption of fungal cell wall synthesis and 
ultimately cell lysis when high concentrations are employed (Deresinski and Stevins 
2003). In the results presented here, and in those of the earlier work (Kelly and Kavanagh 
2010), stationary phase cultures of A. fumigatus or C. albicans were exposed to 
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caspofungin so de novo wall formation would not have been significant. Consequently, it is 
possible that in addition to inhibiting glucan biosynthesis, caspofungin may have a 
secondary effect on membrane permeability and thus facilitate the leakage of amino acids, 
protein and toxins from fungal cells. Depletion of the intracellular gliotoxin concentration 
may stimulate increased biosynthesis of the toxin to replenish the lost gliotoxin in order to 
restore the redox balance within the cell (Schrettl et al., 2010). This phenomenon of 
caspofungin-induced gliotoxin leakage and de novo biosynthesis has the potential to 
contribute to elevated levels of pulmonary damage and immunosuppression (Tsunawaki et 
al., 2004). It is possible that administration of caspofungin to patients may lead to eventual 
fungal cell death but that before this is achieved internal gliotoxin would be released from 
cells and the cells could have the opportunity to commence synthesizing more toxins to 
replenish that which is lost into surrounding tissue. Previous work that examined the 
response of C. albicans to amphotericin B illustrated the ability of cells to recover from 
antifungal therapy even though they appeared incapable of replicating in culture thus 
highlighting the possibility of continued cell survival in the presence of fungicidal 
concentrations of drug (Liao et al., 1999). This finding illustrates the possibility of 
continued gliotoxin biosynthesis in the presence of caspofungin concentrations that would 
inhibit fungal cell growth.  
Analysis of the changes in the release of proteins following exposure of A. 
fumigatus to 0.1 µg/ml caspofungin indicated the increased abundance of a number of 
proteins. It was of interest to investigate if larger molecules could escape through this 
altered membrane and protein leakage was assessed via one-dimensional and two-
dimensional electrophoresis. It was determined that caspofungin caused the escape of both 
large and small proteins from A. fumigatus. Five and twelve proteins were positively 
identified from one-dimensional and two-dimensional gels respectively and the leakage of 
all of these was increased upon exposure to low and high doses of caspofungin. Proteins 
come from different locations within the cell some of proteins originated from the cytosol 
as triosephosphate isomerase, allergen Asp F3 6-phosphogluconolactonase and aldehyde 
dehydrogenase, mitochondrial protein e.g mitochondrial peroxiredoxin Prx1 and 
ATPB_NEUCR ATP synthase beta chain, mitochondrial precursor. Cell wall protein such 
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as endochitosanase and nuclear proteins such as molecular chaperone allergen mod-
E/Hsp90/Hsp1were leaked.  
Ergosterol is the principle sterol in fungi, which is similar to cholesterol in 
mammalian membrane but with significant difference in structure (Parks and Casey, 1995). 
Ergosterol plays a part in membrane integrity and permeability (Abu-Salah 1996). In 
contrast to the control, exposure of hyphae to caspofungin resulted in an increase in 
ergosterol content. Any change in membrane structure or function of the membrane may 
result in the loss of selective permeability of the membrane (Ghosh and Ghosh, 1963). 
Altered cell membrane may lead to leaking of intracellular content includes the large 
molecules which escaped through these pores. 
This Chapter demonstrates that caspofungin exposure increase the release of amino 
acids, proteins and gliotoxin. Biosynthesis of gliotoxin was also enhanced and increased 
production. Caspofungin causes an increase in ergosterol biosynthesis. Protein leakage was 
increased due to the effect of caspofungin and leaked proteins came from different 
locations within the cell. 
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Chapter 5 
5 ANALYSIS OF THE PROTEOMIC 
RESPONSE OF ASPERGILLUS FUMIGATUS 
TO CASPOFUNGIN 
 
5.1 Introduction 
Caspofungin is a member of the newest class of antifungal drugs and inhibits the 
biosynthesis of ß-1,3,-D-glucan, which is the principal cell wall component (Kahn et 
al.,2006). Caspofungin shows a high level of efficacy against A. fumigatus (Pfaller et al., 
2009) and there are limited reports of clinical resistance (Perlin, 2009). Exposure to sub-
inhibitory concentrations of caspofungin also leads to the unmasking of ß-glucan in the cell 
wall of C. albicans (Wheeler et al., 2006, 2008) which may provoke an enhanced immune 
response and possibly lead to increased cell-mediated killing of the fungus in the body. 
Analysis of the proteomic changes that occur in A. fumigatus following exposure to 
caspofungin revealed decreased expression of proteins associated with the mitochondrial 
hypoxia response (Cagas et al., 2011).  In addition decreased expression of Asp F1 was 
also observed.  While echinocandins are effective antifungal agents (Walsh et al., 2004), 
they also demonstrate negligible toxicity to humans (Denning, 2003).  
The aim of the work presented in this Chapter was to analyse the response of A. 
fumigatus hyphae to caspofungin in order to determine whether the fungus could mount a 
protective response against the effects of this antifungal agent. The proteomic response of 
A. fumigatus to caspofungin was evaluated by LC-MS. The fold change in relative 
abundance of selected proteins following exposure to caspofungin at sub MIC (1.0 µg/ml) 
was determined. 
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5.2 Examination of the effect of caspofungin on the protein 
profile of A. fumigatus 
5.2.1 One-dimensional SDS-PAGE protein profile of A. fumigatus exposed to 
caspofungin 
A. fumigatus cultures (96 hour old) were exposed to various concentrations of 
caspofungin for 4 hours and whole cell protein was extracted as described in section 2.22. 
This was resolved by one dimensional gel electrophoresis as in section 2.25.1 and stained 
with coomassie blue stain. The protein profile of A. fumigatus is illustrated in Figure 5.1. It 
is evident from this gel that caspofungin treatment of cells caused some differences in the 
A. fumigatus protein profile. For example proteins between the molecular weight 90 and 50 
KDa appeared to be up-regulated and appeared to be increased in intensity upon treatment 
with (0.1 and 1.0 µg/ml) caspofungin. Table 5.1 shows proteins altered in expression in A. 
fumigatus treated with caspofungin. Band 3, identified as fructose-bisphosphate aldolase 
showed a 2.9 fold increase at 1.0 µg/ml caspofungin. Alcohol dehydrogenase (band 4) was 
up-regulated by 3.7 fold at 1.0 µg/ml caspofungin and 2.8 fold at 0.1 µg/ml. Both fructose-
bisphosphate aldolase and alcohol dehydrogenase are cell wall proteins (Pitarch et al., 
2002) characterised as highly immunogenic in nature and the elevated release of these 
immunogenic proteins could lead to a stronger immune response and possibly inflamation 
during infections (Swoboda et al., 1993; Kelly and Kavanagh, 2010). Prevous studies have 
demonstrated fructose-biphosphate aldolase to be immunogenic (Pitarch et al., 2004). The 
intensity of protein in band 5 (Mn superoxide dismutase) was increased by 2.1 fold at the 
same concentration of caspofungin. Superoxide anions and peroxides play a direct role in 
killing of A. fumigatus in an immunocompromised host and proteins including stress 
response proteins such as Mn-superoxide dismutase were increased in expression when 
Aspergillus hyphae were exposed to caspofungin (Cagas et al., 2011). 
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Figure 5.1 One-dimensional protein analysis of caspofungin treated A. fumigatus.  
(Hyphae of 96 hour old culture were used), DMSO is positive control, and caspofungin 
concentration of 0.1 and 1.0 µg/ml were used. PM protein marker, L1 Control, L2 DMSO, 
L3 0.1 µg/ml Caspofungin, L4 1.0 µg/ml caspofungin 
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5.2.2 Effect of Caspofungin on the proteome of A. fumigatus as assessed by two-
dimensional SDS-PAGE analysis 
Following the observation of changes to the 1-D protein profile of caspofungin 
treated hyphae, it was decide to investigate these changes by 2-D analysis. Cultures 
were grown for 96 hours at 37 oC, hyphae were harvested and washed with PBS as 
described. Hyphae (1.5g) were exposed to caspofungin (0.1 or 1.0 µg/ml) for 4 hours.  
Hyphae were harvested, washed with PBS and ground to a fine powder using a pestle 
and mortar by temporary freezing in liquid nitrogen. Protein extraction buffer was 
added. Proteins were separated by pH at range from 3 to 10 then by molecular weight 
as described in section 2.25 and the acrylamide gels were stained with coomassie blue. 
Figure 5.2 and 5.3 demonstrate 2-D protein profile of A. fumigatus with and without 
exposure to caspofungin. It was evident that the expression of protein was changed 
between control and caspofungin treated samples, some proteins were up-regulated 
when sample were treated with drug and some were down-regulated. Progenesis 
analysis was performed on a selection of spots in order to ascertain the fold change 
Proteins showing alteration in intensity were excised and identified by LC/MS. A 
wide range of proteins demonstrated altered expression following exposure of A. 
fumigatus to caspofungin (Table 5.2). Strong identities were recorded for nineteen 
proteins. A range of proteins showed homology to proteins involved in stress responses 
e.g. spot B18 (catalase) was up-regulated by 1.3 and 1.4 fold at 0.1 and 1.0 µg/ml 
caspofungin respectively. Spot B2 (CipC-like antibiotic response protein), was up-
regulated by 4.7 fold at 0.1 µg/ml caspofungin. CipC-like antibiotic response protein is 
located in cytoplasm and involved as a virulence factor in some fungal strains, and 
increased release of immunogenic proteins may lead to stronger immune response (Cobos 
et al., 2010; Kelly and Kavanagh, 2010). Spot B15 (Aspartic endopeptidase Pep2) was 
down-regulated by 0.8 fold at both caspofungin concentrations.  Aspartic endopeptidase 
pep2 is an aspartic proteinases which are a group of proteolytic enzymes. Aspartic acid 
proteases depend on aspartic acid residues for their catalytic activity, but on the conidial 
surface may play an important role in the processing of allergens causing fungal 
infections such as aspergillosis (Jehangir and Ahmed, 2013). Spot B16 (Vacuolar 
protease A) was decreased by 0.8 and 0.9 at 0.1 and 1.0  µg/ml caspofungin respectively, 
and showed homology to proteins associated with the virulence of A. fumigatus. Spot 
B19 (molecular chaperone Hsp70), was up-regulated by 2 fold at 0.1 µg/ml caspofungin 
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and spot B12 (thioredoxin reductase) showed 1.2 fold increase at both concentrations. 
Both showed homology to proteins involved in stress responses. Elevated expression of 
these proteins display antigenic properties of A. fumigatus (Diaz-Arevalo et al., 2012; 
Carberry et al., 2012).  
A number of spots showed homology to proteins associated with the virulence of 
A. fumigatus (e.g. spot B1 (18kDa antigen), spot B3 (allergen Asp F3)), and with cell 
homeostasis (e.g. spot B7 (glyceraldehyde 3-phosphate), spot B9 (translation elongation 
factor), and spot B17 (ATP synthase F1). Protein spot B1 (18 kDa antigen) and spot B3 
(allergen Asp F3) which are associated with virulence were also increased in abundance.  
Cagas et al., (2011) noted an increase in the secretion of Asp F3 (3.5 fold) from 
susceptible A. fumigatus strains exposed to caspofungin. This allergen is a thioredoxin 
peroxidase and is increased in expression in cells experiencing oxidative stress as a result 
of exposure to hydrogen peroxide (Lessing et al., 2007; Cagas et al., 2011). The 
increased expression of a variety of proteins involved in the oxidative stress response e.g. 
catalase (spot B18), antibiotic response protein (spot B2), virulence e.g. Asp F3 (spot 
B3), 18kDa antigen (spot B1) and homeostasis e.g. glyceraldehyde 3-phosphate (spot 
B7), translation elongation factor (spot B9), ATP synthase F1 (spot B17). 
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Figure 5.2 Identified spots chosen for fold change analysis from
 tw
o-dim
ensional gels from
 A. fum
igatus.  
Spots w
ere analysed and the fold changes w
ere calculated using Progenesis Sam
eSpots TM. 
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5.2.3 Summary 
The results presented here indicate that when A. fumigatus is exposed to 
caspofungin there is increased expression of a number of proteins associated with 
virulence (e.g. 18kDa antigen and allergen Asp F3) and the oxidative stress response 
(e.g catalase, superoxide dismutase).  
 
5.3 Investigation into the effect of caspofungin on the activity 
of enzymes involved with the oxidative stress response 
In this section the effect of exposure to caspofungin on the activity of a range of 
detoxifying enzymes of A. fumigatus was examined. A. fumigatus hyphae (96 hr 
culture, 1 g) were exposed to caspofungin (0.1 µg/ml) for 15, 30 or 60 minutes or to 
hydrogen peroxide (0.5 mM) as described in section 2.28. At each time point hyphae 
were harvested, washed in PBS and resuspended in 8 ml of lysing buffer as described 
previously. Supernatant was used for evaluation of enzymatic activity.  
5.3.1 Analysis of Catalase activity in caspofungin treated A. fumigatus cultures 
Microbiological resistance to antifungal polyenes may be associated with 
phenotypic switching, such as increased catalase activity with decreased susceptibility 
to oxidative damage (Chamilos et al., 2007; Paris et al., 2003). Catalase activity was 
measured as described (Larsen & White, 1995) with slight modifications as detailed 
previously (Section 2.28.3). Exposure of A. fumigatus to 0.1 µg/ml caspofungin for 30 
minutes induced a six-fold increase in catalase activity while exposure to the drug for 
60 minutes induced a seven-fold increase in activity (Figure 5.3).  Exposure of hyphae 
to hydrogen peroxide for 15 minutes resulted in a four-fold increase in catalase activity. 
Catalase demonstrates anti-oxidant properties and is essential in maintaining the redox 
balance of the cell.  
5.3.2 Detection of glutathione reductase (GLR) activity in caspofungin treated A. 
fumigatus cultures 
Glutathione reductase (GLR) activity was measured in caspofungin and hydrogen 
peroxide treated A. fumigatus as described in section 2.28.2. Exposure of A. fumigatus 
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to 0.1µg/ml caspofungin for 15 – 60 minutes resulted in a two fold increase in GLR 
activity (p < 0.02).  GLR is essential for the recycling of oxidized glutathione to its 
reduced form and plays a key role in detoxifying the cell. The results (Figure 5.4) 
demonstrate the elevated activity of GLR following treatment with the drug at all 
timepoints used in comparison to the control sample.  Results show a significant 
increased in GLR activity occurred especially after 30 minutes, increasing from a value 
of 3.15E-05 units/ml (± 3.3) in the control to 7.21E-05 units/ml (±3.1) units/ml in 
caspofungin treated cells. Hydrogen peroxide was found to be a strong inducer of GLR 
activity with levels rising to 7.35E-05 (± 3.6) units/ml after 30 minutes. 
 
5.3.3 Detection of superoxide dismutase (SOD) activity in caspofungin treated A. 
fumigatus cultures 
SOD is an anti-oxidant enzyme that catalyses the dismutation of superoxide 
radicals into dioxygen and hydrogen peroxide. The transcription of many genes 
including SOD1 and SOD5 were involved in detoxification of oxidative species, were 
up-regulated in the presence of human neutrophils (Fradin et al., 2005). Superoxide 
dismutase (SOD) activity was measured using a SOD Assay Kit (Fluka Biochemika) in 
accordance with the manufacturer’s instructions, using a concentration of 1.0 µg/µl of 
protein extract as described (Foster & Hess, 1980). Exposure of A. fumigatus to 
caspofungin lead to elevated activity of SOD at all timepoints compared to the control. 
SOD activity was increased significantly (p = 0.05) when A. fumigatus was exposed to 
hydrogen peroxide. SOD activity was increased by approximately two fold following 
exposure of A. fumigatus to caspofungin for 15 – 60 minutes. The highest value was 
recorded after 30 minutes with activity rising from 42.0 (± 2.1) % in the control to 84 
(± 3.2) % in drug treated cells (Figure 5.5). Hydrogen peroxide treated cells elevated 
the SOD activity to 86 (± 5.2) % compared to control. 
 
 
 
 
 
 
174 
 
 
 
 
 
 
Figure: 5.3 Catalase activity in caspofungin treated A. fumigatus hyphae compared to 
control. Hydrogen peroxide is the positive control. 
Hyphae were exposed to 0.5 mM hydrogen peroxide for 15 minutes or 1.0 µg/ml 
caspofungin for 15, 30 or 60 minutes. Indicates a p value = 0.05 
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Figure 5.4 Glutathione reductase activity in caspofungin treated A. fumigatus. 
Hydrogen peroxide is the positive control. 
Hyphae were exposed to 0.5 mM hydrogen peroxide for 15 minutes or 1.0 µg/ml 
caspofungin for 15, 30 or 60 minutes. Indicates a (p < 0.02) 
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Figure 5.5 Superoxide dismutase activity in caspofungin treated A. fumigatus 
Hyphae were exposed to 0.5 mM hydrogen peroxide for 15 minutes or 1.0 µg/ml 
caspofungin for 15, 30 or 60 minutes. Indicates a p value = 0.05 
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5.4 Discussion 
Caspofungin is widely used in the treatment of systemic fungal infections and 
has the advantage of being highly effective but of negligible toxicity to humans 
(Denning, 2003).  The aim of the work presented here was to establish how A. 
fumigatus responded to caspofungin and to determine whether the fungus mounted a 
response aimed at minimizing the effect(s) of the drug. Previous work established that 
exposure of C. albicans to caspofungin lead to the induction of oxidative and osmotic 
stress responses as evidenced by the activation of the Cap and Hog pathways (Kelly et 
al., 2009). 
The release of protein from A. fumigatus following exposure to caspofungin 
(section 4.3.2) could indicate a general increase in cell permeability thus suggesting the 
need for the cell to counteract the elevated permeability of the cell. Analysis of the 
changes in the expression of proteins following exposure of A. fumigatus to 0.1 µg/ml 
caspofungin   indicated the increased expression of a number of proteins associated 
with the oxidative stress response including spot B18 (catalase), spot B19 (Hsp70), and 
spot 12 (thioredoxin reductase).  Protein spot B1 (18 kDa antigen) and spot B3 
(allergen Asp F3) which are associated with virulence were also increased in 
abundance.  Cagas el al., (2011) noted an increase in the secretion of Asp F3 (3.5 fold) 
from susceptible A. fumigatus strains exposed to caspofungin.  This allergen is a 
thioredoxin peroxidase and is increased in expression in cells experiencing oxidative 
stress as a result of exposure to hydrogen peroxide (Lessing et al., 2007).  Exposure of 
A. fumigatus to caspofungin resulted in the elevated activity of catalase, glutathione 
reductase and superoxide dismutase, which are associated with the oxidative stress 
response. Increased activity of these enzymes has also been observed in C. albicans 
exposed to caspofungin or hydrogen peroxide (Kelly et al., 2009).  
While caspofungin is a highly effective antifungal agent and has proven clinical 
efficacy, the response of fungal cells to it may not be fully determined.  The primary 
action of caspofungin lies in the inhibition of glucan synthase and the consequent 
disruption of cell wall formation in fungi. However it has been established that 
exposure of  C. albicans to this agent leads  to increased chitin content (Walker et al., 
2008) and the induction of a number of genes associated with the PKC pathway in C. 
albicans leading to alterations in cell wall  architecture (Munro et al., 2007). In 
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addition, caspofungin has been shown to unmask glucan in the cell wall and thus may 
lead to a potentially elevated immune response (Wheeler et al., 2008). 
The results presented here indicate that exposure of A. fumigatus to caspofungin 
leads to the induction of an oxidative stress response as indicated by the increased 
expression and activity of a number of stress–response proteins and enzymes. Previous 
work demonstrated the enhanced leakage and de novo biosynthesis of gliotoxin from 
caspofungin-treated A. fumigatus (Chapter 4). Elevated production of this toxin by A. 
fumigatus following its amphotericin B- or caspofungin-mediated  release (Reeves et 
al., 2004; chapter 4) may be associated with restoring the redox balance within the 
fungus (Schrettl et al., 2010). Cagas et al., (2011) have demonstrated altered expression 
of a range of proteins in A. fumigatus following exposure to caspofungin. The work 
presented here demonstrates the increased expression of a number of protein associated 
with the oxidative response and the elevated activity of enzymes associated with this 
response.  
While the primary mode of action of caspofungin is the inhibition of glucan 
biosynthesis (Denning, 2003) this work and that of others (Walker et al., 2008; 
Wheeler et al., 2008; Stevens et al., 2006; Kelly et al., 2009; Cagas et al., 2011) 
demonstrate other effects including the stimulation of chitin synthesis and the induction 
of an oxidative stress response as the fungal cell attempts to counteract the direct and 
indirect effects of the antifungal.  
 
 
 
 
 
 
 
 
 
179 
 
Chapter 6 
 
6 GENERAL DISCUSION 
 
Aspergillus is the second most common pathogenic fungus after Candida and is 
responsible for up to 30 % of all fungal infections in cancer patients. However A. 
fumigatus and other species have emerged as important causes of morbidity and 
mortality in immunocompromised individuals (Fluckiger et al., 2006). A. fumigatus is 
recognised as an important cause of life-threatening fungal infections in the 
immunocompromised population. This expanding population is composed of patients 
with prolonged neutropenia, HIV infection, and patients who have undergone 
hematopoietic stem cell transplantation (HSCT) and/or lung transplantation (Walsh et 
al., 2004). The major forms of aspergillosis are invasive aspergillosis, aspergilloma, 
and allergic forms of aspergillosis (ABPA). Invasive aspergillosis currently constitutes 
the most common cause of mortality in pneumonia patients and is an important cause 
of opportunistic respiratory and disseminated infection in other immunocompromised 
populations (Dagenais and Keller, 2009). Furthermore, Aspergillus species also 
produce a wide range of chronic, saprophytic, and allergic conditions. Invasive 
aspergillosis (IA) is one of the most difficult infections to treat, with high mortality 
rates approaching 90% in the most severely immunocompromised patients.  
Antifungal therapy remains the mainstay of treatment for invasive aspergillosis. 
The main groups of drugs used to treat aspergillosis are azoles, (voriconazole, 
itraconazole, posaconazole), polyene (amphotericin B) and echinocandins, 
(caspofungin, micafungin). Caspofungin is recommended for use in patients with 
invasive aspergillosis that is refractory to or intolerant of azole and polyene drugs.  
The nephrotoxicity is the main side effect of polyene antifungal drugs. 
Amphotericin B have been documented and the demonstrated rates of renal failure as 
high as 30% in patients. The use of itraconazole, voriconazole and posaconazole has 
been evaluated with voriconazole proving to be the recommended therapy for most 
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immunocompromised patients to reduce the nephrotoxicity side effect and increase 
efficacy of drug (Steinbach and Stevens, 2003). The use of the echinocandin drugs 
caspofungin, micafungin, and anidulafungin has also been demonstrated in combination 
therapy with azole antifungals. The echinocandins are effective at inhibiting hyphal 
growth and have limited toxicity thus highlighting their utility in antifungal treatment 
(Sable et al., 2008). Caspofungin is an echinocandin antifungal compound, first 
licensed for use by FDA in the United States in 2001 (Kartsonis et al., 2003). 
Caspofungin is indicated for the treatment of invasive aspergillosis in patients who are 
intolerant of amphotericin B, lipid formulations of amphotericin B and/or azoles. It is 
the first representative of glucan synthesis inhibitors, a new class of antifungal agents 
that inhibit the synthesis of beta (1,3)-D-glucan, an integral polymer part of the fungal 
cell wall. Caspofungin is a sterile powder of lyophilised product for intravenous 
infusion that contains 70 mg caspofungin; the recommended dose is 70 mg as a single 
loading dose on Day 1, followed by 50 mg daily thereafter.  
This study looked at the antifungal activity of caspofungin on A. fumigatus. It is 
difficult to determine the actual MIC for caspofungin as the paradoxical effect of 
caspofungin recorded when caspofungin was used at concentrations above MIC on the 
growth of C. albicans (Stevens et al., 2004). This phenomenon has been clearly 
observed in this study especially when using different types of culture media for 
susceptibility testing. The reasons for this effect are still unclear. This effect has been 
observed elsewhere, where high growth was recorded after caspofungin treatment 
(Kyselgof et al., 2007). This phenomenon may indicate that caspofungin may not kill 
the cells, but prevent them from actively dividing. Morphological alterations of hyphae 
were observed using electron microscopy after exposure to caspofungin (Section 4.6 / 
Figure 4.29). The unique mechanism of action of the echinocandins results in a lack of 
cross-resistance with azoles and polyenes and the spectrum of activity includes 
Aspergillus and Candida species. Development of resistance to caspofungin is a rare 
event. In recent years the over-use of antifungal drugs induced the emergence of azole 
resistance as a result of mutations in the cyp51A gene however it is now believed that 
some other genes may be responsible for the resistance (Verweij et al., 2009). It was 
reported that reduced susceptibility of clinical and laboratory C. albicans strains to 
caspofungin is linked with mutations in FKS1 at codon 645 in which serine is replaced 
by proline, tyrosine, or phenylalanine (Balashov et al., 2005). It have been 
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demonstrated that caspofungin resistance can occur at a high frequency following 
mutation in the FKS1 gene of C. albicans and most prominently to alterations of serine 
645 of Fks1p (Sergey et al., 2006). Previous studies indicate that neither target site 
mutations, nor changes in target gene expression are present in A. fumigatus. Instead, 
other groups found that results indicate that the molecular mechanism underlying 
reduced susceptibility to caspofungin in the A. fumigatus strains is novel, possibly due 
to remodelling of the cell wall components (Gardiner et al., 2005). 
The advantages of caspofungin versus fluconazole include the expanded 
spectrum of activity against Candida and Aspergillus, and their decreased potential for 
drug interactions. Potential disadvantages include their higher cost, lack of oral 
formulations and lack of activity against some emerging pathogens such as 
Scedosporium, Fusarium, and zygomyces (Gregory et al., 2007).  
Previous work demonstrated that non-growing C. albicans cells are susceptible 
to the effect of caspofungin and it mediated the release of proteins which could lead to 
a stronger immune response in vivo (Kelly and Kavanagh, 2010).  In addition to 
hampering cell wall synthesis, caspofungin may also interfere with the permeability of 
the fungal cell wall (Kelly and Kavanagh, 2010). Analysis of the proteomic changes 
that occur in A. fumigatus following exposure to caspofungin revealed decreased 
expression of proteins associated with the mitochondrial hypoxia response (Cagas et 
al., 2011).  In addition decreased expression of Asp F1 was also observed.    
The experiments described in Chapter three investigated the effect of 
environmental factors (e.g. pH, glucose, protein and serum concentration) on the 
growth and susceptibility to caspofungin of A. fumigatus and C. albicans. As 
caspofungin interferes with cell wall synthesis it was postulated that only actively 
growing cells would be susceptible to drug treatment. However previous work 
established that caspofungin was effective against growth arrested cells of C. albicans 
despite the reduction in the activity of β 1,3 glucan synthase (Kelly & Kavanagh, 
2009). It is clear from this study that environmental factors affect the antifungal activity 
of caspofungin and the response of the fungi to this drug. The results presented here 
can lead to another conclusion that the in vitro result may translate in vivo and may be 
of clinical relevance. Caspofungin may not be as effective as other antifungal agents in 
the treatment of vulvovaginal candidiasis (VVD), in women where the pH is within 
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range of 4 to 5 (Fidel & Sobel, 1996). Another condition is commonly associated with 
elevated fungal infection is diabetes mellitus which is associated with higher blood 
glucose level (Belazi et al., 2005). Caspofungin may also display a reduction in activity 
in acidic environment such as the stomach in cases of Candida infection. Change in the 
protein profile within different environmental conditions give further understanding of 
the effect of protein on the increased tolerance of C. albicans and A. fumigatus to 
caspofungin.  
Mycotoxins production has been identified as a key factor in the modulation of 
the host immune response during pathogenic fungal infection. A. fumigatus has been 
demonstrated to produce a range of secondary metabolites including mycotoxins with 
different harmful effects. These include gliotoxin, fumagillin, helvolic acid, 
fumitremorgin, fumigaclavine C, aureperone C, restrictocin (Dagenais and Keller, 
2009). A. fumigatus produces a variety of secondary metabolites and enzymes which 
are associated with growth and persistence within pulmonary tissue (Bennet and Klich, 
2003; Ben-Ami et al., 2010). As a result of this an analysis of the production of 
gliotoxin within caspofungin-treated hyphae was necessary to facilitate an improved 
understanding of A. fumigatus pathogenesis in vivo.  It has been demonstrated that 
gliotoxin was produced in significant quantities in vitro and reached peak production 
after exposure to Amphotericin B (Reeves et al., 2004). It was previously established 
that exposure of growth arrested stationary phase C. albicans cells to caspofungin 
induced the release of amino acids and a variety of intracellular peptides (Kelly and 
Kavanagh, 2010). In the results presented in Chapter four stationary phase cultures of 
A. fumigatus were exposed to caspofungin so de novo wall formation would not have 
been a significant occurrence. Caspofungin induced leakage of gliotoxin and the fungus 
responded to this by synthesizing elevated levels of toxin intra-cellularly. Caspofungin 
caused an increased release of gliotoxin. The immunosuppressive effects of gliotoxin 
are well established (Tsunawaki et al., 2004) and any therapy that inadvertently 
induced the increased biosynthesis and release of this toxin could exacerbate 
inflammation and tissue damage at the site of infection. Caspofungin also increased the 
biosynthesis of ergosterol, this mechanism may protect the cell when the cell wall is 
targeted with drugs (section 4.5.1). Consequently, it is possible that in addition to 
inhibiting glucan biosynthesis, caspofungin may have a secondary effect on membrane 
permeability and thus facilitate the leakage of amino acids, protein and toxins from 
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fungal cells. Depletion of the intracellular gliotoxin may stimulate increased 
biosynthesis of the toxin to replenish the lost gliotoxin in order to restore the redox 
balance within the cell (Schrettl et al., 2010). This phenomenon of caspofungin-
induced gliotoxin leakage and biosynthesis has the potential to contribute to elevated 
levels of pulmonary damage and immunosuppression (KwonChung and Sugui, 2009; 
Tsunawaki et al., 2004). It is possible that administration of caspofungin to patients 
may lead to eventual fungal cell death but that before this is achieved, internal gliotoxin 
would be released from cells and the cells could have the opportunity to commence 
synthesizing more gliotoxin to replenish that was lost into surrounding tissue. Previous 
work that examined the response of C. albicans to amphotericin B illustrated the ability 
of cells to recover from antifungal therapy even though they appeared incapable of 
replicating in culture (Liao et al., 1999). 
The results presented in Chapter five indicate that exposure of A. fumigatus to 
caspofungin leads to the induction of an oxidative stress response as indicated by the 
increased abundance and activity of a number of stress response proteins and enzymes. 
In addition, caspofungin has been shown to unmask glucan in the cell wall and thus 
may lead to a potentially elevated immune response (Wheeler et al., 2008). Exposure of 
A. fumigatus to caspofungin resulted in the elevated activity of catalase, glutathione 
reductase and superoxide dismutase which are associated with the oxidative stress 
response. Increased activity of these enzymes has also been observed in C. albicans 
exposed to caspofungin or hydrogen peroxide (Kelly et al., 2009).  
It can be concluded from this work that caspofungin results in the activation of 
an oxidative stress response in A. fumigatus. As shown in a previous study (Kelly and 
Kavanagh, 2010), caspofungin caused leakage of intracellular component from C. 
albicans and increased in ergosterol level of the membrane (Chapter 4, Figure 4.26 ) it 
may lead to changes in the membrane permeability or cell wall organization, which 
possibly results in the oxidative stress within the cell. Interestingly, another conclusion 
that can be made is that caspofungin resulted in the leakage of proteins from different 
locations within the cell including cell wall, cytoplasm and mitochondria. 
C. albicans and A. fumigatus were capable of growing in the diverse range of 
culture conditions but the environmental factors affect the antifungal activity of 
caspofungin or the response of the cells to this drug. The data presented in this study 
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show that in vitro results may translate to in vivo and may lead to a significant clinical 
relevance for some diseases e.g diabetes, vulvovaginal candidiasis and hyper acidosis. 
As caspofungin interferes with cell wall synthesis, it is not surprising to see escape of 
proteins from a range of location within the cell and caspofungin also alter the protein 
profile of cells. This suggests that cell may attempt to protect itself by altering various 
biosynthetic pathways. 
The results presented in this study indicate that environmental factors play a 
significant role in altering the susceptibility of A. fumigatus and C. albicans to 
caspofungin.  Future work might examine whether patients displaying high blood 
glucose levels (e.g. diabetes mellitus) display altered susceptibility to caspofungin as a 
result of altered fungal metabolism.  In particular, due to the development of cross-
resistance, the various modes of action of caspofungin may be used as combination 
therapy with polyenes or azoles and could lead to a synergistic effect. Future work 
might also examine the mechanism of caspofungin-induced in vivo leakage of gliotoxin 
from A. fumigatus.   
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